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During the phenotypic and genotypic changes which occur during the 
processes respectively known as C modulation and phase degradation, 
several virulence-associated properties of Bordetella pertussis and 
adenylate cyclase (AC) are lost (Parton and Durham, 1978; Wardlaw and 
Parton, 1979)* The main aim of the present investigation- was to 
assess whether AC plays a causal role in these two distinct processes 
as this enzyme is known to play a key regulatory role in the 
Enterobacteriaceae*
Growth of B. pertussis in Stainer and Scholte medium (SS-X) containing 
high levels of MgSO^, Na^SO^, Na butyrate, Na caprylate, Na succinate 
or nicotinic acid resulted in C modulation as shown by marked reductions 
in AC activity, histamine-sensitizing activity (HSA) and the 28k and 30k 
cell-envelope polypeptides (X polypeptides)• Although there was some 
variation between the susceptibility of strains to pro-C-mode salts, 
there was no instance of components being lost independently of each 
other. The level of cAMP in the supernate of C-mode cultures was less 
than of that of X-mode cultures. Magnesium chloride, present at 
four times the molar concentration of MgSO^ required to induce C modulation, 
was ineffective at inducing loss of AC activity,HSA, or the X polypeptides. 
During MgSD^-induced modulation, AC activity in three compartments 
(viz. culture supernate, cell-associated but extracytoplasmic, and 
cytoplasmic) was reduced to the same extent.
Time-course studies on the rate of loss of AC activity, HSA, and 
the X-polypeptides during MgSO^-induced modulation indicated that 
these properties were lost simultaneously. Furthermore, losses 
could be accounted for by complete repression of the synthesis of 
the components when cells were introduced into C-medium.
The low levels of cAMP in the supernate of C-mode cultures 
could not be accounted for by the ability of pro-C-mode salts to 
inhibit iui vitro AC activity, or by inhibition of cAMP excretion by
IB
C medium.
Loss of AC activity during C modulation required growth and was 
not due to prolonged exposure to C medium, as chloramphenicol added to 
C medium prevented loss of AC activity. Loss of HSA and the X polypeptides 
also required growth or protein synthesis. C-mode cell lysate did not 
inhibit AC activity of X-mode cell lysate suggesting that loss of AC 
activity during C modulation is not due to production of an inactivating 
or inhibitory factor. Similarly, C-mode cell lysate did not destroy 
HSA present in X-mode cell lysate.,
Sodium fluoride caused marked inhibition of vitro AC activity, 
but, at the same concentration, had little effect on the synthesis of 
cAMP during growth. Growth in X medium containing B. pertussis AC 
activator (calmodulin) resulted in a four fold-increase in culture 
supernate cAMP levels. The critical concentration of MgSO^ required 
to induce loss of the X polypeptides was 10 - 11 mM. In one culture, 
containing 10 mM MgSO^ and AC activator, partial loss of the X polypeptides 
occurred yet cAMP levels in the supernate were twice that which normally 
occurred in X-mode cultures without activator.
Respiration rates of amino acids by B. pertussis variants was investigatec 
to determine whether cAMP played a role in amino acid catabolism in 
the organism. The ability of washed suspensions of X- and C-mode and 
phase IV B. pertussis to respire L-glutamate, L-aspartate, L-proline,
L-alanine and L-serine was demonstrated. While differences were found 
between the respiration rates of different amino acids, there were no
significant differences between the ability of variants of B. pertussis
to respire any particular amino acid.
Phosphonomycin resistance has been used as a convenient method 
to isolate AC mutants of Escherichia coli. However, eight independently 
isolated phosphonomycin resistant mutants of B. pertussis possessed the 
same AC activity as the original strain.
Exogenous cAMP and dibutyryl cAMP, in X and C media, had no effect
on the production of AC, the X polypeptides or haemagglutinin.
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Attempts were made to determine if a cyclic AMP-receptor protein 
(CRP) analogous to that in E. coli exists in B. pertussis. [^h ] c AMP 
binding activity was demonstrated in several strains of B. pertussis 
and was about half that obtained for E. coli. Anti-E. coli CRP gave 
two precipitin lines with E. coli cell extract but none with B. pertussis 
cell extract.
In conclusion, the results of this study suggest that AC does not 
play a causal role in modulation, and that the mechanism responsible 
for repressing synthesis of X-mode specific components (such as pertussigen) 
during modulation, also represses synthesis of AC.
INTRODUCTION
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PART 1; BÜRDETELLA PERTUSSIS
1. Pertussis; General Background
Whooping cough (pertussis) is a highly communicable, non-invasive 
infection of the upper respiratory tract which most commonly affects 
young infants. The disease is characterised by extremely distressing 
coughing, lymphocytosis, hypoglycaemia and neurological disorders 
(Pittman, 1970).
Bordet and Gsngou in 1905 first isolated the causative organism, 
Bordetella pertussis, on a blood-based potato glycerol agar (Bordet- 
Gengou medium). This is still widely accepted as the best medium 
for the primary isolation of B. pertussis.
1.1 Epidemiology
Prior to this century, whooping cough was a major cause of 
child mortality and morbidity, ranking among the most severe'infectious 
diseases of childhood ie. diphtheria, measles, scarlet fever etc.
In the developed countries, the incidence of and deaths from whooping 
cough have dropped dramatically due to the combined effect of improved 
medical care, improved standards of living and widespread vaccination. 
Since widespread vaccination began in the UK in 1957, regular epidemics 
have occurred every 3 - 4  years.,' but only twice exceeding 35,000 cases 
per annum up to the year 1980 (Fig. l). However, pertussis still 
remains an important childhood disease due to its prolonged and 
distressing nature. About 10^ of cases required hospitalization 
in a recent epidemic (Miller and Fletcher, 1976), Improved intensive 
care in hospitals has greatly helped to reduce the fatality rate. 
Pertussis is a greater problem in the underdeveloped countries which 
account for 95^ of pertussis deaths (World Health Organization, 1977).
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Figure 1 ; Whooping cough notifications and deaths in England and 
Wales from 1945 - 60
(Taken with permission from Reports, 1981a)
Notifications
160- Deaths
140-
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Man is the only known reservoir of B. pertussis. There have 
been no proven cases of chronic carriers, although clinically unrecognised 
cases do occur (Linnemann, 1979). Pertussis may appear in adults 
as an atypical disease, but it occurs with a greater frequency and 
severity in young infants (Linnemann and Masenberry, 1977). The 
fatality rate is highest for infants in the first year of life (Pittman, 
1955; Brooks and Buchanan,1970). Unlike other infectious childhood 
diseases, there is no maternal transfer of immunity (Reports, .1981a),
B. pertussis is transmitted by airborne droplets expelled during 
coughing. Communicability is very high, ranging from 25 - 50^ in 
schools, to 70 - 100% in household contacts (Linnemann, 1979).
1.2 The disease, diagnosis and treatment
The incubation period of pertussis ranges from 6 - 2 0  days with 
an average of 7 days. A catarrhal stage recognizable as a common 
respiratory infection ensues lasting 1 - 2  weeks. The paroxysmal stage 
follows during which the patient suffers severe episodes of coughing 
and usually lasts 4 - 8  weeks but sometimes up to 20. Each attack 
consists of 10 - 30 forceful coughs and is often so prolonged that 
anoxia and cyanosis may result. The paroxysms begin without anticipation 
and continue without interruption until the lungs are almost depleted 
of air. Finally, with a massive effort, inspiration ensues, and as 
air rushes into the lungs, the characteristic whoop is often produced.
,At the termination of the paroxysm, the patient frequently vomits 
(Pittman, 1970; Olson, 1975). Not all pertussis victims whoop and 
in the infant, cyanosis and choking are more prominent than the whoop.
The greatest danger occurs during the coughing paroxysms during which 
prolonged hypoxia and apnoea may cause irreversible damage to the 
central nervous system or death. The most common neurological complications 
are convulsions, coma, paralysis, deafness, blindness and movement 
disorders (Pittman, 1970; Linnemann, 1979). The most common causes of 
Heath, hni.iswer. are secondary infections such as pneumonia and broncho-
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pneumonia, which may be caused by organisms other than B. pertussis 
(Reports, 1981a).
B. pertussis may be identified either by direct immunofluorescence 
or cultural methods (Parker and Linnemann, 1980). Pertussis is 
often misdiagnosed as: (l) many hospitals do not have the appropriate 
media or experience in growing B. pertussis, (2) positive cultures 
decline to 50% after the third week and are negative within a few 
days if the patient has been given chemotherapy, (3) direct immuno­
fluorescence may produce false positives in inexperienced hands 
(Linnemann, 1979),
Antibiotic treatment is of little value unless started prior to 
the paroxysmal stage— a stage which is difficult to anticipate because 
of problems in diagnosis (Bass et al., 1959). Erythromycin is effective 
in rendering the patient non-infectious and in preventing secondary 
infections (Altemeier and Aijoub, 1977). In severe hospitalized 
cases maintenance of adequate oxygenation, hydration and electrolyte 
balance is of great importance.
1.3. The organism
B. pertussis is a small, non-motile. Gram-negative cocco-bacillus 
(0.3 - 0.5 X 0.5 - 1.0 pm), arranged singly, in pairs, and rarely 
short chains (Pittman, 1974). A capsule has been described (Lawson, 
1940), but is not readily detectable in most strains (Munoz and 
Bergman, 1977). Colonial appearance on Bordet-Gengou medium, is that 
of small, pearly, glistening, smooth colonies, surrounded by a.zone 
of haemolysis.
B. pertussis is a strict aerobe with an optimum growth temperature 
of 35° - 37°C. It does not oxidize or ferment carbohydrates but 
utilizes amino acids as a source of energy, carbon, nitrogen and 
sulphur. The growth requirements of B. pertussis are relatively simple, 
but growth is inhibited by several components present in conventional 
media (Parker, 1976).
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The genus Bordetella was proposed by Moreno-Lopez to encompass 
three serologically-related strains all associated with localized 
respiratory infections in man and animals (Pittman and Wardlaw, 1981). 
These are B. pertussis. B. parapertussis and B. bronchiseptica.
R. pertussis is the most important to man and causes most cases of 
whooping cough. B..parapertussis and B. pertussis are strictly human 
pathogens, whereas B. bronchiseptica is more important in pets and 
domestic animals, especially piglets. The three species can be 
differentiated according to Table 1.
The existence of three Bordetella species has recently been 
questioned (Kloos et al., 1979; 1981) due to their very close genetic 
relationship as shown by DNA-DNA hybridization. Furthermore, Kumazawa 
and Yoshikawa (1978) reported the mutagenesis of B. pertussis to 
an organism biochemically and serologically recognisable as 
B. parapertussis. Recently, it has been suggested that B. pertussis 
might be a lysogenic strain of B. parapertussis (Granstrom and Askelof,
1982).
1.4. Aetiology
MacDonald and MacDonald (1933) verified the causal relationship 
when they infected two of their own children each with 140 viable 
organisms of B. pertussis. However, all three species of Bordetella 
can be isolated from cases with the whooping cough syndrome. Pertussis 
is generally more severe and prevalent than parapertussis (caused 
by B. parapertussis) (Linnemann, 1979), but parapertussis may be more 
significant in some parts of the world (Olson, 1975), B. bronchiseptica 
is only rarely isolated from cases of whooping cough*
Adenoviruses have been demonstrated in patients with the pertussis 
syndrome; both in cases where Bordetellq has and has not been isolated 
(Keller et al., 1980). The role of adenovirus infection in pertussis 
is not known.
2b
Table 1: Characteristics of Bordetella species
Property B. pertussis B. parapertussis B. bronchiseptica
Flagella - — +
Nitrate reduction - - +
Citrate utilization - + +
Urease activity - + + (in 4 h)
Oxidase activity +/- - +
Growth on peptone - + +
agar
Browning of peptone 
agar
- + -
Specific heat-labile . 1 14 12
agglutinogen
Heat-labile toxin + + +
Sensitization of + - +
mice to histamine
G 4- C content 61, 67-70 61, 68-70 66-69
(moles %)
a, data taken from Pittman and Wardlaw (1981); +, present; -, absent.
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2. Vaccination Against Pertussis
Based on the empirical success of vaccines for other diseases, 
there have been many attempts to develop an effective vaccine against 
whooping cough. Leslie and Gardner's (1931) observation of phase 
degradation paved the way by ensuring the selection of strains which 
would give high levels of protective activity. In addition, problems 
had to be overcome in developing assays to enable standardization 
of protective and toxic levels (Pittman, 1956).
During the early 1950's, the Medical Research Council (MRC) 
conducted a series of randomized double-blind controlled field trials 
(MRC, 1951). Individual vaccines varied greatly; some giving a 
high degree of protection even against household exposure to the 
disease, while others were ineffective. Later trials (MRC,1956) 
confirmed the existence of potent vaccines. Protection in the field 
correlated well with the intracerebral mouse protection test (Standfast, 
1958; MRC,1959), Thus the intracerebral mouse protection test of 
Kendrick et ai» (1947) was recommended by the World Health Organisation 
(1964) to standardize the potency of pertussis vaccines .
In the UK, some pertussis vaccination took place during the 
early 1950's. From 1957 it was promoted nationally as a constituent 
of the triple vaccine (heat-killed whole cells of B. pertussis combined 
with diphtheria and tetanus toxoids).
The progressive decline in the incidence and mortality rate of 
pertussis since the turn of the century and before the introduction 
of vaccination makes it difficult to assess the impact of vaccination 
in Britain. Vaccination against, pertussis has not been as successful 
as that against diphtheria and poliomyelitis which have been virtually 
eradicated from the country (Reports, 1981a). Nevertheless, the 
decline in the incidence was sustained until 1977 with peaks at 
intervals of 3 - 4 years only once exceeding 35,000 cases per year.
Eradication of pertussis has been considered as the ultimate goal
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(Kendrick, 1975). Anderson and May (1982) suggest that 95% of each 
year's crop of children must be immunized by the age of two to provide 
sufficient herd immunity to eradicate the disease. However, the present 
vaccine does not give 100% protection.
Reports in the UK on the efficacy of vaccines during recent 
community outbreaks are varied and range from 50 - 90% protection 
(Oenkinson, 1978; Stuart-Harris, 1979; Church, 1979; Report, 1981b). 
However, one report from an outbreak in Shetland reported the vaccine 
to be ineffective (Oitchburn, 1979)* These differences may be attributable 
to differences in efficacy between different batches of vaccine (Griffith,
1978) and differences in other factors such as the nature of exposure. 
Pertussis vaccination is associated with a number of mild and severe
side reactions. The latter include convulsions, abnormal screaming 
fits, and brain damage. Brain damage is the most alarming despite 
its rare occurrence. Assessment of complications is difficult as cases 
tend to be under-reported and reactions may be attributable to an 
idiosyncracy on the part of the individual (Reports, 1981a). Reports 
on the incidence of brain damage vary and have ranged from 1 per 6,000 
to 1 in 300,000 injections (Reports, 1981a).
Claims have been made that improved socio-economic conditions 
has been the main and perhaps sole reason for the decline in the incidence 
of pertussis and that the risk of brain damage is too high to justify 
continued use of the vaccine (Bassili and Stewart, 1976; Stewart, 1977;
1979). Doubts over the safety of the vaccine were widely publicized 
during the mid-1970's when the incidence of the disease was low. This
was followed in 1977 - 79 by the largest upsurge of pertussis notifications 
since 1957. There were 102,500 cases out of which 27 died and about 
17 had severe neurological damage (Reports, 1981a). In a study of 
98 areas, the incidence of pertussis showed a strong inverse correlation 
with the vaccine acceptance rate (Stuart-Harris, 1979).
Concern about the reactogenicity of the vaccine led the Ooint 
Committee on Vaccination and Immunization (OCVl) to set up the National
Zü
Childhood Encephalopathy Study (NCES), The NCES studied cases from 
June 1976 - 79 and assessed the rate of brain damage, occurring within 
7 days of vaccination, to be 1 in 310,000 injections. In balancing 
the risks with benefits, the JCUI reaffirmed their, advice of 1974 and 
1977, to continue recommendation of the vaccine but with due attention 
to contraindications (Reports, 1981a).
However, with parents confused by the language of statistics and the 
hysteria of the mass media, the vaccine acceptance rate is still low 
and we are currently amid another epidemic with notifications as high 
as those before widespread vaccination(Anderson and May, 1982).
3, Pathophysiologically-Active Components of B. pertussis
Whole cells or products of B. pertussis elicit several pathophysiological 
effects in animals or animal tissues. Some of these show parallels with 
the pertussis syndrome in man. A large portion of recent pertussis 
research has gone towards studying and purifying the components responsible 
and assessing their role in pathogenesis, immunity and reactogenicity, 
the aim being to produce a more defined vaccine with greater efficacy 
and reduced toxicity. However, such knowledge is still limited due 
to the inadequacy of present animal models, and technical.difficulties 
in purification of components (as shown by the lack of reproducibility 
between workers).
3.1. Filamentous haemaqqlutinin
B. pertussis possesses two distinct types of haemagglutinin (HA) 
activity (Arai and Sato, 1976). One of these is associated with pertussigen 
(LPF-HA) and has low HA activity, while the other (F-HA) is associated 
with filamentous molecules with dimensions 2 x 40 nm, and has seven­
fold higher HA activity, F-HA has an estimated molecular weight of 
100,000. LPF-HA binds specifically to haptoglobin and other sialoproteins, 
whereas F-HA, is unaffected by sialoproteins but is specifically inhibited
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by cholesterol (irons and MacLennan, 1979). Anti-F-HA, but not anti- 
LPF-HA, prevented attachment of B* pertussis to mammalian cells in vitro, 
suggesting a role for F-HA in attachment (Sato et al., 1979; 1981).
Further associated properties of LPF-HA are described in section 3.4.
Sato et al. (1979) reported the interaction of specific anti-F-HA 
with pilus-like structures of B. pertussis. It was widely believed that 
F-HA was derived from pili and often the term fimbrial haemagglutinin 
has been used. However, recently published results indicated that pili 
did not label with anti-F-HA, but were labelled with antibody towards 
serotype-specific agglutinogen 2 (Ashworth et al., 1982).
3.2. Heat-labile toxin
Heat-labile toxin (HLT) has a cytoplasmic location and is liberated 
upon cell lysis (Cowell et al*, 1979). When administered intraperitoneally, 
it is lethal to mice, guinea pigs and rabbits (Munoz, 1971). It is 
dermonecrotic when given subeutaheously and is sometimes referred to as 
dermonecrotic toxin. HLT is an unstable protein losing all its activity 
when heated for 56^C for 10 min* It's mode of action is unknown.
The toxin is a poor immunogen. It becomes more immunogenic when 
converted to a toxoid by treatment with formalin. This may be related 
to the degeneration of the spleen and possibly lymph nodes which occurs 
after administration of HLT (Wood, 1940; Munoz, 1971). All three species 
of Bordetella possess HLT (Olson, 1975).
3.3. Endotoxin
The endotoxin of B. pertussis has the characteristics of the entero­
bacterial endotoxins. It is toxic, pyrogenic, gives a local Schwartzman 
reaction and acts as an adjuvant (Ayme e^ âi*» 1980). It's chemical 
composition is unusual in that it possesses two polysaccharide side 
chains linked to a lipid A moiety. An additional lipid (lipid X) exists 
within the complex which is also.responsible for toxicity, pyrogenicity 
and the Schwartzman reaction (Le Dur et al., 1978; 1980; Ayme gt al., 1980),
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3.4. Pertussigen
Purification studies by different workers indicate that several 
of the pathophysiological activities of B. pertussis are attributes of 
a single component (Lehrer, 1979; Morse, 1977; Yajima et al., 1978;
Munoz et al., 1981a). Munoz (1976) proposed the term "pertussigen" 
to describe the factor but Pittman (1979) suggested that "pertussis toxin" 
was more appropriate. Pertussigen is referred to by other names such 
as histamine-sensitization factor (HSF), lymphocytosis-promoting factor 
(LPF) and islets-activating protein (lAP), due to it's different manifes­
tations in animals. Although no one has seriously challenged the idea 
of a single component, few workers have committed themselves to use 
either "pertussigen" or "pertussis toxin", and still prefer the terms 
HSF, LPF and ÏAP. Pertussigen and it's activities are unique to 
B. pertussis and probably play an important role in the pathogenesis 
of whooping cough (Pittman, 1979; Wardlaw and Parton, 1985).
Purification procedures for pertussigen are varied and so are the 
reported physiochemical properties. Independent studies indicate that 
pertussigen is predominantly protein with a molecular weight between 
60k - 100k and consists of 4 - 6 subunits (reviewed by Wardlaw and Parton,
1983). The activities of pertussigen are fairly stable to heat and pH. 
Little of the histamine-sensitizing or lymphocytosis-promoting activities 
are lost by heat treatment (30 min at 56°C) during vaccine production.
Pertussigen is associated with the cell envelope of actively growing 
B. pertussis and is liberated into the medium in older cultures (Munoz and 
Bergman, 1977).
The following activities have been attributed to pertussigen:-
(i) Histamine sensitization
When mice are given an intraperitoneal injection of pertussis vaccine, 
they become up to 100-fold more sensitive to a subsequent injection of 
histamine or serotonin (Parfentjev and Goodline, 1948). This effect 
has been attributed to HSF and is inseparable from the other activities 
described below for pertussigen (Munoz, 1976; Lehrer, 1979), HSF sensitizes
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mice to other agents or types of shock eg, bradykinin, methacholine, 
anoxia^ cold shock, X-irradiation and endotoxin (Munoz and Bergman,
1968). Sensitization to histamine may persist in the mouse for months 
(Munoz and Bergman, .1956) and can be detected even when small numbers 
of live or heat-killed organisms are inoculated intranasally (Geller 
and Pittman, 1973). Highly purified pertussigen is very potent with an 
HSD^Qof 0.5 ng per mouse (Arai and Munoz, 1981).
(ii) Lymphocytosis promotion
In pertussis patients and in experimentally infected animals, there 
is an increase in the number of circulating leukocytes which is thought 
to be attributable to pertussigen (Munoz and Bergman, 1977). This 
activity is not due to a proliferation of new cells (Morse and Riester,
1967), but appears to be due to the inability of circulating lymphocytes 
to return from the bloodstream to the lymphoid tissues (Morse and Baron,
1970).
(iii) Islets activation
Rats and mice when injected with B. pertussis vaccine, exhibit a 
marked hyperinsulinaemia in response to insulin eecretagogues such as 
glucose (Sumi and Ui, 1975). The purified component responsible for this 
effect, lAP, also exhibits histamine-sensitizing and lymphocytosis- 
promoting activities (Yajima et al., 1978).
(iv) Other activities
Other activities inseparable from histamine-sensitizing and lymphocytosis- 
promoting activities include; several distinct types of adjuvanticity, 
induction of hypoproteinaemia and increased vascular permeability in 
skin and striated muscle, systemic and local toxicity, iji vitro mitogenicity 
for T lymphocytes, and haptoglobin-specific HA activity (Morse, 1976;
Munoz and Bergman, 1977; Wardlaw and Parton, 1983),
The mechanism of pertussigen action is not properly understood.
It affects a wide range of cell types. Wardlaw and Parton (1983) 
suggested that pertussigen interacts with these cell types through 
sialoprotein receptors. Accumulated evidence (Parker and Morse, 1973;
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Krzanouski et al., 1976; Qrtez, 1977; Lee, 1977) indicates that pertussigen 
alters the responsiveness of different cells to adrenergic and other 
agents, and upsets cAMP metabolism. Recently, work by Katada and Ui 
(l9B2a,b ) and-Katada et al., (1982) on the molecular action of lAP on 
C5 glioma cells,indicated that lAR causes ADP-ribosylation of a membrane 
protein, which in turn increases receptor-mediated and GTP-induced 
activation of adenylate cyclase. This mechanism is similar to that of 
cholera toxin, although it appears that each causes ADP-ribosylation 
of separate membrane proteins. Cholera toxin blocks hydrolysis of 
bound GTP whereas pertussigen renders more GTP available for the GTP 
binding sites (Helmreich and Bakardjieva, 1980; Katada et al., 1982).
3.5. Other active components
A number of other active substances of B. pertussis have been 
described which are less well characterised. These include a haemolysin 
(Lautrop, I960), a polymorphonuclear leukocyte-inhibitory factor which 
may be another attribute of pertussigen (Utsumi et al., 1978; Imagawa 
et al., 1980), a neurotoxin (Kuwajima, 1978), a factor which affects 
macrophage function (Benjamin et al., 1981), and a trachael cytotoxin 
(Goldman et al., 1982).
4. Role of B. pertussis Components in Disease,
Immunity, and Reactogenicity of Vaccines
4.1. Disease
The pathogenic mechanisms of B. pertussis are not well understood.
The disease or infection commences when the bacteria attach specifically 
to the ciliated epithelium of the respiratory tract. Theabacteria 
multiply among the cilia, but do not penetrate any of the tissues (Olson, 
1975). Attachment may be mediated via, F-HA (Sato et al., 1979*
Pittman, 1979). Pittman (1979) suggests HLT may be involved during
the initial stages of infection causing ciliostasis and local inflammatory
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lesions. The recently described tracheal cytotoxin by Goldman e^ al.
(1982), which causes ciliostasis in vitro, may also have a prime role 
in lodgement.
The mechanism of the paroxysmal cough is not understood. Pertussigen 
has been proposed as the causative .agent (Pittman, 1979; Wardlaw and 
Parton, 198%). However, this does not explain the whooping cough syndrome 
caused by 8. parapertussis or B* bronchiseptica (Olson, 1975). In 
this respect, HLT, which is common to Bordetella, or the recently reported 
trachael cytotoxin (Goldman et al., 1982), may play a role. It seems 
likely that pertussigen is responsible for leukocytosis, hypoglycaemia 
and other metabolic disturbances of pertussis. The neurological complications 
of pertussis may result from anoxia or cerebral haemorrage as a direct 
consequence of the cough. Hypoglycaemia may also be involved (Linnemann,
1979).
4.2. Immunity
Knowledge of the protective factors of B. pertussis is hindered 
by the inadequacy of current animal models. Pertussis vaccine manufac­
turers must comply with the conditions of the intracerebral mouse protection 
test. However, hospital isolates have low mouse intracerebral virulence 
and serotypes prevalent in child infections do not parallel those 
isolated from mouse brain infections (Preston, 1976). Other animal models 
have been proposed to supplement the intracerebral mouse protection test 
such as pernasal infections in marmosets, rabbits and mice (Stanbridge 
and Preston, 1974a; Preston e;b al., 1980; Pittman _et al., 1980). However, 
no infected animal exhibits the paroxysmal cough, which is the essence 
of the inflicted damage of pertussis in man*
Pittman (1979) has suggested that immunity to pertussis depends
on immunity towards the components responsible for attachment and initiation
of the disease, and the later toxic effects responsible for the paroxysmal
cough. F-HA and pertussigen seem, to be the likely candidates,
Sato et al. (1979) and Irons and MacLennan (1979) found purifiqd
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F-HA to protect mice against intracerebral and intranasal challenge 
of B. pertussis. However, LPF— HA was intracerebrally non-protective at 
4 jig per mouse (highest, non-toxic doss). In contrast, Munoz et al.
(1981b) found purified pertussigen (detoxified by glutaraldehyde treatment) 
intracerebrally protective at 1.7 pg per mouse, and F-HA (free of 
histamine-sensitizing activity) intracerebrally non-protective at 
12 pg per mouse. Recent published results by Sato and co-workers 
contradict earlier findings, and indicate that both their LPF and 
F-HA preparations protected mice from intracerebral challenge (Cowell 
et al., 1982; Sato et al., 1982).
Watanabe and Nakase (1982) isolated F-HA deficient mutants possessing 
histamine-sensitizing and lymphocytosis-promoting activities, from 
strain 18323. These mutants were as protective as the parent strain 
by the intracerebral mouse protection test, but showed reduced virulence. 
Thus F-HA is not the sole protective antigen, but may be important 
in infection.
Preston and co-workers believe the agglutinogens (about eight 
components which react with corresponding monospecific antisera causing 
cell agglutination) to play an important role in protection. The 
relation of the agglutinogens to the other active components is not known, 
although it appears that agglutinogens 1 and 3 are separable from HSF 
(Ross and Munoz, 1971) and agglutinogen 2 may be associated with pili 
(Ashworth et al., 1982). Agglutinogens 1 - 3  were assessed as being 
the most important for infection in the child (Preston, 1975). Preston 
and Stanbridge (1976) stressed that the absence of agglutinogens 2 and 3 
may go unnoticed in the intracerebral mouse protection test, Preston 
(1966) proposed that the large pertussis epidemic in the early 1960's was 
due to a lack of agglutinogen 3 in many commercial vaccines. The 
World Health Organization (1979) recommended that vaccines contain 
all three agglutinogens
In summary, it would appear that protectivity is not attributable to a
single protective antigen, but probably relies on several factors.
Adjuvanticity of certain components may render others more protective.
Immunity towards a toxic component may prevent disease but not infection.
4.3. Reactogenicity of vaccines
The mouse weight-gain test is used to control and minimize toxicity 
of pertussis vaccines. Several reports suggest this test correlates 
with reactivity of vaccines in children (reviewed by Wardlaw and Parton,
198%). In present vaccines, at least two toxins, endotoxin and pertussigen, 
are fully active. Wardlaw and Parton (1983) suggested that these 
are probably responsible for the reactivity of the vaccine; pertussigen 
especially, in view of it's potential for causing metabolic and neurological 
disturbances. Askelof and Bartfai (1979) found that rats injected 
intraperitoneally with pertussis vaccine exhibited an increase in 
cerebellar cyclic GMP levels* They suggested that this effect may be 
related to neurological complications observed in children after vaccination, 
as some convulsive agents also exhibit such increases in cerebellar 
cyclic GMP levels. Recently Askelof and Gillenius (1982) found intra- 
peritoneal injection of purified LPF, but not HLT or LPS (lipolysaccharide), 
to cause this effect in rats*
The recent success in producing a pertussigen toxoid with glutaraldehyde 
(Munoz et al., 1981a,b) is an encouraging development for an improved vaccine.
5. Growth Requirements and Metabolism of B. pertussis
5.1. Growth requirements
B. pertussis is a fastidious, slow growing organism which will not 
grow in conventional media. Bordet-Gengou medium (BG) is still acknowledged 
as the best medium for the primary isolation of B. pertussis and strain 
maintenance. Several liquid media have been described (Hornibrook, 1939;
Cohen and Wheeler, 1946; Wilson, 1963; Stainer and Scholte, 1971), but growth 
in these media requires a heavy inoculum of actively growing cellso
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Paradoxically, B. pertussis has simple growth requirements and will 
grow in a chemically defined medium containing glutamate, proline, 
cysteine, glutathione, ascorbic acid, nicotinic acid and various salts 
(Stainer and Scholte, 1971). The inability of B. pertussis to grow 
on conventional media,such as nutrient agar, is thought to be due to 
inhibitory substances in these media. Inhibitory substances include 
fatty acids, colloidal sulphur and sulphides, organic peroxides and 
manganous ions (Rowatt, 1957; Parker, 1976). Agar, peptone and other 
medium constituents contain fatty.acids. Agar also contains large 
amounts of sulphur, and the inhibitory effect of agar may be due to 
colloidal sulphur compounds formed during autoclaving. Substances 
such as blood, starch, albumin, charcoal, catalase and anion exchange 
resins, have been added to media to neutralise inhibitory substances.
The inhibitory mechanisms are not known, but are of interest as inhibitory 
substances select for avirulent. forms of B. pertussis, which have greater 
resistance (Parker, 1976).
Early work indicated that B. pertussis utilized only a few amino 
acids at a significant rate (Table 2), but no sugars or carbohydrates. 
Various workers agree that glutamate can be utilized as the principle 
source of carbon, nitrogen and energy (Jebb and Tomlinson, 1951, 1955; 
Rowatt, 1955; Goldner et al., 1966; Vajdic et al., 1966; Stainer and 
Scholte, 1971). Olson (1975) pointed out that it may be pertinent 
to pathogensis that B. pertussis utilizes amino acids but not carbohydrates, 
as amino acids are expected to be more abundant in the mucus layer of the 
respiratory tract and even more so after inflammation and necrosis of 
the epithelium.
B. pertussis requires an organic sulphur source which is only 
satisfied by cysteine, cystine or glutathione (Hornibrook, 1939; Jebb 
and Tomlinson, 1957). Parker (1976) has suggested that this may be due 
to the neutralization of inhibitors or the requirement for a reduced 
environment. Oxygenases, which may play a role in amino acid metabolism, 
require both oxygen and reduced compounds for activity. The organism
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also has an absolute requirement for either nicotinic acid or nicotinamide 
(Hornibrook, 1940; 3ebb and Tomlinson, 1955).'
5.2. Metabolism ■
Little is known about the metabolism or physiology of B. pertussis.
Jebb and Tomlinson (1951) found that out of 21 amino acids, only L-proline, 
L-serine, L-alanine, L-aspartate,L-glutamate, and D-glutamate were 
respired at an appreciable rate by washed cell suspensions. The organic 
acids oc-ketoglutarate, 5 lactate and succinate were also respired. 
a-Ketoglutarate, was formed during respiration of L-glutamate.
Abe (cited by Fukumi et al., 1953) found B» pertussis able to 
respire fumarate, malate, succinate, rt-ketoglutarate, citrate and acetate, 
suggesting a functional citric acid cycle. Later studies demonstrated
aconitase and isocitrate dehydrogenase activities (Fukumi et al., 1953),
'
Presumably, glutamate enters the citric acid cycle by oxidative deamination 
to a-ketoglutarate. Other amino acids may be converted to glutamate 
by interaction with a-ketoglutarate via. transaminases, which have been 
demonstrated in B. pertussis for various amino acidsr(Kobayashi and Fukumi, 
1954a). Kobayashi and Fukumi (1954b) demonstrated aldolase, but lack 
of hexokinase activity in B. pertussis cell-free extracts. Thus B. pertussis 
may not be able to utilize sugars due to the lack of hexokinase or the 
appropriate permeases. The presence of aldolase suggests that sugar 
precursors, required for polysaccharide and nucleic acid synthesis, may be 
synthesized from intermediates of the citric acid cycle via. gluconeogenesis.
Two different electron transport chains have been described for 
B. pertussis. One of these is dependent on cytochrome oxidase and is 
cyanide sensitive, while the other is not (Ezzell gt al., 1979, 1981a).
How amino acid metabolism is regulated in B. pertussis is not known 
but several observations suggest regulatory mechanisms do exist. Some 
workers have found amino acids not to be utilized until glutamate was depleted 
from the medium (Rowatt, 1955; Goldner et al.. 1966; Vajdic et al.,1966). 
Pusztai et al. (i960) found proline to be utilized first. On the other hand.
Lane (1970), using an amino acid analyser, reported glutamate, aspartate, 
alanine, serine, proline, and glycine all to be utilized simultaneously.
He claimed previous findings may have been due to the use of insensitive 
paper chromatographic analysis and the unequal amounts of amino acids in 
the media used, •
Some reports have indicated that varying the concentration of glutamate 
or proline in media resulted in changes in intracerebral mouse-protective 
activity (MPA), and HSF (Goldner at al., 1966; Stainer and Scholte, 1959;
Lane, 1970). It is not known whether this is due to uptake of these 
amino acids or changes in the growth rate, but suggests mechanisms by 
which expression of the pathophysiological activities of B. pertussis 
may be regulated in response to levels of nutrients.
Both adenylate cyclase and glutamine synthetase have been demonstrated 
in B. pertussis (Hewlett et al., 1976; Zakharova et al., 1979). These enzymes 
play a key regulatory role in the acquisition of carbon and nitrogen 
sources respectively in the enterobacteria (Pastan and Adhya, 1976; Magasanik, 
1977). Perhaps these enzymes play a role in the above described regulatory 
phenomena observed for B. pertussis.
6. Variation of B. pertussis
A notable feature of Bo pertussis is it's tendency to undergo 
antigenic and colonial variation. This can occur by two processes, 
namely, phase degradation and antigenic modulation. Phase degradation 
is an irreversible process involving.step-wise mutational events and occurs 
with continous subculture. Antigenic modulation is an environmentally- 
induced process involving phenotypic changes and is freely reversible.
6.1. Phase variation
Leslie and Gardner (1931) found strains of B. pertussis could be 
divided into four well defined serological groups, phases I - IV. Phases 
I and II gave smooth, virulent colonies, while phases III and IV were rough
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and avirulent. Subculture of phase I in various media resulted in
phase, degradation through phases II and HI to the stable phase IV, although
phase II did not occur as a regular intermediate.
Standfast (1951) found repeated subculture of different hospital 
isolates to cause independent and random loss of virulence, protective 
activity, HA, growth requirements and agglutination. In general HA was 
one of the less stable characters and protective activity one of the more 
stable characters.
Although the terms phase I and phase IV are still in use to describe 
virulent and avirulent strains, indentification of the four phasgs is no 
longer possible due to the lack of-Leslie and Gardner's strains and antisera. 
Parker (1979) suggested the use of the terms fresh isolate, intermediate 
strain (laboratory strain) and degraded strain (avirulent strain).
Degraded strains grow on nutrient agar presumably because they have 
developed greater resistance to inhibitory substances than their fresh- 
isolate ancestors. Parker (1976) suggested that inhibitory substances 
present in media provide a selective pressure for degraded strains.
Peppier (1982) reported the frequency of phase I or II to phase III or IV
variation to be between 5 x 10"*^  to 5 x 10”^ per culture.
6o2. Antigenic modulation
Lacey (1951) noted that B. pertussis grown on BG plates in which 
the NaCl was replaced by MgSO^, failed to agglutinate with B. parapertussis 
antiserum. He later reported this process to occur uniformly in a whole 
population and to be completely reversible within one subculture, provided 
that the inoculum was not too large (Lacey, I960). The process required 
4 - 7  cell divisions and was not due to a direct effect of MgSO^ on the 
antigens. This was clearly a process involving phenotypic changes not
requiring mutation. Growth with NaCl gave X-mode B. pertussis (so-called
because of the xanthic, ochre appearance of confluent growth) while growth 
with MgSO^ gave C-mode (cyanic) B. pertussis. An I-mode (intermediate) arose 
when B. pertussis was grown on BG with a critical concentration ratio
of NaCl to MgSO^* In addition to antigenic changes, other properties 
were lost during X to C modulation such as haemolysis, HA, agglutinability 
by AuClg and HgCl^ and intranasal mouse virulence.
Antigenic modulation was also induced by several cations, anions, and 
organic acids. Some ions were clearly pro-C-mode whereas others were pro- 
X-mode, Fatty acids were the most potent pro-C-mode substances with 
activity increasing with chain length. The outcome of any combined mixture 
of salts depended on the sum of the individual potencies for modulation.
Lacey (i960) also reported that growth at 25°C caused similar C modulation. 
This process was not characteristic of fresh isolates, but required 
the initial selection of mutants capable of growing at low temperature.
Pusztai and 3oo (1967) reported a type of antigenic modulation which is 
induced by growth in high levels of nicotinic acid (500 pg ml ). Although 
these workers did not examine MgSO^-induced modulation, they maintained 
nicotinic acid-induced modulation was different from that reported by Lacey 
as: (1) although agglutinability was reduced, specificity was unchanged,
(2) no changes occurred in intraperitoneal toxicity. Nicotinic acid-induced 
modulation has an element of specificity in that nicotinamide, present at 
the same high level, does not cause variation (Wardlaw et al., 1976)
6.3. Changes in activities and properties during phase variation and modulation
Several activities and properties of B. pertussis are lost during 
the processes of phase degradation and antigenic modulation along with 
virulence and protective activity (Table 3). Although smooth to rough 
variation in the enterobacteria is associated with a loss of the terminal 
0 side chains in their LPS, little work has been done on the effect of 
phase degradation and modulation on B. pertussis LPS. Aprils and Wardlaw
(1973) found heat-stable antigenic determinants to vary between strains, 
but there was no correlation with phase. Whereas some of the lost properties, 
such as pertussigen-related activities, F-HA and HLT, may play a role 
in pathogenesis, the functions of others such as adenylate cyclase 
and the 28k and 30k cell-envelope. polypeptides (X polypeptides), are 
not known. It appears that these properties are lost in unison during
Table.3; Activities and properties lost during antigenic variation
of B. pertussis
*
Reference
Property or 
activity Phase
Antigenic modulation
degradation
MgSO^-rinduced Nicotinic acid- 
induced
MPA 3, 5, 10 9, 12, 18, 21 8, 12
HSF 4, 10 12, 18, 21 8, 12
LPF 23 18, 21
Adjuvant activity 19
HA 2, 3, 23 6
HLT 1 13 22
28k and 30k cell- 
envelope polypeptides
11, 12, 15 11,
21
12, 15, 18, 12
Agglutinogen 1 7 9 20
Adenylate cyclase 14, 17, 23 14 20
Cytochrome d^^g 15 15
Sensitivity to 
certain antibiotics 15, 16
1, Roberts and Ospeck (1942); 2, Keogh and North (1948); 3, Standfast 
(1951); 4, Kind (1953); 5, Kasuga et al. (1954); 6, Lacey (i960); 7, Eldering 
^  a]^ . (1962); 8, Pusztai and Ooo (1967); 9, Holt and Spasojevic (1968); 10, 
Aprils (1972); 11, Parton and Wardlaw (1975); 12, Wardlaw et al.(l976); 13, 
Livey et al. (1978); 14, Parton and Durham (1978); 15, Dobrogosz et al. (1979); 
16, Field and Parker (1979); 17, Hewlett et al. (I979a); 18, Wardlaw and Parton 
(1979); 19, Wardlaw e^ al. (1979); 20, McPheat (19B0); 21, Idigbe et al. (I98l) 
22, Livey (1981); 23, Peppier (1982).
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antigenic modulation and phase degradation (Wardlaw and Parton, 1979;
Peppier, 1982), Some of these components (eg. pertussigen) are located 
in the cell envelope, others are cytoplasmic (eg, HLT). The common loss 
of these activities may suggest the perturbation of a common regulatory 
mechanism by mutational events or the influence of certain ions, being 
responsible for variation.
Conversely,a few reports, in need of verification, suggest a differential 
loss of activities, Pusztai and Joo (1967) reported that HSF, but not 
HLT, was reduced during nicotinic acid-induced modulation. This contrasts 
with findings of Livey (1981) where HLT was reduced by 6D^, Pusztai and 3oo
also reported the loss of HSF but not agglutinability during nicotinic acid-
induced modulation of one strain. Wardlaw et al. (1975) found that 
succinate-induced modulation caused a 30^ loss of HSF but no apparent loss 
of the X polypeptides,
6.4. Other types of variation
Other forms of antigenic or colonial variation have been reported,
but their relation to phase degradation is not known. B, pertussis 
subcultured from a mouse brain, on occasion, resulted in the segregation of 
large and small colonies (Andersen, 1952). Small colonies tended to be 
more intracerebrally virulent and toxic than large colonies. When 
individual colonies were subcultured, differences in colony morphology 
disappeared, although their original differences in virulence, toxicity and 
agglutinogens were retained. Presumed homogenous strains of B. pertussis, 
when grown on BG and Cohen and Wheeler medium,segregated into many 
colony types (Cameron, 1967), These differed in terms of colony morphology, 
haemolysis, agglutinogens, toxicity, HSF and MPA suggesting that variation 
occurs very readily, Stanbridge and Preston (1974b) reported gradual 
loss of agglutinogens during serial subculture from type 1,2,3 to types 1,2 
or 1,3 to type 1, The process was reversible and agglutinogens could be 
regained. The rate of mutation varied with strain. Changes in serotype also 
occurred during the course of per-nasal infections in the marmoset and
rabbit (Stanbridge and Preston,1974a; Preston et al., 1980). Type 1,2,3 
strains could change to types 1,2 or 1,3 but only seldomly and late on 
in infection to type 1. Moreover, infection with type 1 resulted in 
mutation to types 1,2, 1,3 and 1,2,3 which were more predominant during 
infection. However, these changes in serotype do not occur when the mouse 
brain is infected with type 1. Preston and co-workers stressed the importance 
of agglutinogens 1, ,2 and 3 for infection and protection in the child 
(Preston, 1976).
7. Adenylate Cyclase of 8. pertussis
Adenylate cyclase (AC) activity is demonstrable in all three speoies 
of Bordetella (Endoh et al., 1980). Ide (1971) screened 21 species 
of bacteria for AC activity. When present, AC was either membrane
bound, as in Escherichia coli.or cytoplasmic, as in the case of 
Brevibacterium liquefaciens. Two notable features of B. pertussis AC 
are it’s location and it’s activation by calmodulin.
Substantial quantities of AC (about 20^ of the total) are found 
in the supernate of B. pertussis cultures (Hewlett £t ^  ., 1976; Endoh et al.,
1980). Hewlett et al.(1976) reported that AC accumulated in culture 
supernates during exponential growth. This was not due to cell lysis as 
intracellular markers such as DNA and malate dehydrogenase could not be
detected. Of the cell associated AC, about 90^ was extracytoplasmic being
1
senstive to trypsin prior to cell disruption. Enzyme activity could be 
determined by adding ATP to intact cells and assaying for cAMP production.
This was referred to as whole-cell AC activity and accounted for a 
substantial portion of cell-envelope associated AC depending on the 
concentration of ATP used (Hewlett et ^ . , 1976). It was suggested that 
AC may have a periplasmic location and is thus easily released into the 
medium. However, only 1% of AC was lost by sucrose, EDTA treatment and 
osmotic shock, which would be expected to release periplasmic components 
(Cowell et al., 1979). Nevertheless, culture supernate AC and
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extracytoplasmic cell-associated AC are^sofaras is known, unique to 
Bordetella (Hewlett e^ , 1980; Endoh , 1980). Despite the large
proportion of extracytoplasmic AC, significant cytoplasmic AC activity 
probably occurs during growth as cAMP can be detected in culture supernates 
(20 - 100 pmol ml”'*) (Parton and Durham, 1978; Endoh £t ad., 1980). This 
is unlikely to be formed by extracytoplasmic enzyme due to lack of the 
substrate ATP.
Culture supernate AC has been purified and characterized (Hewlett and 
Wolff, 1976). ,B. pertussis AC has the smallest molecular weight (70,000)
reported so far for this enzyme. Unlike the AC of other prokaryotes 
and eukaryotes, B. pertussis AC is insensitive to oc-ketoacids or GTP.
Like other bacterial AC, it has a divalent cation requirement best 
satisfied by Mg"^. It has an optimum pH of 7 - 8 and is sensitive to 
trypsin and temperature. It is mildly inhibited by sodium salts, but is 
markedly inhibited by NaF. Despite it's heat sensitivity, significant AC 
activity is detectable in some commercial vaccines (^Hewlett ^  al., 1977).
The other peculiar feature of B. pertussis AC is it's marked sensitivity 
to calmodulin. AC activity, for a wide range of 26 other species 
(pathogenic and non-pathogenic), was unresponsive to calmodulin (Hewlett 
et al., 1980). Calmodulin, which is synthesized by most eukaryotic cells, 
has never been demonstrated in prokaryotes and is most probably absent from 
B. pertussis (Wolff et al., 1980). Calmodulin is a small, heat-stable 
protein (molecular weight 16,700), which activates a large number of enzymes 
in a calcium-dependent two-step mechanism (Klee et al., 1980):-
4-4-
calmodulin + Ca <*—* calmodulin. Ca
-H-
enzyme^^^^^^^^g^ + calmodulin.Ca » enzyme.calmodulin.Ca (active)
Hewlett et aj.. (1978) noted that B. pertussis grown on BG 
had an AC activity 100-fold greater than when grown in Stainer and Scholte 
medium. These workers attributed this difference to an activator present 
in erythrocytes. The activator was very potent and a few subcultures 
in Stainer and Scholte were required before AC activity reached a basal level.
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Activator activity was also found in many commercial protein preparations 
and mammalian tissues such as liver, muscle and tracheal mucosa (Hewlett 
et al., 1978; 1979a; Goldhammer et al., 1981). Commercial bovine catalase 
was a particular good source of activator. The activator was heat and 
pH stable. While whole-cell AC activity could be stimulated about 
240-fold, culture supernate AC was stimulated only 7-fold, and purified AC 
was insensitive to the activator (Hewlett et al., 1979b). This suggested 
that an additional factor was required for activation. The activator, 
from several sources, was eventually identified as calmodulin due to;
(1) requirement for Ca ions, (2) sensitivity to ethylene glycol bis 
((3-aminoethyl ether)-N,i\l,N* ,N'"tetraacetic acid (EGTA, a chelator of 
Ca ions), (3) sensitivity to trifluoperazine, (4) heat and pH stability,
(5) similar chromatographic profile to authentio calmodulin (Wolff £t al., 
1980; Goldhammer et al., 1981). B. pertussis AC is highly sensitive 
to activation and can be used to trace pico mole quantities of calmodulin. 
These workers have proposed activation of B. pertussis AC as a convenient 
model to study the mechanism of action of calmodulin.
Calmodulin activation of B. pertussis AC differs from that of
mammalian brain AC as EGTA is ineffective unless added before calmodulin
(Wolff et al., 1980). Recently, results from an independent group of
workers (Greenlee £t ^ .  , 1982) conflicted with those of Wolff ^  (1980).
Greenlee ^  (1982) found calmodulin activation of B. pertussis AC
to be unique in that there was no requirement for Ca"^ for the majority
of^activation observed. Photoaffinity cross-linking experiments with 
r ^ 2 5 n
azido I Ij calmodulin suggested that the catalytic subunit of calmodulin- 
sensitive AC was responsible for rendering culture supernate AC and 
purified AC insensitive to calmodulin.
Hewlett e_t al. (1979a) observed a second type of influence on AC 
activity during growth. When B. pertussis was subcultured from BG to Stainer 
and Scholte medium there was a marked decline in AC activity (presumably
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due to lack of activator). However, during the first few hours of growth 
in Stainer and Scholte, specific activity gradually increased about 10-fold.
Neither the function of AC in B. pertussis nor the physiological 
significance of its marked responsiveness to calmodulin is known. AC 
activity is greatly reduced in C-mode and phase IV B. pertussis. It has 
been suggested that AC may play a regulatory role in B. pertussis in governing 
the expression of virulence factors (Parton and Durham, 1978; Hewlett £jt al., 
1979a; Wardlaw and Parton, 1979). This proposal has been further extended 
by the suggestion that calmodulin may facilitate the parasitic state of 
the organism in the respiratory tract (Hewlett et al., 1978). However, 
exogenous cAMP (O.l - 10 mfl) had no effect in inducing the X-mode/ 
phase I phenotype in phase IV and C-mode B. pertussis, although uptake 
of cAMP was not demonstrated (Dobrogosz et al., 1979; Ezzell £t ad., 1981b). 
Alternatively it has been suggested that AC itself may act as a virulence 
factor (Hewlett £^ t gd., 1979a; Confer and Eaton, 1982),
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PART 2; ADENOSINE 3',5*-PH0SPHATE IN PROKARYOTES
Adenosine 3',5'-phosphate (cyclic AMP or cAMP) has been demonstrated 
in a variety of prokaryotes, although it's occurrence is not ubiquitous 
(Botsford, 1981). Most work on the physiological role of cAMP has been 
done with Escherichia coli and Salmonella typhimurium. The involvment of 
cAMP in catabolite repression is well established (Pastan and Perlman, 
1970; Rickenberg, 1974; Pastan and Adhya, 1976). However, little is known 
of the role of cAMP in other bacteria; except that' it has been identified, 
and when added exogenously, altered expression of certain phenotypes. 
Sections 1 to 5 are restricted to a discussion of cAMP in E. coli and 
S. typhimurium.
1, Mechanism of Action
The current model of the mechanism of action of cAMP is supported 
by a variety of physiological, genetic and biochemical evidence (Pastan 
and Adhya, 1976). The cAMP regulatory model requires two functional 
proteins, adenylate cyclase (AC) and cAMP-receptor protein (CRP). AC 
catalyses the hydrolysis of ATP to cAMP and in E. coli and S. typhimurium 
is a membrane bound enzyme. CRP is a dimer which binds to two molecules of 
cAMP (one per subunit).
When CRP binds to cAMP, it undergoes a marked allosteric change 
(Kumar, 1980). In this active conformation, CRP-cAMP preferentially 
binds to specific sites on the DNA, promoting access of RNA polymerase, and 
initiation of transcription (Pastan and Adhya, 1976). The CRP-cAMP 
binding sites have been sequenced for the lac (Dickson et al., 1975), 
era (Lee e;t ^ . , 1981) and gal opérons (Taniguchi ^  al. « 1979), and they 
are similar, but not identical.
CRP-cAMP binds to one site on the lac operon, which in the presence 
of the inducer, enables transcription of the structural genes. The ara 
operon has two CRP-cAMP binding sites. Binding to one of these enables
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transcription of a gene coding for an ara repressor, which blocks the 
CRP-cAMP binding sites. In the presence of arabinose, the ara repressor is 
ineffective (Lee et al., 1981). The gal operon has two promoters.
Initiation of transcription at one promoter is inhibited by CRP-cAMP, 
whereas initiation at the other is stimulated (Adhya and Miller, 1979).
Thus optimum transcription of gal depends on a critical concentration of 
cAMP. The proposed rationale for this is that the gal operon has a 
biosynthetic as well as a catabolic role.
Different promoters have different affinities for CRP-cAMP. The lac, 
ara, and tna (tryptophanase) opérons require different concentrations of 
cAMP for transcription (Lis and Schleif, 1973; Piovant and Lazdunski, 1975).
The significance of this is discussed later.
2. Catabolite Repression and Cyclic AMP
It has long been recognized that when glucose was not limited 
during growth of bacteria, the capacity to ferment various sugars was lost 
(Gale, 1943). Magasanik (1961) proposed that glucose catabolism, being faster 
than that of other sugars, resulted in higher levels of catabolic intermediates 
one of which repressed synthesis of inducible enzymes. Thus the term 
catabolite repression was proposed.
Several years after Sutherland and co-workers discovered cAMP as an 
intermediate in the hyperglycaemic effect of adrenalin and glucagon,
Makman and Sutherland (1965) observed cAMP in E. coli. These workers also 
noted that the addition of gluoose caused a significant decrease in the 
intracellular cAMP concentration. In later studies, the addition of 
exogenous cAMP derepressed enzymes and permeases subject to catabolic 
repression (Pastan and Perlman,1970). Epstein et al., (1975) found 
good correlation between the effect of carbon source on intracellular cAMP 
concentrations and (3-galactosidase activity.
The strongest evidence for the involvement of cAMP and CRP in 
catabolite repression came from the isolation of two classes of mutants.
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□ne of these, cya, is defective in AC and the other, crp, is defective in 
CRP. Both these mutants are pleiotropic and are unable to utilize 
carbohydrates where metabolism is subject to catabolite repression (Perlman 
and Pastan, 1969). This ability can be restored in cya, but not in crp 
mutants, by the,addition of cAMP. Sensitivity to various antibiotics 
and inhibitors is lost in cya and crp mutants, presumably due to the lack 
of the permeases. This has provided an easy means for their selection 
(Alper and Ames, 1978; Aono ^  aj^., 1979; Swenson, 1979).
Cyclic AMP and CRP are not essential for growth in all conditions as 
cya and crp deletion mutants have been isolated. However, the growth rate 
of these mutants is impaired. The reason for this is not known (Pastan and 
Adhya, 1976).
Criteria which have been used to implicate the involvement of 
CRP-cAMP in the expression of a particular phenotype include :-
(i) The expression of the phenotype correlates with observed cAMP levels,
(ii)The phenotype is expressed if cAMP is added exogenously.
(iii) An alteration in phenotype occurs by manipulating growth 
conditions such as to alter cAMP metabolism.
(iv) The phenotype is absent in crp and cya mutants, but can be 
restored in cya mutants if grown with exogenous cAMP.
Observing the fourth criterion is generally regarded as the most 
convincing evidence, although the possibility of an alternative regulatory 
mechanism, itself under control by cAMP, cannot be excluded.
CRP-cAMP is required for the expression of several structural 
proteins as well as catabolic enzymes and permeases (Table 4), Some of 
these proteins, though not essential for survival, may aid in nutrient 
acquisition. A generalization is that cAMP is an indicator of carbon 
insufficiency and promotes a phenotype which enables exploitation of 
other available carbon sources. AC may itself be negatively regulated by 
CRP-cAMP (Botsford and Drexler, 1978; Oanecek at al., 1979; Majerfeld at al.,
1981).
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Table 4; Components and properties controlled by CRP-cAMP in E. coli
Component or function Criterion
**
Reference
Outer membrane proteins A, B, C 9, 11, 12
Phage receptor proteins B, C 5, 10
Flagella B, C 1
Pili B, C 13
Chemoreception A, B 3
Extracellular hydrolysis A, B 8
Cytochromes B, C 4
Membrane-associated B, C 7
bioenergetic functions
Plasmid replication A, B, C 2
lac, ara, and gal opérons A, B, C, D, E 6
*
A, glucose effect noted; B, function altered in cya and crp; C, exogenous 
cAMP affects function ; D, correlation with cAMP levels and function;
E, operon sequenced and CRP-cAMP binding site identified.
1, Yokota and Cots (1970); 2, Katz at (1973); 3, Adler and Epstein
(1974); 4, Broman e^ (1974); 5, Kumar (1975); 6, Pastan and Adhya (1976); 
7, Dills and Dobrogosz (1977); 8, Kier e^ (1977); 9, Aono a^. (1978); 
10, Alderman at ^  (1979); 11, Mallick and Herrlich (1979); 12, Scott and 
Harwood (1980); 13, Eisenstein et al. (1981).
More extensive lists can be found in reviews by Pastan and Perlman (1970' 
Rickenberg (1974), Pastan and Adhya (1976), Peterkofsky (1976) and 
Botsford (1981).
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3. Other Factors Involved in Catabolite Repression
Accumulating evidence indicates that CRP-cAMP is not solely responsible 
for catabolite repression:-
1 . A mutation causing a defect in the sigma subunit of RNA polymerase, 
resulted in 15 to 30^ of wild-type p-galactosidase activity in a cya or 
crp background. This activity is sensitive to catabolite repression 
(Silverstone et al., 1972).
2. Mutations, which map in crp, may suppress cya deletions and 
render the organism sensitive to catabolite repression (Dessein et al., 
1978a; Botsford and Drexler, 1978).
3. A low molecular weight, pH stable, and heat-stable factor has 
been isolated and termed catabolite modulator factor (CMF). CMF plays
a negative regulatory role in catabolite repression and acts independently 
of CRP or cAMP (Dessein et al., 1978a,b).
4. Compounds other than cAMP can activate CRP. Indole acetic acid 
and imidazole acetic acid can replace cAMP for expression of the ara operon 
(Kline et al., 1980a,b).
5. Mutants with a defective transcription termination factor rho, in a 
crp background are able to express lac, mal, ara and tna opérons which
are sensitive to catabolite repressionCGuidi-Rontani et al., 1980).
It should be noted that catabolite repression is a feature of many 
organisms other than the enterobacteria, although glucose is not'necessarily 
the preferred carbon source. Bacillus meqaterium. Pseudomonas aeruginosa, 
and Rhizobium meliloti all exhibit catabolite repression, but cAMP does 
not appear to be involved (Ullmann,1974; Ucker and Signer, 1978; Phillips 
and Mulfinger, 1981).
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4. Regulation of Cyclic AMP Levels
An understanding of how intracellular cAMP levels are regulated 
is central to understanding how sugars effect catabolite repression.
There are three possible means for regulating, intracellular cAMP concentration 
synthesis of cAMP by AC, degradation of cAMp by phosphdiesterase, or 
excretion of cAMP.
4.1. Synthesis of cAMP
AC is a membrane-bound enzyme and it's activity is regulated by 
interactions with transport proteins. This may be analogous to regulation 
of animal cell AC by interactions with hormone receptors (Harwood and 
Peterkofsky, 1977). AC activity is subject to glucose inhibition in whole 
cells but not in cell-free extracts (Peterkofsky and Gazdar, 1973),
Sugar inhibition of AC depends on sugar transport but not sugar metabolism 
(Peterkofsky et al., 1975). Glucose and mannitol are transported by the 
phosphotransferase system (PTS), lactose by a proton symport mechanism and 
glycerol by facilitated diffusion. All these sugars inhibit cAMP production 
presumably by different mechanisms.
Peterkofsky and co-workers proposed that sugars transported by PTS 
inhibit cAMP production by the interaction of AC with enzyme 1 of the PTS 
(Peterkofsky, 1976; 1977). When enzyme 1 of the PTS is phosphorylated 
(due to no sugar transport), AC is in the active state. When non- 
phosphorylated (due to the rapid transfer of phosphate through the pTS 
during sugar transport), AC is in the non-active state. This model is 
supported by genetic evidence. An alternative model for PTS mediated AC 
regulation has been proposed in which AC is activated by allosteric 
interaction with a phosphorylated err (catabolite repression resistant) 
gene product. The err gene product is phosphorylated by the HPr (heat- 
stable protein) component of the PTS (Saier and Feucht, 1975; Feucht and 
Saier, I960). Sugars transported by proton symport mechanisms may 
inhibit AC activity by causing collapse of the proton electro-chemical
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gradient (Peterkofsky and Gazdar, 1979), It was mentioned previously 
that AC may be negatively controlled by CRP-cAMP. This may enable the 
organism to respond rapidly to changes in carbon/energy supplies (Botsford, 
1981).
4.2. Degradation of cAMP
The significance of cAMP phosphodiesterase is uncertain. It's 
specific activity is not affected by the growth medium (Nielsen e^ al., 
1973). Botsford (1981) reported unpublished results which showed that 
S. typhimurium strains, which lacked phosphodiesterase activity, had the 
same level of intracellular cAMP as the wild type, although culture 
supernate levels were three times greater. Thus phosphodiesterase does 
not appear to play an important role in regulating cAMP levels in response 
to growth conditions,
4.3. Excretion of cAMP
Cyclic AMP is actively excreted both by cells (Saier et al., 1975) and 
membrane vesicles (Goldenbaum and Hall,1979), and substantial quantities 
of cAMP can be detected in culture supernates of E. coli (Buettner et al., 
1973). On the other hand, cAMP uptake occurs by facilitated diffusion 
(Goldenbaum and Hall, 1979). Efflux of cAMP is stimulated by metabolizable 
sugars, but not by non-metabolizable analogues such as a-methyl-glucoside, 
which have the capacity for catabolite repression. During growth, the 
rate of cAMP excretion is proportional to its synthesis (Epstein et al., 
1975). The significance of cAMP excretion is not known.
5. Physiological Strategy of Cyclic AMP Regulation
It has been suggested that the cAMP regulatory system enables the 
prokaryotic cell to respond to a range of nutritional environments such 
that the cell preferentially utilizes those carbon sources which are best 
at promoting growth (Rickenberg, 1974; Alper and Ames, 1978). The cell 
receives information on the "nutritional status" of the environment 
through transport and possibly other mechanisms. Some of these have been 
shown to interact with AC (also located at the cell surface) and alter 
cAMP production. Intracellular levels of cAMP appear to be inversely 
related to the efficiency of the available carbon /  energy source at 
promoting growth (Buettner et al., 1973; Botsford, 1975; Epstein et al., 
1975; Botsford and Drexler, 1978). CRP and cAMP may exist in equilibrium 
with CRP-cAMP (Botsford, 1981). Thus CRP-cAMP would be favoured by high 
levels of cAMP.
It has been suggested that a hierarchy of sensitivity of opérons 
to CRP-cAMP may exist (Rickenberg, 1974; Alper and Ames, 1978). It was 
previously mentioned that the trn, lac, qal and ara opérons all require 
different concentrations of cAMP for optimum expression. Further evidenoe 
for a control hierarchy comes from a series of leaky crp and cya mutants 
which are defective only in some cAMP sensitive systems (Alper and Ames, 
1978).
Thus a wide variety of nutritional environments can be differentiated 
by receptor-mediated stimuli at the cell surface (transport mechanisms) 
which are relayed to the transcriptional apparatus via. cAMPo This enables 
the cell to respond best to nutritional circumstances^ and economize 
on unnecessary protein synthesis.
6o Cyclic AMP in Prokaryotes Other than E. coli
This section serves to illustrate cAMP-associated manifestations 
in other prokaryotes and to point out the parallels and non-parallels
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with the cAMP regulatory system of the model organism E. coli.
Alcaliqenes eutrophicus. Synthesis of hydrogenase, in this facultative 
chemoautotroph, is stimulated by exogenous cAMR when grown heterotrophically.
A cAMP-receptor protein has been identified and partially characterized 
(Tait et , 1981).
Arthrobacter crystallopoietes. This organism grows rapidly as rods 
in the presence of succinate or certain amino acids. When the preferred 
carbon source is exhausted, the organism changes to a spherical form.
Cyclic AMP appears to be involved in this transition, but not in catabolite 
repression (Hamilton and Kolenbrander, 1978).
Benekea harveyi. The enzyme luciferase, responsible for bioluminescence, 
is subject to the glucose effect and is influenced by cAMP (Ulitzer and Yasphe 
1975). This is in contrast to the luminescent system in several species of 
Photobacterium which is subject to glucose repression, but is not influenced 
by cAMP (Nealson and Hastings, 1979), An immunologically similar protein to 
E.coli CRP has been demonstrated in B. harveyi (Nealson and Hastings, 1979).
Caulobacter crescentus. Cyclic AMP and cGMP are involved in the 
morphogenesis of this dimorphic organism, although they may act indirectly 
by influencing critical catabolic.reactions. Cyclic AMP and cGMP act 
antagonistically (Kurn et al., 1977). Receptor proteins for cAMP and cGMP 
have been identified (Shapiro, 1976).
Mycoplasma. Mycoplasma species possess a fully functional PTS 
for the transport of sugars. Genetic evidence indicates that this interacts 
with AC. However, in contrast to E. coli, Mycoplasma produce more cAMP 
during growth with glucose than with fructose (Mugharbil and Cirillo, 1978).
Mycobacteria. Cyclic AMP production has been demonstrated in 
M. smeqmatis (Lee, 1977), M. microti (Lowrie et al., 1975) and 
M. tuberculosis (Padh and Venkitasubramanian, 1979). In M. tuberculosis 
and M. smeqmatis cAMP production is inhibited by glucose. The significance 
of this is not known as M. smeqmatis lacks any detectable cAMP binding
activity (Padh and Venkitasubramanian, 1980). Lowrie et al. (1975) 
suggested that M. microti may protect itself within phagocytes by releasing 
cAMP and thus preventing phagosomal-lysosomal fusion.
Pseudomonas aeruginosa.. The role of cAMP in Ps. aeruginosa is not 
known. Intracellular levels of cAMP do not alter with growth;conditions 
and exogenous cAMP fails to relieve catabolite repression of glucose 6- 
phosphate dehydrogenase by succinate (the preferred energy/carbon source) 
(Phillips and Mulfinger, 1981).
Streptomycates. Cyclic AMP has been reported to be involved in anti­
biotic production in streptomycetes. In So qriseus, cAMP inhibits 
production of candicidin, but this is thought to be a non-specific effect 
and due to phosphate inhibition (Martin and DeMain, 1977). In So hyqroscopius, 
turimycin production is inhibited by phosphate which can be reversed by 
exogenous cAMP (Gersch et al., 1978). It has been suggested that cAMP 
may be involved in the change over from primary metabolism (growth) to 
secondary metabolism (antibiotic synthesis) (Gersch, 1979).
Vibrio chderae. V. choleras mutants lacking AC have been isolated 
and show many analogies-with eya E a coli mutants eg. pleiotropic deficiency 
in carbohydrate utilization, lack of flagella, and defects in the cell 
envelope (Yokota and Kuwahara, 1974).
Nitrogen-fixing bacteria. Nitrogen fixation is an energetically 
expensive process and cAMP appears to play a role in several nitrogen- 
fixing bacteria in co-ordinating the expression of nitrogen fixation.
Exogenous cAMP has been reported to stimulate derepression of nitrogenase 
in Azotobacter vinelandi (Lepo and Wyss, 1974)o In Anabaena variabilis. cAMP 
levels are lower when the organism grows heterotrophically than when 
growing autotrophically. When starved of a fixed nitrogen source, cAMP 
levels rise (Hood et al.. 1979). Exogenous cAMP represses formation 
of glutamine synthetase,glutamate synthase and glutamate dehydrogenase.
This in turn probably enhances expression of nitrogen fixation (Upchurch 
and Elkan, 1978).
As mentioned previously, cAMP is not ubiquitous in bacteria.
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Despite intensive searches, cAMP has not been detected in several species 
of Bacillus (Bernlohr at al., 1974; Sarkar and Paulus, 1975; Setlow and 
Setlou, 1978), in Bacteriodes fraqilus, an obligate.anaerobe (Siegel et al., 
1977) or in Lactobacillus pl'antarum (Sahyoun and Durr, 1972). Whether 
cAMP or it's metabolic enzymes exist in Neisseria gonorrhoeas is disputed 
by two groups (Morse et al., 1977; Morris and Lawson, 1979).
Ullmann(1974) has questioned whether the observed effects of exogenous 
cAMP in all organisms are related to underlying ijn vivo mechanisms.
Bacillus megaterium lacks cAMP and it's metabolic enzymes, and yet still 
exhibits catabolite repression which can be relieved by exogenous cAMP.
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PART 3: EXPRESSION OF VIRULENCE
1. Variation in Virulence
Virulence is not a permanent feature of pathogens, but is subject to 
variation depending on past and present growth conditions. Nor are the 
responsible components essential for growth under all conditions. It has 
long been recognised that virulence of many pathogens is lost during 
subculture iji vitro and can be regained with animal passage. The smooth 
to rough transition is a classical feature of several species.
Pathogenic determinants have been studied mainly using jji vitro grown 
organisms for the sake of convenience. However, the need to study 
pathogens during and after jj} vivo growth has been stressed (Smith 1958, 
1964). Indeed, several pathogenic determinants only became recognized 
after the organism had been grown irj_ vivo. Examples include the toxin of 
Bacillus anthracis, surface components of Yersinia pestis which inhibit 
phagocytosis, and surface components of Brucella abortus which protect 
against intracellular bacteriocidins of phagocytes (Smith 1958, 1976). This 
may explain why some attenuated vaccines, such as BCG for tuberculosis and 
519 for contagious abortion, are more effective than heat-killed vaccines. 
Similarly, expression of protective antigens only during growth iji vivo, 
may explain why natural infection and recovery affords greater protection 
than vaccination for many infectious diseases.
Neiseria gonorrhoeas grown in chambers subcutaneously■ 
implanted in guinea pigs showed enhanced resistance to human phagocytes 
and human serum (Penn et al», 1977). Resistance to human serum was a 
phenotypic change whereas resistance to phagocytes was due to selection 
for mutants.
Another feature of several pathogens grown jji vivo is a tendency 
to become more permeable by changes in the cell wall, or call membrane.
In some cases, the cell wall may largely disappear giving rise to the 
L-phase variants. Increased leakiness of pathogens may contribute to
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in vivo survival by allowing freer entry of nutrients. L-phase variants and 
"leakiness" may be important properties of intracellular pathogens, and 
pathogens associated with chronicity and latency (Smith, 1976).
While some of the above may be due to selection of genotypes, others 
involve phenotypic changes. Smith (1977) has suggested that growth- 
limiting conditions in the host may contribute to phenotypic changes.
Two main mechanisms exist which enable flexibility of expression 
of virulence factors in pathogens. One of these is that many pathogenic 
determinants are plasmid- or phage-encoded (Elwell and Shipley, I960; Maas, 
1981). The other is that regulatory mechanisms exist such that 
determinants are only expressed under certain circumstances. Other 
less well-defined mechanisms may exist. Norlander et al. (1979) reported 
that virulent l\l. qonorrhoeae subcultured ijn vitro gave rise to a large number 
of avirulent colonial variants. This variation occurred after active 
growth and was sensitive to deoxyribonuclease. These workers suggest that 
transformation and recombination mechanisms were responsible for the 
rapid rate of colonial variation. Variation in flagellar antigens in 
Salmonella (phase variation) involves an invertible DNA segment which 
undergoes "site-specific" recombination by virtue of inverted repeat 
sequences (Makela and Stocker,1981).
2. Regulation of Virulence Factors
It has long been recognized that production of toxins and aggressins 
is often influenced by the composition of the medium and the stage of 
growth. However, it is only recently that molecular genetics has entered 
the field of microbial pathogenicity and little is known of the regulatory 
mechanisms involved.
Based on studies of toxin production, isolation of mutants defective 
in toxin production, and sometimes the mapping of mutations, a few 
transcriptional regulatory models have been proposed. It has long been known
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that iron represses synthesis of diphtheria toxin. Murphy ^  al. (1978) 
proposed that iron acts as a co-repressor which forms a complex with a 
protein repressor encoded by the chromosome. The iron-repressor complex 
presumably acts at the corynephage p tox operator locus, preventing 
transcription. Mekalanos and Murphy (1980) suggested a protein repressor 
mechanism for the regulation of toxin production by V . choleras. A common 
regulatory mechanism for the synthesis of protein A, coagulase, alpha- 
toxin and.other exoproteins by Staphylococcus aureus has been proposed.
This involves the activation of a factor, possibly by an intermediate 
metabolite, which stimulates transcription (Bjorklind and Arvidson, 1980).
A number of virulence factors or possible virulence factors in 
different organisms may be regulated in part by cAMP (Table 5). However, 
there is no evidence to indicate that the regulatory mechanisms involved are 
the same as those for the lac, qal and ara opérons of E. coli.
In Part 2 it was mentioned that cAMP was a cytoplasmic indicator 
of carbon insufficiency. A corollary from this with regard to regulation 
of virulence factors by cAMP might be that optimum expression of pathogenic 
determinants occurs when the level of certain nutrients is low, as is 
likely to occur during the initial stages of infection. This mechanism 
would enable the pathogen to lodge and invade the host, combat the host 
defence mechanisms, and thus gain access to better nutritional environments, 
Certain pathogens such as Bacillus anthracis and Streptococcus pneumoniae 
multiply rapidly in_ vivo only during the terminal stages of infection 
after the host defence mechanisms have been overcome (Smith, 1958),
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Table 5; Virulence factors of microbial pathogens possibly controlled
by cAMP
Virulence factor Positive or Criterion Reference
negative
influence
Type 1 pili in E. coli +/-
Type 1 pili in +
5. typhimurium
Heat-stable cnterotoxin +
of E, coli
Heat-labile enterotoxin 
of E . coli
Alpha-toxin of +
Staphyloccocus aureus
n protein of +
Streptoccocus pyogenes
Aflatoxin of Aspergillus -
parasiticus
Yeast to mycelial trans=- +
ition in Candida albicans
Yeast to mycelial trans- +
ition in Histoplasma 
capsulatum
Pectate lyase in Erwina +
carotovora
B, C 
B, C
A, B, C
A, C
c".
Eisenstein et al. (1981) 
Saier et al. (1978)
Alderete and Robertson (1977) 
and Martinez-Cadena e^ al. 
(1981)
Gilligan and Robertson (1979)
Duncan and Cho (1972)
Pine and Reeves (l978)
Applebaum and Buchanan (1979)
Nimi et al. (1980)
Medoff et al. (1981)
A, C, D Tsuyuma (1979)
a, as for Table 4; b, dependent on strain; c, phenotype promoted by exogenous 
dibutyryl cAMP.
OBJECT OF RESEARCH
b3
B. pertussis produces several pathophysiologically-active components. 
Some of these have been implicated as virulence factors in the patho­
genesis of pertussis, some as protective factors in immunity to pertussis 
and some as responsible for the reactogenicity of the vaccine. With 
knowledge of how these various components are regulated in B. pertussis, 
it may be possible to manipulate their production by either cultural 
or genetic means. This could be used to provide a better starting point 
in the production of a more acceptable vaccine. Such knowledge might also 
be useful if B. pertussis activities were to be cloned, for example in 
E. coli. It is also of basic importance to understand how a pathogen 
regulates it's physiology in response to the host environment.
Many of the pathophysiological activities of B. pertussis are lost 
during the phenotypic changes of antigenic modulation and the genotypic 
changes of phase degradation. This suggests that a common regulatory 
mechanism lies at the root of these two processes.
In view of the regulatory role that cAMP plays or may play in certain 
bacterial species in the synthesis of many proteins, including some 
associated with virulence, it is conceivable that cAMP plays a major 
regulatory role in the synthesis of virulence factors in Bo pertussis.
The observation that AC activity is extensively reduced in C-mode and . . 
phase IV variants, compared to their X-mode and phase I counterparts, 
has led to the suggestion that. AC may be the target site of both modulation 
and phase degradation (Parton and Durham, 1978; Hewlett et al., 1979a; 
Wardlaw and Parton, 1979). The main aim of this project was to determine 
whether the loss of AC activity had a causal or coincidental relationship 
towards the loss of virulence factors,and to assess the role of cAMP in 
governing the expression of these factors.
MATERIALS AND METHODS
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I. Cultivation. Preparation and Standardization of Bacteria
1,1 Organisms, strains and storage
Organisms and strains used are shown in Table 6 0 Lyophilized 
suspensions of B. pertussis strains were reconstituted and grown on 
BG at 35°C for 3 or 4 days. Confluent growth was resuspended to give a 
turbid suspension in 1% (w/v) casamino acids,pH 7.0 (Appendix 1) containing 
10^ (v/v) glycerol and was stored either at -70°C or in liquid nitrogen.
Eo coli strains were stored suspended in saline (0.85^ (w/v) IMaCl) at 
-70°C.
1.2o Media
BG (Gibco Biocult Ltd.), Nutrient agar (Oxoid), and MacConkey agar 
(Oxoid) were made up according to the manufacturers instructions, BG 
was supplemented with 20^ (v/v) defibrinated horse blood (Gibco Biocult Ltd.) 
The procedure for preparation of BG-X and BG-C (X- and C-mode BG made 
from basic ingredients is given in Appendix 1),
Liquid media were:- 1, SS-X arid SS-C (X- and C-mode Stainer and Scholte 
medium (Stainer and Scholte, 1971)); 2, H-X and H-C (X- and C-mode 
modified Hornibrook medium (Wardlaw et alo. 1976)); 3, Yeast Glucose 
medium (Pastan et al.. 1974). The procedure for preparation of media 
is given in Appendix 1q SS-X was often modified as described in the Results. 
Heat-labile additives (viz. bovine catalase, chloramphenicol, phosphonomycin 
and N-methyl-N'-nitro-N-nitroso-guanidine (NTG)) were filter sterilized 
before adding aseptically to the autoclaved media (15 psi, 121°C for 
15 min). Media containing cAMP and N ,0 '-dibutyryl cAMP were pH adjusted 
after their addition and filter sterilized. All other ingredients, were 
added prior to pH adjustment and autoclaving.
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1,3o Growth and cultivation
Frozen suspensions of B# pertussis were allowSd to thaw and then spread 
on BG plates. BG plates were incubated in sealed plastic boxes at 35°C 
for 48 - 72 h.Bacteria vvereresuspended in a small volume of sterile 
liquid medium which was used to inoculate flasks of medium./ Except 
where stated, cultures refer to shake cultures grown in media contained 
in dimpled Ehrlenmsyer flasks (2 L flasks containing 0.5 L or 1 L of medium, 
or 250 ml flasks containing 50 ml or 100 ml of medium) which were 
incubated at 35^C on an orbital shaker at 100 cycles min ^. Static 
cultures were grown in 250 ml flasks containing 25 ml of medium which 
were incubated at 35°C. Purity of cultures was checked by Gram-staining 
and slide agglutination with phase I B. pertussis antiserum. Liquid 
cultures were harvested by centrifugation at 10,000 x g for 15 min at 4°C.
1o4. Standardization of bacterial suspensions
Bacterial suspensions were standardized either by opacity, 
absorption at 66Gnm or by protein concentration. Opacity units (ou) 
were determined by noting the dilution of the suspension which gave 
the same opacity (as judged by eye) as a 10 ou reference (the International 
Opacity Standard obtained from W.H.0.oInternational Lab. for Biol. Standards, 
Nat. Inst for Biological Standardization and Control, Holly Hill,
Hampstead, London). Protein concentration was determined by the Lowry 
method modified for use with whole cells (Herbert et al., 196?) using 
bovine serum albumin as a standard. For convenience, a standard 
curve of absorbance at 660 nm versus dry weight and protein concentration 
was constructed. B. pertussis Taberman was grown for 48 h in SS-X and SB-C 
and harvested. Pellets were resuspended in saline to give a range of 
absorbance values, and samples were assayed for protein concentration.
To determine dry weights, large samples (75 ml) were centrifuged and the 
pellets resuspended in a small volume of distilled water. Pellets 
and centrifuge tube rinses were filtered onto previously weighed 
membrane filters (47 nm diameter, 0.45 pm pore size) and dried to constant
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weight. Figure A1 (Appendix 2) is a plot of the combined results 
from two experiments,
1.5. Cell disruption
Cell lysates were prepared by passing frozen cell suspensions 
three times through a LKB X-press (Biotech Ltd., Stockholm).
2. Biochemical Methods
2.1. Adenylate cyclase assay
This was based on the method described by Hewlett and Wolff (1976), 
but with the ATP regenerating system omitted (creatine phosphokinase 
is now known to be contaminated with B. pertussis AC activator). Test- 
tubes containing 80 pi of 180 mfl N-tris-(hydroxymethyl)-methyl glycine 
(Tricine) pH 8.0, and 40 pi of enzyme, were incubated for 4 min in a 
30°C water bath. The reaction was started by the addition of 120 pi 
2 mM ATP in 20 mil FlgCl^* After 10 min, the reaction was terminated 
by the addition of 1 ml cAMP assay buffer (Appendix 3) and immersion in a 
boiling water bath for 10 min. Samples were stored sealed at -20°C and 
assayed for cAMP at a later date. Up to 100 pg protein of sample was 
present in assay mixtures. Samples were assayed in duplicate.
Intact cells were often used as an enzyme source and their activity 
was referred to as intact-cell AC activity. Harvested cells were 
resuspended in saline and standardized by measuring the absorbance at 
66Unm. Cell suspensions were assayed as soon as possible and not stored 
fxozen unless cell lysates were to be used as an enzyme source.
Specific activity was standardized by protein concentration which was 
determined using a calibration graph (Appendix 2, Fig. Al). X- and C-mode 
lysates heated at 100°C for 10 min destroyed all detectable activity 
when 100 pg protein of sample was assayed for activity (>99^ and ^80^ 
loss of activity for X- and C- mode cell lysates respectively).
When additional compounds were present in the assay mixture, as 
described in the Results, they were dissolved in 180 mM Tricine buffer, pH 8.0,
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at three times their final concentration in the assay mixture and added 
in place of unmodified Tricine buffer.
2.2. Cyclic AMP assay
. Cyclic AMP was assayed by the cAMP binding protein method of Gilman. 
(1970). This assay is based on the competition between unlabelled cAMP 
and a fixed quantity of [^h ] cAMP, for a highly specific binding protein. 
Unbound cAMP is removed by the addition of activated charcoal followed
r-3 -,
by centrifugation. Protein-bound [ Hj cAMP, in the supernate, is inversely 
proportional to cAMP in the sample.
The following reagents (preparation given in Appendix 3) were added 
to 8 X 75 mm test-tubes, which were incubated in an ice bath:- (1) 50 pi 
of sample or standard, (2) 50 pi of [^h ] c AMP reagent, (3) 100 pi of 
binding-protein reagent. Standards consisted of a doubling dilution series 
of cAMP ranging from 16 - 0.25 pmol per tube. Cyclic AMP assay buffer 
was added in place of sample or standard in two tubes ("C^ tubes")*
Two "blank" tubes contained 100 pi cAMP assay buffer in place of 
binding-protein reagent. All tubes were vortex-mixed and incubated on 
ice for 2 - 3 h. Charcoal reagent (100 pi) was added to 40 tubes at a time. 
These were vortex-mixed and immediately centrifuged (within 5 min of adding 
charcoal reagent to the first tube) for 3 min at 3,000rpm (2,300 x g) in 
a MSE Mistral 6L centrifuge, Supernate (200 pi) was carefully removed into 
scintillation vials and 3 ml of scintillant fluid (Packard 299) was added.
Vials were counted for 5 - 10 min in a Packard Tri-Carb scintillation 
counter. Vials containing 50 pi of [^h J cAMP reagent plus 3 ml scintillant 
fluid were also counted to determine the binding efficiency of the binding 
protein.
The cpm obtained from the "blank" tubes were subtracted From all other 
counts, C^ was designated as the average blank-subtracted cpm obtained 
from the "C^ tubes". C^ was designated as
the variable blank-subtracted cpm obtained from each sample and standard tube. 
The C /c was plotted against cAMP concentration of the standards i.,hinh
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was used to determine the cAMP levels in the unknowns. A typical standard 
curve is.shown in Appendix 2, Fig, 2A.
To test the authenticity of cAMP detected in culture supernate and 
after enzyme/substrate-incubation, some samples were incubated with 10 pg ml  ^
bovine heart 3*,5*-cyclic nucleotide phosphodiesterase and 10 mMMgClg 
for 20 min at 3D°C. In testing the validity of cAMP assays, cAMP assay 
buffer was not added until after the phosphodiesterase treatment as 
ethylenediamine-tetraacetic acid (EDTA), which is present in the buffer, 
inhibits phosphodiesterase activity. At least 96^ of culture supernate 
cAMP was destroyed and >99% and >80% of cAMP produced in 10 min by X- and 
C-mode lysates respectively were destroyed.
2.3, Cyclic AMP binding assay
Cyclic AMP binding activity was determined in extracts of B. pertussis 
and E. coli by the method described by Pastan e_t al.(1974), B. pertussis 
strains were grown in SS-X or SS-C for 48 h and E. coli strains were grown 
in Yeast Glucose medium for 18 h# Harvested cells were resuspended in 
buffer A (Appendix 3) to give a thick suspension. Suspensions were 
X-pressed and centrifuged at 100,000 x g for 1 h, Supernates were removed 
and incubated at 4°C overnight with pancreatic deoxyribonuclease (5 pg ml"^) 
and pancreatic ribonuclease (5 pg ml ^). Samples were adjusted to 20 mg ml"^ 
protein.
Nucleotide reagents were prepared in 10 mM potassium phosphate pH 7,7, 
with the pH adjusted, if necessary,with NaOH. The assay was performed in 
an ice bath. To 2 ml centrifuge tubes were added 30 pi of 33 mM 5*-AMP,
3.3 pM [^H] c AMP (specific activity 1.52 pCi nmol"'*) and 70 pi of sample. 
Control "blank" tubes, one for each sample tube, contained 30 pi of 
33 mM 5'-AMP, 33mM [^h ] c AMP (specific activity 0,152 pCi pmol ^) and 
70 pi of sample. Control "total" tubes contained 70 pi of sample. Tubes 
were vortex-mixed and after 5 min incubation, 0,4 ml of cold saturated 
added. Vortex-mixed tubes ware centrifuged at 12,000 x g, 
in a Beckman Microfuge, for 5 min, Supernate was carefully removed with
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a Pasteur pipette and the remaining moisture was absorbed with a cotton- 
tipped applicator stick. To "total" tubes was added 30 pi of [^ H'j cAMP 
(0,5 pCi ml ^), Pellets were dissolved in 0,5 ml TS-2 tissue solubilizer 
(Koch-Light) and transferred to a vial containing 10 ml Triton-Toluene 
scintillant (Appendix 3), The pipette and tube were washed several times 
with scintillation mixture. Vials were counted for 10 min in a Packard 
Tri-Carb 300 scintillation counter, after leaving in the dark for
several hours until stable counts were obtained. The average cpm of vials 
containing 10 ml scintillant fluid only, was subtracted from the cpm of 
the other vials.
Binding activity (pmol [^h ] cAMP bound mg(protein) ^) was determined 
using the equation:-
(5 - B)/(T X  10) X  A X  l/P 
where S is the cpm obtained from assay tube, B is the cpm obtained from 
"blank" tube, T is the cpm obtained from "total" tube, A is pmol of cAMP 
per assay tube (ie, 100) and P is the mg protein per tube (is, 1,4), Samples 
were assayed in triplicate,
2,4o Cyclic AMP uptake measurements
B, pertussis was grown in SS-X or SS-C for 48 h. Harvested cells
were washed once in saline and then resuspended in SSX or SSC buffer
(Appendix 3) to give an A^GOnm^^ mg(dry weight) ml"^). Cell
suspensions were incubated at 35°C for 10 min before addition to the 
reaction mixture. The reaction mixtures consisted of 9 ml SS-X or SS-C 
with 1 mM [^h ] cAMP or 1 mM [^h ] 0^'-dibutyryl cAMP (specific activity
5 pCi pmol ^) and were preincubated in a 35°C shaking water bath. The 
reaction was started by the addition of 1 ml cell suspension to the 
reaction mixture. At timed intervals, 1 ml was rapidly filtered through 
cellulose acetate/membrane filters of 25mm diameter and 0,45 pm pore 
size (Oxoid) which previously had been washed with SSX buffer. The
filters were washed twice with 3 ml SSX buffer and dried in scintillation
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vials under an infra-red lamp. Triton-Toluene scintillant (10 ml) was 
added and vials counted for 10 min. "Blank counts"' were obtained by 
filtering 0.9 ml of reaction mixture prior to the addition of cell 
suspension. These were washed, dried and counted in the same way as for 
samples, "Total counts" were obtained by adding 25 pi of reaction mixture 
to a filter which was dried and counted in 10 ml of scintillant. The 
background count, of a vial containing 10 ml of scintillant only, was 
subtracted from these. The following equation was used to obtain 
nmol mg (dry weight)
(X - B)/(400 X T) X  A X  i/o 
where X is the cpm of sample, B is the cpm obtained From "Blank", T is the 
back ground-subtracted cpm obtained from "Total", A is the nmol of cAMP
I
or dibutyryl cAMP in reaction mixture (ie, 10,000) and D is the mg dry 
weight of cells filtered (ie, 0.3),
2.5, Measurement of respiration rate
B. pertussis was grown in 100 ml of SS-X or SS-C for 48 h. These 
cultures were used to inoculated 1 L volumes of SS-X or SS-C (10% (v/v) 
inoculum) and after 24 h growth,cultures were harvested. Cells were 
washed twice in SSX to give an A^GOnm^^ 25 (15 mg(dry weight) ml ^),
Cell suspensions were incubated at 35°C for 15 min to use up endogenous 
substrates and thereafter at 4°C for up to 1 h while samples were 
removed to measure respiration rates.
Respiration rates were measured using a Clark oxygen electrode 
(Yellow Springs Instrument Co. Inc., Yellow Springs, Ohio), SSX buffer 
(3 ml), and 100 pi cell suspension, were placed into a chamber with a 
magnetic stirrer, and allowed to equilibrate at 35°C, The oxygen 
electrode was inserted taking care not to trap any air bubbles, and oxygen 
uptake was monitored for several minutes to determine the respiration rate 
due to endogenous substrates (endogenous rate). Substrates were prepared 
in SSX buffer to give 0o2 M and a pH of 7.3, Substrate (0,3 ml) was 
injected into the chamber with care taken to ensure no entry of air
bubbles. Oxygen consumption was monitored for several minutes to determine 
the exogenous rate ( details of calculations are given in Appendix 4).
2.6. Polyacrylamide gel electrophoresis
Sodium dodecyl sulphate-polyacrylamide-gel electrophoresis (SDS-PAGE) 
was done using a discontinuous buffer system, based on the methods of 
Ames (1974) and Laemmli(1970). Separating and stacking•gels contained 
11% and 5% (w/v) acrylamide respectively and were set in B.O x 8.0 x 0.3 cm 
glass moulds. Both gels and electrode buffers contained O.T^I (w/v) SOS. 
Buffers and gels are described in Appendix 5. Gels were run at a constant 
current (15 mA per' gel) in a Uniscil slab gel electrophoresis unit.
For SDS-PAGE of whole cells, harvested cells were washed once in saline
/ -1  \ and resuspended to give an of 5.0 ( about 2 mg protein ml ).
Cell suspensions were mixed with an equal volume of solubilizing buffer
(Appendix 5) and heated at 1D0°C for 5 to 10 min. Samples of 25 pi or
50 pi were added to each track of the gel. To estimate molecular weights
of separated polypeptides, a solubilized mixture of standard proteins
was run in parallel with samples. The standard protein mixture consisted
of bovine serum albumin, ovalbumin, chymotrypsinogen, trypsin and
cytochrome C (200 pg ml  ^ of each in distilled water). The protein
mixture was solubilized in the same way as samples. A standard curve of
distance migrated versis log of molecular weight was used to estimate
molecular weights of polypeptides in samples.
3. Miscellaneous
3.1. Histamine-sensitizing activity
Harvested cells were resuspended in saline to 100 ou. Suspensions 
were heat-killed (56°C for 30 min) and stored at 4°C with merthiolate 
(0,01% (w/v)). Seven to ten-week old mice (HAM/icR) were injected 
intraperitoneally with graded doses of vaccine (0.5 ml per mouse).
Mice were challenged 5 days later with 3 mg histamine dihydrochloride in
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0.5 ml saline. Survivors were counted 3 h after challenge. The results 
were analysed by the probit method (Finney, 1971),using a computer programme 
developed in the Dept, of Epidemiology and Biometrics, School of Hygiene, 
University of Toronto, Canada.
3.2. Haemaqqlutinin activity
HA assays were performed using microtitre trays. Saline (50 pi) 
was added to each well. Sample (50 pi) was added to the first two wells 
in each row and doubling dilutions were made from the second well 
along each row. A washed 2% horse red-blood cell suspension (50 pi) 
was added to each well. The contents of wells were mixed and the trays 
incubated for several hours at 4°C, The HA titre was recorded as the 
reciprocal of the highest dilution giving complete haemagglutination.
Samples were assayed in duplicate.
3.3 Ouchterlony double diffusion precipitin test.
Gel-diffusion medium (Appendix 3) was poured into glass plates 
and allowed to set, Wells were cut out (5 mm diameter, 5 mm apart) and 
a drop of molten medium was added to seal the base of each well.
Samples were added to the wells (100 pi) and plates were stored in sealed 
containers for several days,
3.4. "Crossed-over" Immunoelectrophoresis
This was based on the method described by Culliford (1954).
Immunoelectrophoresis is used to draw antigens and antibodies together
as most antigens,at pH 8.3, migrate towards the anode while antibodies
migrate towards the cathode. This results in a more rapid and intense
precipitin line compared to a double diffusion system. Molten 0.75%
barbitone agar, pH 8,3 (Appendix 3), was pipetted onto clean glass slides
(75 X 50 mm) on a level surface and allowed to solidify. Wells (1.5 mm
diameter) were cut in the agar and filled with about 10 pi sample. 
Electrophoresis was done in barbitone buffer, pH 8.3, at 100 V for
74
30 min using a Shandon electrophoresis apparatus (Kohn type).
To intensify the precipitin lines formed, a staining procedure was 
dona. The slides were immersed in barbitone buffer pH 8.3 overnight to 
remove unreacted protein, washed twice in distilled water (15 min per 
wash) and stained with nigrosine solution (saturated in 2% (v/v) acetic 
acid) for 10 min. Slides were destained by washing in 2% (v/v) acetic acid 
followed by 2% (v/v) acetic acid, 1% (v/v) glycerol.
3.5. Raising of antiserum
Sample was mixed with an equal volume of Freunds incomplete adjuvant 
until a stable water-in-oil emulsion was obtained. The emulsion (1 ml) 
was injected into the muscle of each hind limb of a rabbit. Two further 
intramuscular injections of the same material (1,5 ml) were administered 
at two-weekly intervals. Blood samples were taken from the ear before 
each injection. Six weeks after the first injection, the rabbit was bled 
out by cardiac puncture. The blood was allowed to clot for 1 h at room 
temperature and then stored at ~20°C.
Goat anti-CRP was a gift from Dr., I. Pastan, Lab, Molec. Biol.,
Nat, Cancer Inst,, NIH., Bethesda, Maryland,U.S.A. U.S. standard Do pertussis 
antiserum (rabbit) was obtained from Dr, C. R. Manclark, Biologies 
Standards, NIH., Bethesda, Maryland, U.S.A.
3.6. Viable counts
Viable counts were obtained by doing 10-fold serial dilutions of 
cultures in sterile saline. Appropriate dilutions (0.05 ml) were spread 
on dry BG plates (three for each dilution) which were incubated for 
several days until colonies could be counted easily. Confidence limits 
(95%) were calculated using a weighting method where counts obtained From 
a large number of observed colonies are given more credibility (A. Co Wardlaw, 
personal communication).
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3.7. Chemicals
Nucleotides, commercial enzymes and proteins, activated charcoal. 
Reactive-red Agarose and antibiotics were purchased from Sigma Chemical Co. 
Tritiated compounds were purchased from The Radiochemical Centre, Amersham. 
Diethylaminoethyl- (DEAE-) cellulose, Sephadex G-200 and Blus-dextran 
Sepharose were products of Pharmacia, and Aquacide 11A was a product of 
Calbiochem. NTG was obtained from Aldrich Chemical Co.
RESULTS
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1. A Study of Different Possible Modulating Compounds.
Loss of histamine-sensitizing activity (HSA), the 28k and 30k cell- 
envelope gel bands (X bands) and AC activity occurs when B. pertussis is 
grown in media where the NaCl is replaced by MgSO^ or in media with higher 
than normal levels of nicotinic acid (4.1 mM). Lacey (1960) reported that 
several anions, cations and organic acids could induce C modulation. The 
effect of several of these, and nicotinic acid, on the production of AC 
activity, the X bands and HSA was investigated. The simultaneous loss of 
these would be consistent with the hypothesis of a common regulatory 
mechanism, possibly involving AC, perturbed by pro-C-mode substances.
B. pertussis was grown for 48 h in SS-X where the NaCl was replaced 
by various salts at concentrations which Lacey (i960) reported to cause 
C modulation, NaCl was present at the normal concentration (43 mM) in 
medium containing Na caprylate or high levels of nicotinic acid, to retain 
the osmolarity of these media. After 48 h growth, cultures were centrifuged. 
Culture supernates were assayed for cAMP and AC activity and harvested cells 
were assayed for HSA, intact-cell AC activity and were analysed by SDS-PAGE.
1.1 Adenylate cyclase activity
Growth in several modifications of SS-X caused a severe reduction in 
intact-cell AC activity (Table 7). These results are the averages for 
two experiments. Intact-cell AC activity varied with the strain used after 
growth in unmodified SS-X, whereas, after growth in medium containing 
Na^SO^, MgSO^ or Na butyrate, all strains showed a marked reduction in 
AC activity. Growth in these latter media, caused 89 - 98% loss of activity 
when compared with NaCl-grown cells. Na caprylate-induced loss of AC 
activity appeared .to be strain specific, causing loss for strain 18334 
but not for strain 18323. Growth of strain Taberman was inhibited by 
0.6 mM Na caprylate. Na lactate-induced loss of AC activity, also appeared 
to be strain specific, and only occurred in strain Taberman. However, this
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loss of AC activity was less severs than that caused by MgSO^, Na^SO^,
Na succinate, Na butyrate, or nicotinic acid. Unexpectedly, high levels 
of MgClg caused no significant loss of AC activity for any strain.
Loss of intact-cell AC activity was not due to release of AC as 
the culture supernate AC activity paralleled the intact-cell AC activity 
for strain Taberman (Table 8). Results refer to averages of two experiments.
Hewlett e_t (1978) reported B. pertussis AC could be stimulated
240-fold by an activator present in many mammalian tissues and as a 
contaminant of many commercial protein preparations. Bovine catalase was 
a particularly good source of activator. This activator has recently been 
identified as calmodulin (Wolff et al., 1980). It was of interest to 
determine whether commercial bovine catalase could stimulate intact-cell 
AC activity after growth in various modulating conditions, since it has 
been suggested that activator may play a role in facilitating the parasitic
state of the organism (Hewlett et al., 1978). Intact-cell AC activity
was responsive to activator (present as commercial bovine catalase), 
whether growth conditions had or had not induced loss of AC activity (Table 9). 
However, the extent of activation was reduced by 11 - 50% in'the latter.
Bovine liver catalase was present in the assay mixture at a final concentration
of 1 mg ml . Results refer to the averages of two determinations.
In proposing AC as the target site for modulation or as one of the 
causal factors, it was of interest to determine culture supernate cAMP 
levels after growth in various modifications of SS-X. Culture supernate 
cAMP is presumably a good indicator of cytoplasmic AC activity during 
growth, assuming that the substrate ATP is exclusively intracellular.
The majority of cAMP produced during growth is excreted into the medium 
as cAMP levels were the same whether determined from whole cultures 
(heat treated at 1G0°C for 10 min and centrifuged at 12,000 x g for 10 min), 
from culture supernate, or from heat-treated (100°C for 10 min) culture 
supernate (results not shown). Growth in media which resulted in a marked
79
Table B; Culture-supernate AC activity of strain Taberman after
growth with various additives
Strain Taberman was grown for 48 h in SS-X where the NaCl had been 
replaced by other additives. Culture supernate was assayed for AC activity,
Additive and final AC activity^ (and % Relative to standard^
concentration (mM) standard deviation)
NaCl 43 180 (53) 100
MgSO^ 20 16 (2) 9
MgClg 43 151 (35) 84
NagSO^ 43 17 (5) 9
Na lactate 86 52 (23) 29
Na succinate 86 34 (10) 19
Na butyrate 20 15 (2) 8
Nicotinic acid^ 4.1 19 (5) 11
“1 -1
a, pmol cAMP min ml ; b, standard refers to NaCl-grown cultures;
c, this medium also contains NaCl (43 mM).
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reduction in intact-cell AC activity, also had much reduced levels of
culture-BUpernate cAMP compared to NaCl-grown cultures (Table 10). Results
refer to averages of two experiments# Growth in medium containing high
levels of MgClg resulted in about a 1.4-fold increase in cAMP levels compared
to standard NaCl cultures. This may be related to the fact that optimum
++AC activity requires an optimum concentration of Mg ions. (Hewlett and 
Wolff, 1976).
1.2, Histamine-sensitizing activity
Growth in media which resulted in severe loss of intact-cell AC activity 
(ie. media containing MgSO^, NagSD^, Na butyrate, Na succinate, and 
nicotinic acid) caused a similar loss of HSA (Table 11). Results refer to 
cell suspensions prepared from selected cultures. Data, from which 
results were calculated, are given in Appendix 6, Tables Al, A2 and A3.
Growth of strain Taberman in medium containing Na lactate resulted in a 
less severe loss of HSA (82%) which was paralleled by a similar loss of 
AC activity (89%) (Table 7).
1.3. The X bands
Plates 1 A, IB and 1C show the SDS-PAGE analysis of whole cells of 
B. pertussis after growth in modified SS-X media. Extensive loss of 
the X bands correlated with extensive loss of AC activity and HSA. 
Moreover, these bands were detectable, although fainter, after growth of 
strain Taberman in medium containing Na lactate, where extensive 
but incomplete loss of AC activity and HSA occurred.
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Plate 1 ; SDS-PAGE profiles of B. pertussis cells after growth with
various additives
Strains were grown for 48 h in SS-X where the NaCl had been replaced
various additives. Washed cells were analysed by SDS-PAGE.
strain Taberman; B, strain 18334; C, strain 18323.
Lane Additive and final concentration (mM)
a NaCl 43
b MgSO^ 20
c MgClg 43
d Na^SD^ 43
e Na lactate 86
f Na succinate 86
g Na butyrate 20
h Na caprylate
*
0.6
i Nicotinic acid 4,1
*, these media also contained 43 mM NaCl,
I g f •  d c b a
30 k 
28k
L # :  ;
B »• 9 • e d d c c b b/ ' a
b.. h 9 a d . d l ç c b  b • c
30k 
28 k
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2. Location of Adenylate Cyclase Loss after Growth in C medium
Hewlett et al.(l976) demonstrated at least three compartments of 
AC activity in cultures of B, pertussis. About 20% was released into the 
medium, 70% was cell associated, but extracytoplasmip and sensitive to 
trypsin, and the remaining 10% was insensitive to trypsin. It was therefore 
of interest to determine which compartments of AC activity were lost 
during modulation. This would determine if the observed loss of.intact-cell 
AC activity during C modulation was due to the inhibition of translocation 
of AC to the cell envelope,
or SS-C
Strain Taberman was grown for 48 h in SS-Xy(and culture supernates 
were assayed for AC activity. Cell pellets were resuspended to 
20 mg(protein) ml  ^ and divided into three portions. One portion was 
treated with trypsin (40 pg ml ^) for ID min at 37°C, the reaction was 
terminated by addition of lima bean trypsin inhibitor (40 pg ml ^), and 
the sample was X-pressed. The second portion was X-pressed and then given 
the same trypsin treatment. The third portion was X-pressed,not being 
given any treatment* All samples were assayed for AC activity in duplicate 
(Table 12). These results show that AC activity is compartmentalized in 
cultures of both X- and C-mode B. pertussis. The distribution of AC 
activity compares reasonably with that determined by Hewlett et al. (1976). 
However, the results presented here suggest a larger portion of AC activity 
in the supernate. All compartments of AC activity were uniformly lost 
during growth in SS-C (Table 13).
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Table 12: Distribution of AC activity in B. pertussis cultures after
growth in SS-X and SS-C
Strain Taberman was grown for 48 h in SS-X and SS-C, Fractions 
of cultures were assayed for AC activity. Results refer to-total AC activity 
per culture
Growth medium Fraction of culture 
and treatment
Total AC 
activity*
% of AC activity 
of culture
Supernate 221 46
Intact cells 157 33
X-pressed cells 261 54
SS-X
Trypsin-treated cells 
followed by X-pressing
Trypsin-treated 
cell lysate
40 
< 0.2^
8
Supernate 17 65
Intact cells 4.6 18
X-pressed cells 8.9 34
SS-C
Trypsin-treated cells 
followed by X-pressing
Trypsin-treated 
cell lysate
1.3 
< 0.2.
5
a, nmol cAMP min ^; b, limit of detection.
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Table 13: The effect of MgSO^-induced modulation on AC activity
in various compartments of B. pertussis cultures
Location
X-mode
AC activity^
C-mode % relative to X-mode
Culture supernate 221 17 7.6
Cell-associated 221 7.6 3.4
extracytoplasmic^
Cytoplasmic^ 40 1.3 3.3
- 1 -1
a, nmol cAMP min L ; b, extracytoplasmic activity is defined as that 
portion of total cell-associated activity which is sensitive to trypsin 
treatment prior to X-pressing, while cytoplasmic activity is that portion 
which is only sensitive to trypsin treatment after X-pressing cells.
3. Studies on the Rate of flgSO^-Induced Modulation
The loss with time of AC activity, HSA and the X bands, were investigates 
during MgSO^-induced modulation. The purpose was to determine if these 
properties merely diminished in accordance with the growth rate during 
modulation. If so, this would indicate that loss of these properties 
could be accounted for by a complete, cessation in the synthesis of the 
components responsible (ie. AC, pertussigen, and the X polypeptides) 
when X-mode cells were transferred to SS-C. A slower rate of loss would 
suggest partial repression of synthesis, whereas, a rapid loss would 
suggest that inactivation or destructive mechanisms were involved. If 
AC is a causal factor in modulation, one might expect loss of AC activity 
to precede loss of other activities.
Strain Taberman was grown in 1 L of SS-X for 48 h. This was used to 
inoculate SS-C (200 ml of inoculum plus BOO ml of 1.25 x normal strength 
SS-C). A heavy inoculum was required so that sufficient cells in 100 ml 
could be removed at early stages of growth and analysed for AC activity,
HSA and by SDS-PAGE. SS-X (1.25 x normal strength) was also inoculated 
(20% (v/v)) as a control. Media were -warmed to 35°C before
inoculation to minimise any lag phase.
3.1. Growth curves
Figures 2 and 3 show growth curves during the X to X and X to C 
transitions. Biomass was calculated from optical density using a convertion 
factor derived from a standard curve (Appendix 2, Fig. Al). Growth rates 
appeared to be consistently greater in SS-C than in SS-X (Table 14). It 
was a general observation throughout this work that SS-C gave more turbid 
growth and larger pellets than SS-X.
3.2. Adenylate.cyclase activity
During the X to C transition, loss of intact-cell AC activity 
occurred immediately and continued to decline exponentially thereafter
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Figure 2; Changes in biomass during growth of strain Taberman in 
SS-X and SS-C
SS-X and SS-C (1.25 x normal strength) received a 20% (v/v) inoculum 
from a 48 h SS-X culture. Biomass was calculated Using a convertion 
factor relating to dry weight. Biomass was determined for three
experiments (o,A,0) during growth in SS-X (a ) and SS-C (B).
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Figure 3 : Changes in viable numbers during growth of strain Taberman
in SS-X and SS-C
SS-X and SS-C (1.25 x normal strength).received a 20^ (v/v) inoculum 
from a 48 h SS-X culture. At timed intervals viable counts were determined 
using BG plates. Viable counts were determined for two experiments (o,□) 
during growth in SS-X (A) and in SS-C (B). Bars refer to 95^ confidence 
limits.
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Table 14; Maximum growth rates during growth of strain Taberman 
in SS-X and SS-C
A 20^ (v/v) inoculum from a 48 h SS-X culture was given. Results 
are derived from Fig. 2 and 3.
Medium Experiment Doubling time (h) 
using optical density Using viable counts
1 3.7 3.9
SS-X 2 3.5 3.7
3 5.0
1 3.1 2.4
SS-C 2 3.2 2,6
3 3.2
... not done
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(Fig. 4). Intact-cell activity did not alter greatly during growth in 
SS-X.
Culture supernate cAMP levels increased gradually during growth in 
SS-X but appeared to decline slightly during growth in SS-C (Fig. 5) 
suggesting that SS-C may inhibit cAMP synthesis or activate .its destruction.
3.3. Histamine-sensitizing activity
It is difficult to assess the rate of loss of HSA due to the large 
95^ confidence limits of the HSA results (Fig.6). Nevertheless, these
results comply with a gradual loss of HSA during the course of C modulation.
Data,from which results wete calculated, are given in Appendix 6, Table A4*» 
HSA during growth in SS-X was not tested as this has been previously shown 
not to alter greatly (idigbe et al., 1981).
3.4. SDS-PAGE of whole cells
During C modulation, gradual loss of several polypeptides occurred 
(Plate 2, Fig. 7)* A gradual loss of the X bands was observed while the
major 37k band remained relatively constant. Other changes were also
observed, notably the loss of at least two close bands in the region of 
100k. These probably correspond to the 100k band or the 98k and 88k 
bands reported by other workers to be lost during C modulation of 
Bo pertussis (idigbe, 1979; Dobrogosz et al., 1979). Another minor 
polypeptide, with a molecular weight of about 20k, may have been derepressed 
during growth in SS-C. During C modulation, the relative intensity of the
X bands declined exponentially when plotted against time (Fig. 8),
whereas little changes occurred during growth in SS-X.
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Figure 4 ; Intact-cell AC activity during growth of strain Taberman
in SS-X and SS-C
SS-X and SS-C (1.25 x normal strength) received a 20^ (v/v) inoculum 
from a 48 h SS-X culture. At timed intervals samples were removed and 
harvested intact cells were assayed for AC activity. .O, A, AC activity 
after growth in SS-X for two determination^, AC activity after growth
in SS-C for two determinations.
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Figure 5: Culture supernate cAFiP levels during growth of strain
Taberman in SS-X and SS-C
SS-X and SS-C (1.25 x normal strength) received a 20^ (v/v) inoculum 
from a 48 h SS-X culture. At timed intervals samples were removed and 
supernate was assayed for cAMP. O, A, cAMP levels during growth in SS-X 
for two experiments; •, cAMP levels during growth in SS-C for two 
experiments.
100
e
CL
1
ü

95
Figure 6 ; Changes in relative potency of HSA of cells during growth
of strain Taberman in SS-C
SS-C (1.25 X concentrated)receiuBd a 20^ (v/v) inoculum from a 
48 h SS-X culture. At timed intervals samples were removed and harvests 
cells (heat treated at 56°C for 30 min) were assayed for HSA.
0> A , HSA potencies relative to inoculum for two experiments; bars ,indie 
95^ confidence limits.
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Plate 2; SDS-PAGE profilas of B. pertussis cells at various stages
of C modulation'
A 48 h SS-X culture of strain Taberman was used to inoculate SS-C 
(20% (v/v) inoculum). At timed intervals cells were harvested, washed and 
analysed by SDS-PAGE. a, inoculum; b, 2 h; c, 4 h; d, 6 h; e, 8 h; f, 20
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Figure 7 ; Densitometer traces of SDS-PAGE of whole cells of strain
Taberman during C modulation
SS-C (1.25 X normal strength) received a 20% (v/v) inoculum from a 
48 h SS-X culture. At timed intervals samples were removed and washed 
cells were analysed by SDS-PAGE. A, inoculum; B, 2 h; C, 4 h ; D, 6 h; 
E, a h; F, 20 h.
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Figure B : Relative intensities of the X bands during growth of strain
Taberman in SS-X and SS-C
'
Ï
SS-X and SS-C (1.25 x normal strength) received a 20$ (v/v) inoculum
from a 48 h SS-X"culture. Samples were taken at variousitime intervals
/■’
and washed cells were analysed by SDS-PAGE. The intensities of the 
30k and 28k gel bands were standardized against the intensity of the
major 37k band which remained relatively constant whether:cells were grown
I
in SS-X or SS-C. O, relative intensities of the 30k anjd 28k gel bands 
during growth in SS-X; #, A 7  relative intensities of the 30k and 28k 
gel bands during growth in SS-C.
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3.5. Expected loss of activities
Fig. 9 shows the percentage loss of intact-cell AC activity, HSA, 
and the combined intensities of the X bands, which occurred during 
C modulation. It also contains plots of the expected loss of these 
properties assuming no novo synthesis and no inactivation or. destruction, 
These plots were calculated using the growth curves shown in Fig. 2.
These results suggest that the loss of AC activity, HSA and the X bands 
occurs synchronously and that the loss can be accounted for by 100% 
repression of synthesis of AC, pertussigen and the X polypeptides upon 
transfer of cells to SS-C.
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Figure 9 ; Loss of AC activity, HSA and the X bands during C modulatio 
of strain Taberman '
SS-C (1,25 X normal strength) received a 20% (v/v) inoculum from a 
48 h culture. At timed intervals, harvested cells were assayed for AC 
activity, HSA and analysed by SDS-PAGE, The theoretical loss assuming 
no ^  novo synthesis was calculated using the growth curves shown in 
Fig. 2, A, experiment 1; 0, experiment 2 ; Q ---0 »  theoretical loss
assuming complete repression:A ▲ ,  intact-cell AC activity;
ami? cr..
combined relative intensities of the X bands;g — ■, HSA.
A20
(D
0)
TO
(D
&_
ü
0)
Û
80
100
Sampling tirnè " (h)
B
20
o
U)
S 40 
&_
ü  
0) 
û
§2 60
80
100 20
Sampling time (h)
101
4. A Study of Possible Inhibition Mechanisms Involved in Modulation
4.1. The effect of pro-X- and pro-C-mode compounds on adenylate cyclase 
activity
If cAMP plays a major role in modulation, it is possible that pro-C- 
mode substances alter cAMP metabolism by directly inhibiting AC activity.
It was therefore of interest to determine whether these substances could 
inhibit AC activity when present in the assay mixture. The effect 
of nicotinamide was also investigated as, unlike nicotinic acid, this 
compound does not induce modulation at 500 mg L  ^ (4.1 mM) (Wardlaw st al., 
1976). Intact cells as well as cell lysates were used as enzyme sources, 
as the cell surface is known to have an affinity for some ionic species, 
notably divalent cations. Results for one experiment, samples assayed in 
duplicate, are shown in Table 15. Both nicotinamide and nicotinic acid 
caused substantial loss of activity (about 60%). However, the other pro- 
C-mode substances caused no greater loss of activity than did NaCl.
4.2. The effect of chloramphenicol on modulation
Three possible explanations for the loss of AC activity during
growth in SS-C are:- (1) AC is permanently inactivated by a direct, prolonge
exposure to the medium constituents of SS-C, (2) AC is inactivated or
destroyed by some factor synthesized or activated during modulation,
(3) AC synthesis is repressed. To test the first possibility, B. pertussis
was incubated in SS-X and SS-C with and without chloramphenicol added.
— 1
Chloramphenicol was present at a final concentration of 100 pg ml . This 
concentration completely inhibited growth and incorporation of tritiated 
methionine into acid-insoluble material (results not shown). Flasks 
received a 10% (v/v) inoculum of a 48 h culture of strain Taberman grown 
in SS-X. Flasks were incubated as for normal growth conditions and harvestec 
after 24 h and 48 h.
Intact-cell AC activities ars shown in Table 16. Results refer to 
the averages of duplicate cultures, each of which was assayed in duplicate^
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Table 16: The effect of chloramphenicol on flgSO^-induced loss of
AC activity
A 48 h culture -of strain Taberman was used to inoculate media 
(10% (v/v) inoculum). After 24 h and 48 h incubation, culture supernate 
was assayed for cAMP and harvested intact-cells were assayed for AC activity,
Medium
24 h incubation 48 h incubation
AC activity^ cAMP level^ AC activity cAMP level
SS-X 945 120 990 165
SS-XCAP
760 25 660 35
SS-C 25 15 15 15
SS-CcAP
690 15 625 15
a, pmol cAMP min ^mg(protein) ^; b, pmol cAMP ml \
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Prolonged exposure to SS-C^^p (SS-C with chloramphenicol (100 pg ml )) 
resulted in 20 - 40% loss of activity and was similar to the loss observed 
by exposure to SS-Xj,^p. Growth in SS-C resulted in substantial loss of 
activity (95 - .99% loss). Cyclic AMP levels did not increase greatly 
during non-growing conditions or during growth in SS-C although levels 
appeared to be slightly higher during exposure to SS-X^^p.
HSA for selected samples are shown in Table 17 (further data, from 
which results were calculated,are shown in Appendix 6, Table A5).
Prolonged exposure to SS-X^^pOr SS-C^^p caused no significant loss of 
HSA compared to growth in SS-C where HSA was reduced by about 94%.
Similarly, MgSO^-induced loss of the X-bands was inhibited by chloramphenicol 
indicating that protein synthesis or growth was required for this effect 
(Plate 3).
The effect of chloramphenicol on C to X modulation was also investigated 
Expression of AC activity, HSA and the X bands during these conditions 
required growth or protein synthesis (Table 18, 19 and Plate 4).
Further data, from' which HSA results were calculated, are given in Appendix 6 
Table A6. Culture supernate cAMP was detectable only after growth in 
SS-X.
4.3. The effect of MgSD^ on the production of extracellular cAMP
Certain experiments suggested that SS-C may inhibit.production of 
cAMP by an X-mode inoculum. When SS-C was inoculated with a heavy 
inoculum of X-mode B. pertussis, there appeared to be no net gain of cAMP 
in the culture supernate (Fig. 5) although active AC exists in the inoculum 
initially. Also, after growth of B. pertussis in SS-C containing AC 
activator, using an X-mode inoculum, there were still no detectable 
levels of cAMP in the supernate (Section 5.2). To test whether SS-C did 
inhibit production of culture supernate cAMP^ the following experiment "was 
carried out. A 48 h SS-X culture of strain Taberman was harvested and 
cells' were washed once in saline. Cells were resuspended in ^S-X^^p
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Table 17: The effect of chloramphenicol on MgSD^-induced loss of HSA
A 48 h culture of strain Taberman was used to inoculate media. 
After 24 h and 48 h incubation, harvested cells were heat killed (56°C 
for 30 min) and assayed for HSA.
Medium and time 
of incubation (h)
"SD5 0
% relative potency^
(and 95% confidence limil
SS-X 48 1.7 100
1.9 93 (50, 176)
SS-C 48 29.1 6 (2, 13)
SS-CCAP 24
2.2 79 (47, 149)
SS-CcAP 48
1.7 100 (53, 189)
a, the dose (ou.ml per .mouse) required to kill 50% of the mice, after 
subsequent challenge with histamine; b, relative to activity of cells 
after growth in SS-X.

106
Plate 3: SOS-PAGE profiles of B, pertussis cells after incubation in
X and C* medium with and without chloramphenicol
A 48 h SS-X culture of strain Taberman was used to incoulate media 
(10% (u/v) inoculum). After 48 h incubation, harvested and washed cells 
were analysed by SDS-PAGE. Media were: a, SS-X; b, SS-X^^p? c, SS-C; 
d, ss-c^ p^
3 0 k
2 8 k
1UY
Table 18: The effect of chloramphenicol on the regain of AC activity
during C to X modulation
A 48 h SS-C culture of strain Taberman was used to inoculate media. 
After 24 h and 48 h incubation, harvested intact cells were assayed for
AC activity and culture supernate was assayed for cAMP.
24 h incubation 48 h incubation
Medium
AC activity^ cAMP level^ AC activity cAMP level
SS-X 885 55 915 115
SS-XCAP
15 < 5 10 < 5
SS-C < 5^ < 5 < 5 < 5
SS-CcAP 15 < 5 15 < 5
a, pmol cAMP min ^mg(protein)
-1
; b, pmol cAMP
-1
ml ; c, limit of detectic
Table 19: The effect of chloramphenicol on the regain of HSA during
C to X modulation
A 48HSS-C culture of strain Taberman was used to inoculate media. 
After 48 h incubation, harvested cells were heat killed (56°C for 30 min) 
and assayed for HSA,
Medium % relative potency^
(and 95% confidence limit
SS-X 0.8 100
^^"^CAP
43.1 1.9 (0,0, 6,9)
SS-C > 20^ < 4,2
SS-CcAp 66.0 1.3 (0.0, 5.5)
a, the dose (ou,ml per mouse) required to kill 50% of the mice after 
subsequent challenge with histamine; b, relative to activity of cells 
after growth in SS-X; c, no animals died using 20 ou.ml per mouse as 
highest dose.
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Plate 4: SDS-PAGE profiles of pertussis cells after incubation
of C-mode cells in X and C medium with and without
chloramphenicol
A 48 h SS-C culture of strain Taberman was used to inoculate media 
(10% (v/v)inoculum)* After 48 h incubation, washed cells were analysed 
by SDS-PAGE. Media were; a, SS-C^^p; b, SS-C; c, SS-X^^pS d, SS-X.
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and SS-C^^p to give an AggQ^,^ of 25. Suspensions (10 ml) were incubated 
in 150 ml flasks on an orbital shaker at 35°C. At timed intervals 1 ml 
was removed and supernate was assayed for cAMP. One series of cell 
suspensions contained AC activator (100 pg bovine catalass ml ^).
Results (Fig. 10) were similar for two experiments. Production of 
extracellular cAMP was the same for cells incubated in SS-X or in SS-C.
These results indicate that SS-C does not inhibit production of extracellular 
cAMP.
4.4. Possible inactivating factors in C-mode cell lysates
The possibility that a factor,, which inactivated AC, was produced
during growth in SS-C was investigated by mixing X-mode and C-mode cell
lysates of strain Taberman at 35°C and 4°C and assaying for AC activity
at timed intervals. Strain Taberman was grown in SS-X and SS-C for 48 h,
harvested, and resuspended to 2.5 mg(proteln) ml  ^ prior to X- pressing
and mixing. X- and C-mode cell lysates were mixed in equal volumes and
- 1incubated statically. Chloramphenicol was added (100 pg ml final 
concentration) to prevent possible contamination. Results (Table 20) 
show that no inactivation appeared to occur when X-mode cell lysate 
was incubated with C-mode cell lysate. Similar results were obtained for 
strain 18334 (results not shown).
Idigbe et al.(l98l) found HSA was lost at a greater rate than could 
be accounted for by repression of synthesis during C modulation of 
strain 18334 in Hornibrook medium. This suggested destructive or 
inactivation mechanisms were involved. C-mode cell lysates were therefore 
investigated to see if they contained destructive or inactivation factors 
for X-mode HSA. Strain Taberman was grown for 48 h in SS-X and SS-C. 
Harvested cells were resuspended to 100 ou in culture supernate (in case 
destructive factors were released into the medium) and X-pressed.
X- and C- mode cell lysates were mixed in equal volumes and incubated for

mFigure ID: The effect of MgSO^ and AC activator on the production
of extracellular cAMP by resuspended X-mode cells
Harvested cells of strain Taberman from a 48 h SS-X culture were 
washed once and resuspended in media containing chloramphenicol (100 pg ml
to give an AggQ^m 25. Suspensions (10 ml) were incubated in 150 ml 
flasks in an orbital shaker at 35°C. At timed intervals samples were 
removed and supernate was assayed for cAMP. Media were SS-X^^p (□), 
SS-X^^p with AC activator (100 pg ml bovine catalase) (A), SS-C^^p (■), 
and SS-C^^p with AC activator (A),
or
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Table 20; AC activity in X- and C-mode cell lysates amd mixtures of
cell lysate
Strain Taberman was grown for 48 h in SS-X or SS-C, Harvested cells 
were X-pressed and lysate mixtures were assayed for AC activity after 
various incubation conditions.
Incubation conditions AC activity
a
prior to AC assay
X-mode 
cell lysate
C-mode 
cell lysate
x/c-mode ^ 
cell lysate Expected^
None 1390 55 815 720
24 h at 4°C 1350 70 740 710
0,5 h at 35°C 1280 50 630 665
4 h at 35°C 1055 40 555 555
24 h at 35°C 630 15 365 325
a, pmol cAMP min ^mg(protein) ^; b, X- and C-mode cell lysates mixed in 
equal volumes; c, expected activity of cell lysate mixture assuming 
no loss of activity by destructive factors.
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24 h at 35°C with chloramphenicol (100 pg ml  ^ final concentration),
X- and C-mode cell lysates were also incubated alone. Samples were heat 
treated at 56°C for 30 min and assayed for HSA . (Table 21) . Further data, 
from which results were calculated,are given in Appendix 6, Table A7.
No destructive factors were demonstrated in C-mode cell lysate, since 
the activity in the mixture was approximately half the activity of the 
X-mode cell lysate. However, small changes in activity would not have 
been detected in such an experiment because of the large confidence 
limits obtained. A similar experiment was done with strain 18334 grown 
for 48 h in X- and C-mode Hornibrook medium,as this was the strain and 
medium used by Idigbe et al, (1981). Results are shown in Table 22 and 
further data, from which results were calculated, are given in Appendix 6, 
Table A8. Again, no destructive factors were clearly evident in C- mode 
cell lysates as X-mode/C-mode cell-lysate mixtures had approximately half 
the activity of an X-mode cell lysate.
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Table 21; The effect of incubating C-mode lysate with X-mode lysate 
on HSA of strain Taberman
Strain Taberman was grown in SS-X and SS-C for 48 h* Harvested cells 
were X-pressed. Cell lysates and lysate mixtures were incubated statically 
for 24 h at 35°C* Samples were heat treated (56°C for 30 min) and assayed 
for HSA,
Sample HSD
50
% relative potency
(and 95^ confidence limits)
X-mode cell lysate 1.5 100
C-mode cell lysate > 20^ < 7.5
X/c-mode cell lysate 4.0 37 (18, 75)
mixture
Expected^
3.0 50
a, the dose (ou.ml per mouse) required to kill 50^ of the mice after 
subsequent challenge with histamine; b, relative to HSA of X-mode cell 
lysate; c, no animals died using 20 ou.ml per mouse as highest dose; 
d, X- and C-mode cell lysates were mixed in equal volumes before incubation 
at 35°C; e, expected HSD^Q of the x/C-mode cell lysate mixture assuming 
no inactivation (is,twice the HSD^Q of the X-mode cell lysate).
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Table 22; The effect of incubating C-mode lysate with X-mode lysate 
on HSA of strain 18334
Strain 18334 was grown in H-X and H-C for 48 h. Harvested cells 
were X-pressed. Cell lysates and lysate mixtures were incubated statically 
for 24 h at 35°C. Samples were heat treated (56°C for 30 min) and assayed 
for HSA
Sample (and incubation 
conditions )
HSD
50
% relative potency
(and 95^ confidence limits)
X-mode cell lysate (none) 1.1 100
X-mode cell lysate 
(24 h at 35°C)
1.4 74 (40, 136)
C-mode cell lysate 
(24 h at 35°C)
17.0 6.2 (3,.1, 12)
X/c-mode cell lysate mixture*^ 
(24 h at 35°C), sample 1
1.6 68 (37, 125)
x/c-mode cell lysate mixture'^ 
(24 h at 35°C), sample 2
2.0 52 (28, 96)
Expected^ 2.6 54
a, the dose (ou.ml per mouse) required to kill 50^ of the mice after 
subsequent challenge with histamine; b, relative to HSA of X-mode cell 
lysate not previously incubated at 35°C; c, X- and C-mode cell lysates
were mixed in equal volumes before incubation at 35 C; d, expected HSD 
of x/c-mode cell lysate mixture assuming no inactivation (calculated 
from HSDg^'s of X- and C-mode cell lysates incubated alone).
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5. Purification of Adenylate Cyclase and the Effect of Antisera on
Adenylate Cyclase Activity
Concomitant loss of AC activity with loss of the other properties 
during C modulation may be due to either a coincidental or causal relationship 
If AC is the target site of phase degradation or modulation, it would 
be expected that the loss of AC is due to mutation, in the case of phase 
degradation, or by some inactivating mechanism operating during C modulation. 
Attempts were made to demonstrate whether AC was synthesised to the same 
level in X-mode, C-mode and phase IV B. pertussis by immunological means.
The first stage involved purification of AC.
Blue dextran-Sepharose (BDS) was used with considerable success in 
the purification of bovine brain AC (Stellwagen and Baker, 1976). BDS 
binds to many proteins possessing a dinucleotide fold. Bovine brain AC 
was purified by mixing brain homogenate with BDS and AC was eluted with 
1 mfl ATP. This gave 50^ yield and 150-fold purification in one step.
Reactive red-Agarose (RRA) also binds to proteins with dinucleotide 
folds which can be specifically eluted by nucleotides. It was thought BDS 
or RRA might be useful in the purification of B. pertussis AC since 
B. pertussis.AC may be structurally similar to brain AC as both respond 
to calmodulin. A 48 h SS-X culture of strain 18334 was harvested and 
X-pressed in 10 mM Tris-HCl, pH 8.0. Sujpernate ( 100,000 x g for 60 min) 
was diluted in an equal volume of 10 mM Tris-HCl, pH 8.0, to give 
4.2 mg(protein) ml \  Crude cytoplasmic fraction (3 ml) was added to 
0.5 ml of packed swollen gel of BDS or RRA previously equilibrated with 
10 mM Tris-HCl, pH 8.0, and mixed frequently on ice for 1 h. The tubes 
were centrifuged and supernates collected (unabsorbed fractions). The 
gels were washed three times with 8 ml of buffer. Buffer containing 
10 mM ATP (3 ml) was mixed with the gel, and after 30 min incubation on 
ice, tubes were centrifuged and eluants were collected. AC activities for 
the different fractions are shown in Table 23, BDS and RRA appeared to
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Table 23; Affinity chromatography of Bo 'pertussis AC with Blue
dextran-Sepharose and Reactive red-Agarose
Strain 18334 cytoplasmic fraction (12,6 mg protein) was added to 
0.5 ml packed swollen gel of BDS or RRA. After 1 h incubation on ice, 
supernates were collected (unabsorbed fractions). Gels were washed three 
times. Buffer containing 10 mM ATP was added (3 ml) and supernate was 
collected after 30 min incubation on ice (ATP-eluted samples).
Sample AC activity^
Cytoplasmic fraction 2.35
Supernate after absorption with BDS 2.35
Supernate after absorption with RRA 2.30
ATP elution from BDS < 0.016^
ATP elution from RRA < 0.016
-1 -1
a, nmol cAMP min ml ; b, limit of detections
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have little affinity for B. pertussis AC under the conditions used. SDB-PAGE 
of samples showed that most polypeptides remained in the unabsorbed fractions 
and were not detectable in the ATP eluted samples (results not shown).
Subsequent purification was based on a method described by Hewlett 
and Wolff (1976) whose starting material was culture supernate. Culture 
supernate AC activity did not vary greatly between four strains (results 
not shown), although strain Taberman appeared to produce the highest 
levels and was chosen for purification of AC. Maximum levels of culture 
supernate AC activity occurred after 48 h growth in SS-X (results pot 
shown). Strain Taberman was grown in 500 ml amounts of SS-X for 48 h.
Culture supernate (5 L) was pooled and adjusted to pH 7.4. The supernate 
was pumped through a DEAE-column (2.5 x 25 cm) previously equilibrated with 
10 mM Tris-HCl, pH 7.4, at approximately 90 ml h ^. The column was washed 
with 1 L 10 mM Tris-HCl, pH 7.4, at the same flow rate. A 100 - 300 mM MaCl 
gradient was used to elute AC (flow rate 9 ml h ^) and eluate was collected 
in 4.5 ml fractions. Fig. 11 shows a typical elution profile which was 
similar for two other experiments. DEAE-cellulose chromatography gave 
good separation of AC activity from the major protein peak. The main peak 
of AC activity was pooled for further purification ( in this case 
fraction numbers 37 - 43) and concentrated to 5 ml by dialysis against 
Aquacide IIA. Sample was pumped through a G-200 Sephadex column 
(2.5 X 50 cm) previously equilibrated with 10 mM Tris-HCl, pH 7.4 (flow 
rate of 9 ml h ^) and 4.5 ml fractions were collected. A broad peak of 
AC activity was observed for eight fractions, but no protein peaks were 
observed (results not shown). Fractions containing AC activity were 
concentrated by dialysis against Aquacide IIA to 2.5 ml. A summary of 
measurements during the purification procedure is given in Table 24.
Specific activity of the final preparation was about 72^ of that of Hewlett and 
Wolff (1976) whose preparation which gave a single gel band after SDS-PAGE. 
However, due to the poor yield and the low protein content of the 
purified material achieved in the present study, no gel bands were 
apparent when analysed by SDS-PAGE. SDS-PAGE of material after
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Figure 11; DEAE-cellulose chromatography of B. pertussis AC
Culture supernate (5 L), from 48 h SS-X cultures of strain Taberman, 
was adjusted to pH 7.4 and pumped through a DEAE column at a flow rate 
of 90 ml h " \  The column was washed with 1 L 10 mM Tris-HCl, pH 8.0.
A 100 - 300 mM NaCl gradient was used to elute AC (flow rate 9 ml h"^). 
Eluate was collected in 4.5 ml amounts. 0 » protein concentration;
^ , AC activity; — — , NaCl concentrationo
Protein (pg ml
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DEAE-cellulose chromatography revealed 5 faint bands, the most dense 
of which corresponded to a polypeptide with a molecular weight of about 
70,000 (results not shown).
The pooled material after Sephadex G-200 chromatography was used to 
raise antiserum in a rabbit. Unfortunately, after injecting the rabbit 
it was discovered that the pre-immune serum gave à strong reaction with 
an X-mode B. pertussis cell lysate, Antiserum, raised six weeks after 
the first injection of material was tested for AC inhibitory activity as 
a final resort. X-mode cell lysate (100 pg(protein) ml ^), present in saline 
or saline and 250 mM EGTA ( the highest concentration of EGTA which would 
dissolve), was mixed with an equal volume of serum and incubated at 4°C 
overnight before assaying for AC activity. EGTA was included to eliminate 
the effect of calmodulin present in serum which would activate B. pertussis 
AC and possibly mask any inhibitory effect due to antibody.
Neither antiserum raised against the AC preparation nor the U.S. 
standard antiserum showed any significant inhibitory activity with or without 
EGTA, when compared to the effect of normal serum (Table 25). Raised ,, 
antiserum concentrated 20-fold by dialysis against Aquacide IIA, also 
showed no inhibitory activity, but increased activity relative to other 
sera presumably because of the higher concentration of calmodulin.
EGTA present at 125 mM greatly reduced activator activity, but not totally.
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Table 25; . The effect of antisera and EGTA on cell-lysate AC activity
Sera was mixed with an equal volume of X-mode cell lysate (strain 
Taberman) and incubated at 4°C overnight before assaying for AC activity,
Antiserum
Without
AC activity^ 
EGTA With EGTA (125 mM)
None 1.36 1.38
Normal serum^ 49.8 2.13
Antiserum raised against 
AC preparation
48.9 2.17
Antiserum raised.against 
AC preparation (20 x 
concentrated)
77.6 2.40
U.S. standard antiserum 28.9 2.15
a, nmol cAMP min mg(protein) ; b, serum obtained from an unimmunized 
rabbit which gave no precipitin reaction with a B. pertussis extract.
I/D
6. Manipulation of Cyclic AMP Production During Growth
6.1, The effect of NaF on adenylato cyclase activity
Hewlett and Wolff (1976) reported that NaF strongly inhibited activity 
of purified AC. This was confirmed in this study using cell lysate 
as an enzyme source (Fig. 12).. NaF at 40 mM, and greater, caused 90% loss
of activity. It was thought NaF might be a useful tool in answering
the question
whether cAMP is involved in modulation, if B. pertussis could grow in media 
containing NaF. Strain Taberman was grown in SS-X for 48 h with 
varying concentrations of NaF added aseptically after filter sterilization. 
However, NaF present at concentrations up to 40 mM, did not inhibit 
production of cAMP during growth (Table 26) although growth was largely 
inhibited at 40 mM NaF and completely inhibited at 80 mM, The X bands 
were still present after growth in all media (results not shown),
6.2. The effect of commercial bovine catalase during growth in X and C medium 
Commercial bovine catalase is a good source of 8. pertussis AC
activator (Hewlett et al., 1978) which has now been identified as calmodulin 
(Goldhammer, 1981). It was thought that this might be a useful tool 
in determining whether cAMP plays a role in modulation. Strain Taberman 
was grown in SS-X and SS-C containing bovine catalase for 48 h. Before 
addition to the medium, a suspension of bovine catalase in distilled water 
(ID mg ml ^) ,was heated at 1GD°C for 5 min (calmodulin is heat-stable 
(Hewlett et al., 1979b)'). The precipitate was removed, and the supernate 
was filter sterilized and added to the medium {'\% {m/ m ) final concentration). 
Culture supernates were assayed for cAMP, and cells for AC activity, HSA 
and the X bands (Table 27), Further data of HSA tests, which were used 
to calculate results, are given in Appendix 6, Table A1. Bovine catalase 
appeared to have little or no influence on production of the X bands 
or HSA. Intact-cell AC activity was higher after growth with catalase 
and this may be due to the irreversible nature of activation. Culture 
supernate cAMP was undetectable after growth in SS-C even with bovine
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Figure 12; The effect of NaF on cell-lysate AC activity
Harvested cells from a 48 h SS-X culture of strain Taberman were 
X-pressed in saline and assayed for AC activity with NaF present in 
the assay mixture.
16
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125
Table 26; The effect of NaF on culture supernate cAMP levels
Strain Taberman was grown for 48 h in SS-X containing various 
concentrations of NaF. Culture supernate was assayed for cAFIP.
NaF (mM) cAMP^
^660nm
0 105 1.48
5 107 1.58
10 115 1.27
20 95 0.89
■ 40 125 0.29
a, pmol mg(dry weight of cells) ^
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catalase.
It appeared that modulating conditions were too severe to permit 
cAMP production even with activator in the growth medium. Lacey (i960) 
reported that an intermediate- (I-) mode arose when B. pertussis was 
grown with a critical ratio of pro-X-mode salt to pro-C-mode salto 
It was thought that if cAMP plays a role in modulation, activator present 
in the medium might shift the critical concentration of MgSO^ required 
to induce modulation. Strain Taberman was grown for 48 h in a series of 
modified SS-X media where the NaCl was proportionally replaced by MgSO^, 
and in a parallel series containing bovine catalase (added as described 
previously). The critical concentration of MgSO^ required to induce 
modulation, as judged by loss of the X bands was about 11 mM (Table 28) 
and was not affected by the presence of activator^ The concentration 
of MgSQ^ required to induce an I-mode variant was fairly critical and 
an I-mode variant, showing partial loss of the X bands,was obtained 
only once in three experiments. Culture supernate levels of cAMP 
were only detectable in those cultures where the X bands were present.
In cultures containing activator, cAMP levels ranged from 490 - 580 pmol ml” \  
while in cultures without activator, levels ranged from 80 - 140 pmol ml” \
The one case where an I-mode variant was obtained (ie. where the X-bands 
were partially lost), was in a culture containing activator. Culture 
supernate cAMP in this culture was 210 pmol ml” "*. This was about twice 
as high as that which occurred in X-mode cultures without activator.
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7. The Effect of Exogenous Cyclic Nucleotides
The observed influence of exogenous cAMP on a phenotype has often 
been used as a criterion for establishing a regulatory role for cAMP.
Dibutyryl cAMP is ineffective in overcoming catabolite repression in the 
enterobacteria, but has been used in other microorganisms,.eg. streptomycetes 
and eukaryotic microorganisms, to illustrate regulatory phenomena (Ring 
St al.,1977; Nimi et al., 1980). Dibutyryl cAMP is often more effective 
than cAMP due to the butyryl group rendering the molecule more lipophilic 
and hence more permeable. Dibutyryl cAMP is also more resistant to 
phosphodiesterase (Pasternak et al., 1952).
The effect of exogenous 5 mM cAMP and dibutyryl cAMP on the X bands, 
intact-cell AC activity and HA activity was investigated. Strain Taberman 
was grown for 48 h in SS-X, SS-C, and SS-NA (SS-X with nicotinic acid 
present at 4.1 mM), all with and without cAMP or dibutyryl cAMPo 
Cultures were harvested and washed three times with saline (to remove 
contaminating nucleotides) and assayed for intact-cell AC activity and 
the presence of the X bands. Exogenous cAMP and dibutyryl cAMP had 
little, if any, effect on intact-cell AC activity after growth either 
in SS-X, SS-C, or SS-NA (Table 29). Similarly, neither of these nucleotides 
had any noticable effect on SDS-PAGE profiles after growth in these media 
(Plate 5).
To investigate the effect of these nucleotides on production of 
HA activity, strain Taberman and D30042 I were grown in H-X and H-C, 
with and without nucleotide, statically for 5 dayso Hornibrook medium 
was used as B. pertussis does not grow well statically in Stainer and
Scholte medium (K. A. Burns, personal communication). Harvested cells
were resuspended to 50 ou and assayed for HA activity. HA activity was 
investigated as at the time of this work it was believed that most HA 
activity in B. pertussis was due to pili, which in E. coli and So typhimurium
has been shown to be regulated by cAMP (Saier et al., 1978; Eisanstein ejb al.,
1981). However, growth of B. pertussis with either nucleotide, had no
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Table 29; The effect of exogenous cyclic nucleotides during growth 
on intact-cell AC activity
" Harvested intact cells, of 48 h cultures of strain Taberman, were 
assayed for AC activity. Cyclic nucleotides were present in media at 5 mM,
Medium Cyclic nucleotide AC activity^
SS-X none 380
SS-X cAMP 470
SS-X dibutyryl cAMP 420
SS-C none 15
SS-C cAMP 15
SS-C dibutyryl cAMP 20
SS-NA none 20
SS-NA cAMP 20
SS-NA dibutyryl cAMP 25
— I — 1
a, pmol cAMP min mg(protein)"
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Plate 5: SDS-PAGE profiles of B. pertussis cells after growth in
media containing exogenous cyclic nucleotides
Strain Taberman was grown for 48 h in media. Cyclic nucleotides 
were present at 5 mM, Harvested, washed cells were analysed by SDS-PAGE. 
Media were: a, SS-X; b, SS-X with cAMP; c, SS-X with dibutyryl cAMP; 
d, SS-C; e, SS-C with cAMP; f,SS-C with dibutyryl cAMP; g, SS-NA; h, SS-NA 
with cAMP; i, SS-NA with dibutyryl cAMP.
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effect on HA activity (Table 30).
There existed the poesiblity that Bo pertussis may be 
impermeable to the nucleotides. The ability of Bo pertussis to excrete 
cAMF? into the medium, at levels comparable to those found in E. coli 
cultures, suggested that transport proteins existed* The ability of 
X- and C-mode strain Taberman to take up cAMP and dibutyryl cAMP in 
SS-X and SS-C was investigated. Results for single experiments are shown 
in Fig, 13 - 15, "Uptake” of cAMP was demonstrated for both X-mode and 
C-mode cells in SS-X and SS-C,and dibutyryl cAMP for X-mode cells in 
SS-X and SS-C, However, it is not known whether the results are due to 
nucleotide binding to the call wall or their entry into the cytoplasm.
Nor is it known how much of the nucleotide which entered the cell, 
if any, was subsequently metabolized , The rate of cAMP "uptake" 
by cells grown previously under X-mode conditions appeared to be higher 
than for cells grown previously under C-mode conditions, but it is not 
known if this is significant.
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Table 3D; The effect of exogenous cyclic nucleotides during growth
on HA activity
Strains were grown statically for 5 days. Cyclic nucleotides were 
present in media at 5 mM. Harvested cells were resuspended to 50 ou. 
and assayed for HA activity.
Medium Cyclic nucleotide Haemagglutination titre 
Taberman 030042 I
H-X none 16 4
H-X cAMP 16 4
H-X dibutyryl cAMP 16 4
H-C none < 2 < 2
H-C cAMP < 2 < 2
H-C dibutyryl cAMP < 2 < 2
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Figure 13: Time course of uptake of [^H] c AMP by X-mode B. pertussis
cells
Harvested and washed cells from a 48 h SS-X culture of strain 
Taberman was used. The reaction mixture consisted of cells 
(0.3 mg(dry weight) ml 1 mM [^H] c AMP(specific activity 5 pCi pmol"^) 
in S S - X , O , or SS-C,# .  At timed intervals, the reaction was stopped 
by rapidly filtering 1 ml of cell suspension.
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Figure 14: Time course uptake of [ h ] cAMP by C-mode 6.-pertussis
cells
Harvested and washed cells from a 48 h SS-C culture of strain - 
Taberman was used. The reaction mixture consisted of cells 
(0.3 mg(dry weight) ml ^), 1 mM [^h ] c AMP (specific activity 5 pCi pmol  ^
in SS-X, O  , or SS-C,#. At timed intervals, the reaction mixture was sto 
by rapidly filtering 1 ml of cell suspension.
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Figure 15: Time course of uptake of [^h ] dibutyryl cAMP by X-mode
B« pertussis cells
Harvested and washed cells from a 48 h SS-X culture of strain 
Taberman was used. The reaction mixture consisted of cells 
(0.3 mg(dry weight) ml"^), 1 mM [^h ] dibutyryl cAMP (specific activity 
5 pCi pmol”^) in either SS-X, O,or SS-C,#. At times intervals, the 
reaction was stopped by rapidly filtering 1 ml of cell suspension.
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8. Respiration of Substrates by Variants of B, pertussis
The cya and crp mutants of E. coli and S. typhimurium are pleiotropic 
and are unable to ferment the various sugars whose catabolic enzymes 
are subject to catabolite repression. In addition, they lack the ability 
to catabolizB certain amino acids such as tryptophan and histidine (Pastan 
and Adhya, 1976). This is because expression of the opérons for the 
above catabolic activities requires CRP-cAMP. Work by Ring ejb al. (1977) 
suggests that cAMP may play a regulatory role in the uptake of several 
amino acids by Streptomyces hydroqenans. It was thought possible that cAMP 
could play a major regulatory role in B. pertussis by enabling the organism 
to select for preferred carbon/energy sources (amino acids in the case of 
this organism). Indeed, it has been reported that glutamate is the 
preferred carbon source (introduction. Part 1, 5.2.). It was therefore 
of interest to compare the respiration rates between X- and C-mode, and 
phase IV variants, for different amino acids,since the latter two variants 
have greatly reduced AC activity*
Table 31- shows respiration rates of several amino acids-by X- and 
E-mode and phase IV variants for three experiments, C-mode variants 
were obtained by subculturing twice in SS-C,and X-mode and phase IV 
variants were obtained by subculturing twice in SS-X. Respiration 
was not detected with the sugars D-ribose, D-glucoae, or sucrose or 
with the amino acids glycine, L^glutamine, L-arginine, L-lysine, L-threonine 
or L-histidine (< 0.3 p.1 C^min mg(dry weight) ) (results not shown).
The data appeared to be reasonably normally distributed when assessed 
by Rankit numbers (results not shown). The results were analysed by 
analysis of variance. No significant differences could be found 
between the ability of variants to respire any particular amino acid.
When analysed by two factor analysis of variance, differences between 
the respiration rates for different amino acids were significant at 
the 0.1% probability level while differences between variants were
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Table 31;, Respiration rate for amino acids by variants of B. pertussis
Strain 030042 I was grown twice for 24 h in either SS-X or SS-C
and strain 030042 IV was grown twice for 24 h in SS-X, Respiration
rates were determined for twice washed cells using a Clark oxygen electrode.
1
Cells were present at 0,5 mg(dry weight) ml and substrate at IB mM.
Amino acid
Respiration
X-mode
rate^ (and standard 
C-mode
deviation) 
Phase IV
L-glutamate 6.3 (0.9) 6.5 (0.6) 6.5 (0.3)
L-aspartate 5.5 (0.8) 7.2 (1.3) 6.5 (0.2)
L-proline 3.5 (0.6) 3.9 (0.2) 3.4 (0.2)
L-serine 2.5 (0.3) 2.9 (0.2) 2.5 (0,3)
L-alanine 2.2 (0.3) 2.4 (0.1) 2.7 (0.3)
a, (il Og min”  ^ mg(dry weight)"^
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insignificant at the 5% level. The greatest respiration rates were 
observed for L-glutamate and L-aspartate followed by L-proline, then 
L-alanine and L-serine, SSX buffer, replaced by SSC buffer, did not 
alter the respiration rates of an C-mode cell.suspension for the 
above amino acids (results hot shown). Therefore, Mg.SO^ does not directly 
alter the respiration ratso
In a single experiment, the respiration rates of X- and C-mode 
variants for various metabolic intermediates were compared (Table 32), 
Significant respiration was detected for the substrates acetate, pyruvate, 
lactate, succinate, and formate. Succinate was respired at the greatest 
rate. However, there were no big differences observed between the ability 
of the two variants to respire any particular substrate. Citrate was 
not respired by either variant.
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Table 32: Respiration rates, for metabolic intermediates by 'X- and
C-mode variants of B. pertussis
Strain D30G42 I was grown twice for 24 h in SS-X or SS-C. Respiration
rates were determined for twice-washed cells using a Clark oxygen electrode,
—  1 '
Cells were present at 0,5 mg(dry weight) ml and substrate at 18 mM.
Substrate
X-mode
Respiration rate^
C-mode
Acetate 2.1 1.7
Pyruvate 1.5 1.9
Lactate 1.6 1.2
Succinate 7.8 6.8
Formate 1.7 1.9
— 1 —I
a, pi 0^ min mg(dry weight)
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9. Isolation of Phosphonomycin Resistant Mutants
The absence or presence of a particular phenotype in crp and cya 
mutants of E. coli and 5. typhimurium has been used as strong evidence 
for a regulatory role of cAMP in the expression of such.phenotypes 
(introduction, Part 2, 2). The difficulty in isolating
AC mutants of B. pertussis is that it's function is unknown. In the
enterobacteria, antibiotic resistance has been used as a basis to 
select for crp and cya mutants which lack the appropriate permeases. 
Phosphonomycin resistant mutants isolated in S. typhimurium were almost 
all unable to ferment lactose or ribose. Isolated colonies were 50% 
cya and 50% crp (Alper and Ames, 1978). It was thought that phosphonomycin 
might be useful in isolating AC mutants of B. pertussis.
Phosphonomycin resistance of a phase IV strain and X- and C-mode 
variants was compared (Table 33). To test the minimum inhibitory 
concentration for C-mode variants, strains were first grown on BG-C 
before transfer to BG-C containing phosphonomycin. Phosphonomycin was 
included in BG media to give a doubling dilution series. A degraded 
avirulent strain (D3D042 IV) was significantly more resistant than it's 
virulent counterpart (D3D042 l). However, C-mode variants were as sensitive 
as X-mode variants. In addition, C-mode inocula would not grow on 
nutrient agar containing 20 mM or 40 mM MgSO^ whereas strain D30042 IV would 
(results not shown)o This suggests that there may be differences between 
the C-mode and phase IV phenotypes in terms of sensitivity to inhibitory 
agents.
Attempts were made to isolate AC mutants by mutagenesis with 
NTG and selection for phosphonomycin resistance. Isolating a mutant with 
reduced AC activity and a phase IV phenotype would not verify a virulence 
regulatory role for cAMP as phophonomycin may select for degraded strains.
On the other hand, isolating a mutant lacking AC activity but with a 
phase I. phenotype, would strongly suggest that AC plays no role in the
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Table 33: Minimum-inhibitory concentration of phosphonomycin for
B. pertussis variants
. Three day BG-X and BG-C cultures were used to inoculate BG-X and 
BG-C respectively, containing two-fold increasing concentrations of
phosphonomycin. After three days incubation the minimum-bacteriostatic
concentration was recorded.
Strain
“1
MIC of phosphonomycin (pg ml )
Medium
BG-X BG-C
Taberman 3.12 3.12
18334 6.25 6.25
D30042 phase I 3.12 3.12
D3DD42 phase IV > 200 > 200
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regulation of properties lost during C modulation or phase degradation.
To determine the optimal concentration of NTG and sampling time, 
strain Taberman was grown in SS-X for 40 h. Different concentrations 
of NTG were then added to three cultures which were sampled at various 
times,to determine the viable count (Fig. 16). NTG present.at 50 pg ml  ^
for 20 min gave about 50 % killing and these conditions were used to 
isolate phosphonomycin mutants. It has been reported previously that 
50% killing gives.optimal mutagenesis for auxotrophs (Adelberg et alo,
1965) as more severe conditions lead to double mutations.
To isolate phosphonomycin resistant mutants, samples (1 ml), of 
NTG-treated cultures, were centrifuged in sterile disposable centrifuge 
tubes in a Beckman microfuge (12,000 x g for 1 min). Pellets were 
resuspended in 1% (w/v) casamino acids (Appendix 1) and spread on BG 
plates containing phosphonomycin (100 pg ml ^). This resulted in a large 
number of phosphonomycin resistant colonies (about 50 per plate).
Colonies were subcultured onto BG containing phosphonomycin (100 pg ml ^). 
to give single colonies. Further subcultures from these single colonies 
were used for subsequent analysis. Control cultures (ie not treated 
with NTG),_gave no phosphonomycin resistant colonies.
Eight phosphonomycin resistant mutants, each isolated from a different 
NTG-treated culture, were grown for 48 h in SS-X and analysed for AC 
activity, culture supernate cAMP levels, and the X bands. All eight 
mutants, designated Tab 1 to Tab 8, possessed the same levels of intact­
cell AC activity as the wild type and produced similar amounts of cAMP 
in the culture supernate (Table 34).
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Figure 16; ' The effect of exposure to NTG on viability of strain
Taberman
Strain Taberman was grown in SS-X for 40 h. NTG was then added 
to give final concentrations of 100 pg ml (o), 50 pg ml (&), and 
25 pg ml"^ (□). At times intervals dilutions were plated out on BG plates 
to determine the viable count.
o
T“
X
Ê
3
*4—
ü
4-»
C
3
O
ü
O
(D
>
20 30 40 50 60
T i m e  4 mini
145
Table 34: Intact-cell AC activity and supernate cAMP levels cof
cultures of phosphonomycin resistant mutants of B. pertussis
Strains were grown for 48 h in SS-X. Intact cells were assayed for 
AC activity and culture supernate for cAflP.
Strain Intact-■cell AC activity^ cAMP level^
Taberman (original strain) 835 120
Tab 1 855 135
Tab 2 925 110
Tab 3 780 125
Tab 4 960 115
Tab 5 775 125
Tab 6 825 140
Tab 7 840 110
Tab 8 855 140
—  1 —  1 —  1
a, pmol cAMP min mg(protein) ; b, pmol cAMP ml
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10. Cyclic AMP Binding Activity
In E. coli and 5. typhimurium, the cAMP regulatory model is dependent 
on a functional CRP. Little is known about the role of cAflP in other 
prokaryotes.. However, in some organisms where cAMP related phenomena 
have been observed, cAMP-receptor proteins have been identified. Some 
of these have been shown to be immunologically similar to CRP (Anderson 
and Pastan, 1973).
If cAMP plays a regulatory role in B. pertussis it is most likely 
that it possesses a cAMP binding protein analogous to CRP. Cyclic AMP 
binding activity was measured in cytoplasmic fractions of B. pertussis 
strains and E. coli crp^ and crp strains (Table 35). Cyclic AMP binding 
activity was higher for B, pertussis strains than for E. coli crp , 
although not as high as that for E. coli crp^. There appeared to be no 
great differences between X- and C-mode variants or between phase I and 
phase IV variants.
The presence in B. pertussis of an immunlogically similar protein 
to E, coli CRP was tested by Duchterlony double diffusion precipitin 
test and by "crossed-over" immunoelectrophoresis using goat anti-E.coli CRP 
serum (4 x concentrated). One strong and one faint precipitin line were 
observed against an E. coli 1100 cytoplasmic fraction, but nothing against 
a B. pertussis Taberman cytoplasmic fraction even at.twice the protein 
concentration of the E, coli cytoplasmic fraction (Fig. 17). In addition, 
no reaction was observed against a cytoplasmic fraction of B. pertussis 
18334. Similarly, I'crossed-over” Immunoelectrophoresis gave two precipitin 
lines with the E. coli 1100 cytoplasmic fraction but nothing with the 
B. pertussis Taberman cytoplasmic fraction (Fig. 18)
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Table 35; [ h ] c AMP binding activity in extracts of E. coli and
B, pertussis
E. coli strains were grown for 18 h in Yeast Glucose medium and 
B, pertussis strains were grown for 48 h in SS-X. Supernate of X-pressed 
cells was assayed for cAMP binding activity.
Organism and
[^h ] cAMP binding activity^
strain Experiment
1 2 3
E. coli 1100 (crp'*') 6.9 4.7 2.9
E. coli 5336 (crp ) 0.4 0 1.1
B. pertussis Taberman 3.1 1.8 3.8
B, pertussis 
( C-mode)
Taberman^ 2.2
B, pertussis 18323 2.7
B, pertussis D3D042 I 1.8
B, pertussis D30042 IV 1.6
a, pmol [^H] cAMP bound mg(protein) ^; b, grown in SS-C for 48 h.
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Figure 17: Duchterlony double diffusion precipitin test of anti-
E. coli CRP against B.. pertussis and E, coli cytoplasmic 
fractions
A, goat anti-E. coli CRP serum; B, E. coli 1100 cytoplasmic fraction 
(15 mg(protein) ml ^); C, B. pertussis Taberman cytoplasmic fraction 
(15 mg(protein) ml ^); D, B. pertussis Taberman cytoplasmic fraction 
(30 mg(protein) ml *^ )o
Figure 18: "Crossed-ouer" Immunoelectrophoresis of anti- E. cpli CRP
against B. pertussis and E. coli cytoplasmic fractions
A, goat anti- E. coli CRP; B, normal rabbit serum; C, E. coli 1100 
cytoplasmic fraction (15 mg(protein) ml ^); D, B. pertussis Taberman 
cytoplasmic fraction (15 mg(protein) ml ^).

DISCUSSION
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1. The Modulating Effect of Different Compounds
Lacey (19 6 0 )  found that marked antigenic changes occurred when 
B» pertussis was grown on BG where the NaCl had been replaced by one 
of several salts or organic acids. Since then, the study of modulation 
has been restricted mainly to MgSO^- or nicotinic acid-induced modulation. 
The present study showed that several compounds, other than FlgSD^, induced 
modulation as judged by the loss of the X bands, HSA and AC activity.
Growth in Stainer and Scholte media containing high levels of MgSO^,
Na^SD^, or f\la butytate, consistently caused loss of these properties 
for three strains of B. pertussis: Taberman, a hospital isolate; 18334 ,  
a recognized laboratory strain; and 18323 ,  a mouse intracerebrally- 
virulent strain.
It has been reported that strain 18323 is resistant to MgSO^- and 
nicotinic acid-induced antigenic changes and loss of virulence (Pusztai 
and 3o6, 1967; Adams, 1 9 7 0 ) .  However, the 18323 strain used in these 
studies, reproducibly lost three X-mode specific properties when grown 
with 20 mil dgSO^; but there was some evidence to suggest that strain 
18323 was more resistant to modulation than strain 18334 .  Sodium caprylate 
( 0 . 6  mil) caused modulation for strain 18334 but not for strain 18323;  
strain Taberman would not grow with 0 . 5  mil Na caprylate. Modulation 
of all three strains occurred when grown with 20 mM Na butyrate; but when 
grown with 10 mM Na butyrate, modulation occurred for strains Taberman 
and 18334 but not for strain 18323 (results not shown). Growth with 
86 mM Na lactate caused partial modulation of strain Taberman but not 
of strains 18334 or 18323 suggesting that strain Taberman may be the 
most sensitive to modulation of the three strains. The function of 
modulation in nature is not known but perhaps continuous subculture 
in "unnatural" conditions (eg. in vitro, or the mouse brain), selects for 
strains which are less able to modulate. The possibility that low- 
intracerebral virulence of most strains is due to their tendency to 
modulate in the brain seems unlikely (Adams. 19701: such s t r a i n s
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removed from the mouse brain during the decline phase of infection, and 
transferred to another mouse brain, did not continue to decrease in 
numbers, but initially increased in numbers following the normal course 
of infection for low-intracerebrally-virulent strains. Nevertheless, 
intracerebral-virulence might be due to a virulence factor which is 
permanently expressed in intracerebrally-virulent strains, but which is 
expressed only during certain growth conditions (ie, not during growth 
in vitro or the mouse brain) in intracerebrally- avirulent strains.
The ability to regulate expression of this virulence factor 
might be linked to the ability to modulate.
Growth in media containing 43 mM MgCl2 did not cause modulation for 
any of the strains. Lacey (1960) reported this concentrationof MgCl^ 
and other Mg salts, present in BG, to cause modulation in terms of antigenic 
changes; although he reported MgCl^ to be a weak pro-C-mode salt compared 
to MgSO^. In the present study, the critical concentration of MgSO^ 
required to induce lossiof the X bands for strain Taberman was 1 0 - 1 1  mM. 
This suggests that the important component of MgSD^ for inducing modulation 
is the SO^ aniono Whether higher concentrations of MgCl^ could induce 
modulation was not investigated. It is possible that MgClg may induce 
antigenic changes without causing loss of other properties,
Lacey (i960) reported that various organic acids were pro-C-mode
substances. In this study, Na butyrate, Na succinate, Na lactate,
Na caprylate, and nicotinic acid all induced modulation although some 
strain specificity was observed. Sodium caprylate was a potent pro- 
C-mode compound for strain 18334. When present at 0.6 mM, Na caprylate
caused substantial loss of AC activity, HSA and the X bandso This is
consistent with Lacey's (i960) findings that fatty acids were potent 
pro-C-mode compounds with potency increasing with chain length.
Compared with the effect of other pro-C-mode substances, Na lactate 
(86 mM) caused a less severe loss of AC activity, HSA and the X bands 
of strain Taberman; but had no effect oh the expressibn of these 
activities for strains 18334 or 18323. These conditions may have
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induced the I-mode state, described by Lacey (i960), in strain Taberman.
After growth in media where cells underwent a marked reduction in 
intact-cell AC activity, activity still responded to activator but 
activation was reduced by 50%. This contrasts with Hewlett et al. (1980) 
who reported,that AC activity was unresponsive to activator, after 
growth in medium containing high levels of M g ^  (presumably high levels 
of MgSO^). Hewlett et al* (1979b) reported that during purification 
of AC, responsiveness to activator was lost suggesting the requirement 
for an additional factor for activation. It is possible that during 
modulation, this factor, as well as AC activity, is reduced. On the 
other hand, Greenlee et al. (1982) suggested that partial proteolysis 
was responsible for rendering purified AC insensitive to calmodulin.
If this is true, it is possible that partial proteolysis of AC during 
modulation may explain loss of responsiveness to calmodulin and even 
possibly loss of AC activity.
Molecular weight determinations suggest that pertussigen, the 
X polypeptides and AC are separate entities (Hewlett and Wolff, 1976; 
Irons and MacLennan, 1979), Furthermore, pertussigen is unique to 
B. pertussis whereas the X polypeptides have been demonstrated in 
B. pertussis and B. bronchiseptica and AC activity has been demonstrated 
in all three Bordetella species (Endoh e^ al., 1980; Ezzell al.. 
1981b). The simultaneous loss of these components during growth in 
different modifications of SS-X is consistent with the hypothesis of 
a common regulatory mechanism grossly perturbed during modulation.
As yet, there is no genetic evidence to support such a hypothesis 
but the suggestion that alteration of a regulatory mechanism lies at 
the root of modulation and phase degradation has been expressed elsewhere 
(Wardlaw and Parton, 1979; Peppier, 1982). The three components used 
as markers for modulation are all associated to a large extent with the 
cell envelope. For this reason it would be of interest to know whether 
HLT, which has a predominantly cytoplasmic location, is also lost
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after growth in various modulating media. It has been reported that 
HLT is greatly reduced during growth in medium containing high levels 
of MgSO^ (Livey £t 1978). From this study, there was no evidence to
suggest that different mechanisms were involved during modulation 
induced by different salts,
A few reports have suggested that some modulating conditions 
result in a differential loss of activities. Pusztai and Joo (1976) 
reported that loss of HSA but not HLT occgrred during nicotinic acid- 
induced modulation. However, Livey (1981) and recently Schneider and 
Parker (1982) reported that nicotinic acid-grown B. pertussis contained 
greatly reduced levels of HLT. Wardlaw et aJL.(l976) found that succinate- 
induced modulation of strain 18334 caused 70% loss of HSA but no apparent 
loss of the X bands. It is possible that these conditions induced 
an I-mode variant. It may be that within the common regulatory mechanism 
there exists a hierarchy of sensitivities which enables differential 
expression of different components. Differential expression would 
only be observed during conditions where the regulatory mechanism 
was moderately perturbed (ie. conditions which induced the I-mode variant), 
Perhaps this might explain discrepancies between different workers 
In the present study, 86 mM Na lactate caused less severe loss of AC 
activity, HSA and the X bands compared to other pro-C-mode compounds 
such as MgSD^; but differential expression of these properties was not 
obvious. It would be interesting to know whether levels of HLT were also 
reduced after such growth conditions.
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2. Adenylate Cyclase Activity in B. pertussis
2.1. Levels of cAMP in cultures of B. pertussis variants
Although C-mode and phase IV variants have reduced AC activity 
compared to their X-mode and phase I counterparts, determinations of 
their intracellular levels of cAMP have not been reported. This is relevant 
when proposing a regulatory role for AC as cAMP^and not AC,is the regulatory 
molecule in E. coli. When E. coli is grown in media containing glucose, 
many proteins are repressed due to a low level of intracellular cAMP.
This low level of cAMP arises through direct inhibition of AC activity. 
However, harvested E. coli cell suspensions, broken and intact, have 
higher AC activity after growth in media containing glucose than in media 
containing glycerol as the carbon source (Janecek et al., 1979).
Recent results suggest that this is due to direct inactivation of 
AC by CRP-cAMP (Bankaitis and Bassford, 1982), This illustrates that 
reduced levels of iji vitro AC activity does not necessarily implicate 
involvement of cAMP in any process. Determining the intracellular 
concentration of cAMP in bacteria is technically difficult due to the 
very low levels present. This has led to variable results between 
different workers, even for E. coli (Pastan and Adhya, 1976; Botsford,
1981). Attempts to determine the intracellular concentration of cAMP 
in B. pertussis after 48 h growth in SS-X and SS-C were unsuccessfulo 
The charcoal concentrating method of Epstein et ^ . (  1975) was used.
This may suggest that the intracellular concentration of cAMP in B. pertussis 
is very low ( < 0.2 pmol mg(dry weight)"^). Pastan and Perlman (1970) 
reported the intracellular levels of cAMP in E. coli to vary from 
0.5 - 1.0 pmol mg(wet weight) ^.depending on the carbon source.
In view of the difficulties encountered in measuring intracellular 
cAMP levels in Bo pertussis, the levels in culture supernate or whole 
culture were determined. It seems probable that culture supernate 
cAMP orginates from the cytoplasm as ATP is likely to be exclusively
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intracellular; cAMP is exceptional among the nucleotides in being 
excreted from bacterial cells (Lichenstein et 1960). In E. coli
cAMP is excreted at a rate proportional to it's synthesis (Epstein et al..
1975). Cyclic AMP levels in B. pertussis SS-X or SS-C cultures were 
the same whether determined from culture supernate or whole cultures.
This suggests that the majority of cAMP produced during growth is excreted 
into the medium. Supernate levels of cAMP in 48 h X-mode cultures 
of B. pertussis ranged from 0.1 - 0.2 nM.
Supernate levels of cAMP in cultures of E. coli after exponential
growth vary from 0.1 - 0*5 nM (Buettner et al., 1973)o After growth in
media where substantial loss of AC activity, HSA and the X bands 
occurred, extracellular levels of cAMP were less than 5% of that of 
X-mode cultures. It is likely that levels of intracellular cAMP 
were similarly reduced as later experiments showed that SS-C did not 
inhibit excretion of cAMP from B. pertussis cells. If cAMP plays a 
regulatory role in Bo pertussis, the large changes in cAMP levels 
which occur during modulation, would have the potential to cause phenotypic 
changes.
2.2. Locations of adenylate cyclase activity
Hewlett et al. (1978) reported that four locations of AC activity 
existed in B. pertussis cultures; one associated with the cytoplasm, 
two associated with the cell envelope, and one with the culture supernate. 
Results presented here confirm this* However, a substantially higher 
portion of AC activity (50%) was found in the culture supernate than 
reported by Hewlett et (20%). This is perhaps due to the differences 
in assay procedures. Hewlett et al. included creatine phosphokinase 
in the assay mixture to regenerate ATPo Several-fold more cAMP is produced 
in such assays as commercial creatine phophokinase is now known to be 
contaminated with calmodulin (Coldhammer e^ al.-,, 1981)*
155
In all three main compartments (culture supernate, extracytoplasmic 
but cell associated, and cytoplasmic), AC activity was substantially 
lost after MgSO^-induced modulation. This would suggest that the 
observed loss of intact-cell AC activity, was not due to inhibition 
of translocation from one compartment to another. It is not certain 
whether "trypsin insensitive" AC activity is due to free cytoplasmic 
AC or AC associated with the cytoplasmic membrane, although this could 
of been determined by including a centrifugation step. Furthermore, 
it is not certain which compartment of AC is responsible for cAMP produced 
during growth. The active site must be exposed to the cytoplasm where 
ATP is available. The finding that culture supernate levels of cAMP 
were 3.5-7.5 -fold higher after growth in SS-X containing activator 
(which has a molecular weight of 15,700 and therefore unlikely to enter 
the cell) than after growth in normal SS-X, suggests that at least 
some extracellular cAMP is produced by AC associated with the cytoplasmic 
membrane. The finding that ^  vivo AC activity is responsive to extra­
cellular activator, indicates that the AC of B. pertussis has the potential 
for a regulatory role in relaying cell surface mediated events to the 
genome by the production of cAMP. Cell surface mediated stimuli 
may be in the form of nutrient transport as in the Enterobacteriaceae 
or possibly in the form of changes in the ionic environment as in modulation 
of B. pertussis
2.3. The nature of the loss of adenylate cyclase activity during 
modulation
If AC is the target site of modulation, it would be expected that 
the observed loss of AC activity during modulation would be due to 
inactivation as opposed to repression of AC synthesis. Observing 
repression of AC synthesis would indicate that the target site of modulation 
must' be another regulatory mechanism which governs expression of AC* 
Time-course studies on MgSO^-induced modulation revealed that loss of 
specific intact-cell AC activity paralleled gain in biomass and thus
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could be accounted for by complete inhibition of AC synthesis. Furthermore, 
loss of AC activity did not precede, but coincided with and paralleled the 
loss of the X bands and HSA. These results indicate that loss of these 
activities during modulation can ' be accounted for by the synchronous and 
complete repression of synthesis of the responsible components (ie.
AC, pertussigen and the X polypeptides). This is consistent with recently 
reported results by Hall et al. (1982) who investigated the rate of loss 
of AC activity and the X bands during modulation. However, the results 
do not negate the possibility that in_ Vivo cAMP metabolism is immediately 
altered upon transfer of X-mode cells to SS-C, and that cAMP regulates 
the expression of AC as well as other X-mode specific components.
Specific intact-cell AC activity did not change greatly during 
growth in SS-X suggesting that AC is synthesized at a constant rate 
during growth in such media. This contrasts with observations by 
Hewlett et al. (1979a) who reported that specific intact-cell AC activity 
increased by about 10-fold during the first few hours of growth.
Perhaps this is related to the fact that these workers probably used a 
smaller inoculum of cells which had been grown on BG. In the present 
study a 20% (v/v) inoculum from a 48 h SS-X culture was used.
After incubation of X-mode B. pertussis in SS-X ^ and SS-C ,,
L n  H U n  H
specific intact-cell AC activity was about 60 - 80% of that after growth 
in SS-X; whereas after growth in SS-C, activity was about 1.0 - 2.5% of 
that after growth in SS-X. This observation suggests that AC is a fairly 
stable enzyme and that the loss of AC activity observed during modulation 
is not due to direct inactivation by prolonged exposure to the medium, 
but requires growth or protein synthesis. Similarly, protein synthesis 
or growth was required for the regain of AC activity during C to X modulation. 
This is presumably because the enzyme has to be synthesized de_ novo as 
opposed to being reactivated.
Time-course studies of modulation suggested that synthesis of AC
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was repressed upon introduction of cells to C medium. To verify that 
AC was repressed during modulation attempts wore made to purify AC 
and raise antiserum towards it so as to be able to detect the enzyme 
by immunological means. Sofaras is known, this is the first time 
attempts have been made to raise antiserum towards a prokaryotic AC. 
However, this was unsuccessful probably because of the poor yield 
of the purification method and the small amount of material injected 
into the rabbit. Excessive loss of activity (93%) occurred during 
Sephadex G-200 chromatography. Perhaps this step could be refined to 
give a yield comparable to the 50% yield achieved by Hewlett and Wolff 
(1976). Dye-ligand chromatography has been used successfully for the 
purification of bovine brain AC, but B. pertussis AC had little, if any, 
affinity for either BOS or RRA. Presumably, the structures of the active 
sites of B. pertussis AC and bovine brain AC are different, despite 
their similar responsiveness to calmodulin.
When investigating the effect of sera on AC activity, EGTA was 
included in order to inhibit the effect of AC activator present in serum 
which might have masked any inhibitory effect of the antiserum. EGTA 
(125 mM) greatly reduced AC activator activity present in sera, but not 
totally. This may perhaps relate to the observation by Greenlee et al. 
(1982) that EGTA does not totally eliminate responsiveness of B* pertussis 
AC to calmodulin. Neither antiserum raised towards purified AC nor the 
U.S. standard antiserum showed any significant inhibitory activity, with 
or without EGTA, for B. pertussis AC activity when compared to the effect 
of normal serum. This was presumably due to the lack of AC inhibitory 
antibody in these sera.
The low levels of extracellular cAMP which occurred after growth 
in media where X-mode^componenks were lost, cannot be accounted for by 
direct inactivation of AC by pro-C-mode compounds. Most of these, when 
included in the assay mixture, caused no more inhibition of intact­
cell AC activity than did the pro-X-mode salt, NaCl. The moderate 
inhibition caused by NaCl, Na^SO,. Na succinate, and Na butyrate was
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presumably due to l\la^ ions which Hewlett and Wolff (1976) reported 
to cause mild inhibition of AC activity* The inhibition caused by 
nicotinic acid and nicotinamide was more marked (about 60% loss of 
activity). Nicotinic acid has been reported to decrease cAMP levels 
in adipocyte cells of several mammalian species (Aktories et al..
1980). Lee (1978) reported that 1 mM nicotine adenine dinucleotide 
(NAD) caused 65% loss of AC activity in Mycobacterium smeqmatis. It 
is^ thus possible that the inhibition caused by nicotinic acid and 
nicotinamide was due to a metabolized product such as NAD.
These studies on the direct effect of salts on AC activity are 
limited in that AC activity vitro (ie. under the conditions of the 
assay) does not necessarily reflect that of AC activity in vivo (ie, 
during growth). This is further complicated in B. pertussis by the 
unusual compartmentation of AC. Cytoplasmic AC, which is presumably 
responsible for intracellular cAMP produced during growth, may be subject 
to different regulatory mechanisms than intact-cell AC activity* On 
the other hand, inhibition mechanisms may require the integrity of 
intact cells and would thus not be apparent when using cell lysate as 
an enzyme source. In E* coli, glucose inhibition of AC requires 
glucose transport and is only observed when toluene-treated cells 30 C
are used as an enzyme source (Harwood and Peterkofsky, 1975)* Similarly, 
mammalian AC is a part of a membranous multicomponent system requiring 
membrane integrity for regulation (Helmreich and Bakardjieva, 1980).
In vivo AC activity of E, coli is also influenced by factors such as 
growth rate (Wright et al*, 1979; Calcott, 1982)*
Growth in SS-X containing 4.1 mM nicotinic acid resulted in culture 
supernate levels of cAMP less than 5% of that after growth in normal SS-X. 
It is unlikely that the observed 60% 1jt_ vitro inhibition of AC by 
nicotinic acid explains this fully. It is even more unlikely that this 
inhibition by nicotinic acid explains nicotinic acid-modulation as 
nicotinamide, which also caused .60% irj vitro inhibition of AC, does not 
induce modulation (Wardlaw et al*. 1976)* Differences in the levels
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of extracellular cAMP in X- and C-mode cultures cannot be attributed 
to differences in energy charge as intracellular pools of ATP are similar 
for X- and C-mode cells (Ezzell et a2., 1981a).
. Workers who have suggested that AC may play a role in modulation and
phase degradation have assumed that cAMP plays a positive regulatory 
role in the synthesis of pertussigen, and the X polypeptides etc*
However, the possibility existed that cAMP may in fact play a negative 
regulatory role. SS-C,or other modulating media, may inhibit excretion 
of cAMP and hence allow it to accumulate inside cells. Cyclic AMP may 
in turn inhibit synthesis of pertussigen, the X polypeptides and AC etc.
This seemed equally plausible especially as it has been reported
that CRP-cAMP may repress AC synthesis in E, coli (Botsford, 1981). This
possibility now seems unlikely as extracellular cAMP was produced 
at the same rate whether large quantities of cells were incubated in 
SS-X^^p or SS-C^Qp. These results also suggest that SS-C does not 
directly alter in vivo cAMP metabolism unless for some reason growth 
is required for such alteration. Responsiveness to activator was the same 
whether X-mode cells were incubated in SS-X^^p or SS-C^^^p.
Presumably the apparent non-synthesis of cAMP which was observed 
when SS-C received a 20% (v/v) inoculum of X-mode cells was due to an 
inadequate level of calls. During growth in SS-X, AC is probably 
produced exponentially. Thus a large proportion of cAMP present in 
culture supernate after 48 h growth probably appears during the late 
exponential phase of growth when maximum levels of enzyme are present.
Chloramphenicol present in SS-C prevented loss of intact-cell AC 
activity, but this did not negate the possibility that AC is inactivated 
during modulation by the synthesis of a specific destructive or inactivating 
protein, or a protein which synthesizes a chemical inhibitor. Specific 
proteolysis of AC has been mentioned already as a possible explanation 
for the responsiveness to calmodulin which occurred after modulation.
There was no evidence for AC-inactivation or destructive factors in
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C-mode cell lysates when X- and C-mode cell lysates were mixed and 
incubated for various periods of time. These results also eliminate the 
possibility that the observed low specific AC activity in C-mode cells 
is due to a greater phosphodiesterase activity. As most AC is associated 
with the cell envelope, inactivation or.destructive mechanisms may require 
the integrity of intact cells. This could be tested by adding chloramphenico: 
to the medium at various stages of growth during modulation such as 
to allow initial expression of a possible inactivating mechanism.
2.4. Manipulation of cAMP levels in B. pertussis cultures
It was thought that NaF, a strong inhibitor of AC activity, and 
bovine catalase containing AC activator (calmodulin), might be useful 
in determining whether cAMP plays a role in modulation.
NaF caused marked inhibition of iji vitro AC activity. However, it 
had little effect on the production of extracellular cAMP during growth, 
although it inhibited growth at high concentrations, A possible 
explanation is that 0. pertussis is impermeable to NaF. Alternatively, 
medium constituents may alter the responsiveness of AC to NaF. Calcott 
(1982) reported phencyclidine'to be effective in reducing intracellular 
levels of cAMP in E. coli. It would be of interest to determine if 
this drug has the same effect with B. pertussis
Attempts to shift the critical concentration of MgSO^ required 
to induce modulation with AC activator were unsuccessful. Cyclic AMP 
could not be detected in supernates of C-mode cultures (ie. cultures 
in which the X bands were lost) whether bovine catalase was present 
or absent. This is presumably because of the lack of active enzyme 
in C-mode cultures. X-mode cultures had the same levels of HSA and the 
X bands (as judged by eye) whether activator was present or absent.
However, culture supernate levels of cAMP were 3.5 - 7.5 -fold higher 
in cultures containing bovine catalase. This observation does not 
necessarily eliminate a causal role for cAMP as maximum synthesis
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of the X polypeptides and pertussigen may already occur in X-mode 
cultures and cannot be increased by higher levels of cAMP.
With one exception, loss of the X bands always correlated with 
low levels of extracellular cAMP ( < 5 pmol ml '*). In the one exception, 
partial loss of the X bands occurred after growth in medium containing 
10 mM MgSO^ and bovine catalase. However, the culture supernate 
level of cAMP was about twice as high as that which normally occurred 
in SS-X-grown cultures. This observation suggests that cAMP does not 
play a causal role in modulation.’ It is possible, however, that most of 
this cAMP was produced during the initial period of growth and during 
this period normal synthesis of the X polypeptides occurred; and that 
the synthesis of the X polypeptides ceased later during growth when 
AC activity was reduced. This possibility seems unlikely as time- 
course studies of modulation revealed that loss of in vitro AC activity 
did not precede but paralleled the loss of the X bands suggesting that if cAMP 
is involved in modulation, direct and immediate inactivation of iQ vivo 
AC activity could only account for modulation. An.investigation of a 
time-course study of jjg vivo AC activity during growth in pro-I-mode 
medium containing calmodulin, may shed light on the above discussion.
Exogenous cAMP and dibutyryl cAMP (5 mM) had no effect in counteracting 
MgSG^- or nicotinic acid-induced-ioss of the X bands or AC activity, or 
MgSD^-induced loss of HA activity. Nor did either nucleotide alter 
synthesis of these components during growth in SS-X or H-X. This 
supports findings by Dobrogosz et al. (1979) and Ezzell et al. (1981a) 
who reported that exogenous cAMP at concentrations from 0.1 to 10 mM 
failed to relieve MgSO^-induced loss of the X polypeptides or cytochrome d^^g» 
This failure to relieve modulation does not appear to be due to the 
inability of the organism to take up nucleotide as present experiments 
demonstrated the incorporation of [^h ] c AMP and [^h ] dibutyryl cAMP 
into X-mode B. pertussis cells after incubation in SS-X and SS-C; and 
the incorporation of [^h ] cAMP into C-mode ,P. pertussis cells after 
incubation in SS-Xand SS-C. Differences in "uptake" rates between
162
different conditions were slight and further experiments would be required
to determine if differences were significant. At 1 mM [^h ] cAMP,
“ 1 ""1
"uptake" rates varied between 0.4-0.6 nmol min mg(dry weight) .
This is slightly higher than that reported for E. coli (about 
0.3 nmol min"^mg(protein) ^) when [^h ] c AMP was present at 1 mM 
(Goldenbaum and Hall, 1979). The greater rate of "uptake" observed 
for [?h ] dibutyryl cAMP, in the present study, may be related to the 
generally greater permeability of cells to this analogue. These 
preliminary results do not demonstrate conclusively the uptake of these 
nucleotides as binding of nucleotide to the cell wall is possible.
Cells are generally impermeable to phosphorylated compounds such as 
nucleotides. Therefore, it is likely that if cAMP is taken up, uptake 
occurs by facilitated diffusion as in E. coli or possibly by active 
transport. If this is the case, uptake will presumably be a temperature 
dependent process and will exhibit saturation kinetics. Further studies 
would be required to substantiate uptake of these nucleotides. The 
extent at which these nucleotides are metabolised, if at all, once, they 
enter the cell is not known. Paper chromatography of cells after 
uptake of [^h ] c AMP may be useful in assessing the extent at which 
cAMP metabolism occurs after uptake. The inability to detect intracellular 
cAMP in B. pertussis may perhaps be due to phosphodiesterase activity.
2.5. Phcsphonomycin resistant mutants of B. pertussis
The isolation of cya and crp mutants of E. coli provides the most 
convincing evidence for many of the regulatory roles of cAMP in this 
organism.c A rational basis for the isolation of B. pertussis AC mutants 
is difficult to deduce as none of the functions of AC in B. pertussis are 
known. Isolated phosphonomycin resistant mutants of 5. typhimurium were 
reported to be almost all either cya or crp in equal proportions 
(Alper and Ames, 1978). Eight phosphonomycin resistant mutants of 
B. pertussis each possessed the same level of intact-cell AC activity
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and produced the same levels of extracellular cAMP during growth as the 
wild type strain.
Phosphonomycin (L-cis-1,2-enolpropylphosphoric acid) is a structural 
analogue of phosphosnolpyruvate and specifically inhibits the first 
step of pBptidoglycan synthesis, namely,the transfer of the enolpyruvate 
from phosphosnolpyruvate to UDP-N-acetylglucosamine. This inhibition 
is irreversible. Phosphonomycin has little effect on other enzymes 
such as pyruvate kinase where phophoenolpyruvate is the substrate (Rogers 
et al., 1980). In E. coli and 5. typhimurium. phosphonomycin is actively 
transported by two independent transport systems; that for L-oc-glycerophosphal 
and that for hexose phosphates (Chopra and Ball, 1982), Both these 
transport systems are subject to regulation by cAMP (Koch e^ al., 1964; 
Winkler, 1970). B. pertussis utilizes only amino acids as sources 
of energy, although it is possible that the organism possesses permeases 
for sugars which might be used as precursors for biopolymers. Perhaps 
phosphonomycin is transported by a different mechanism in B. pertussis.
A third mechanism for phosphonomycin transport has been suggested which 
is related to the transport of inorganic phosphate (Kahan et al..
1974). Although the majority of phosphonomycin resistant mutants 
of bacterial species are defective in the two main transport mechanisms, 
it is possible that all or some B. pertussis mutants are defect in 
enolpyruvate transferase. There has only been one case reported where 
resistance in a bacterial species was due to a decreased affinity of 
the enolpyruvate transferase for the antibiotic (Uenkateswaran and Wu,
1972) and this was a temperature sensitive mutant.
The observation that a phase IV strain of B. pertussis was much 
more resistant to phosphonomycin than it's phase I counterpart suggests 
that the transport protein(s) required for phosphonomycin sensitivity 
are lost during phase degradation. Dobrogosz al^ . (1979) and Field 
and Parker (1979) reported that degraded strains were more resistant 
to certain antibiotics (viz. penicillin, ampicillin, streptomycin.
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erythromycin and tetracycline)* In this study C-mode variants of 
B. pertussis were as sensitive to phophonomycin as X-mode variants. In 
addition C-mode variants of B* pertussis would not grow on nutrient 
agar containing MgSO^ while the phase IV variant would, Dobrogosz et al.
(1979) reported that while phase IV variants were more resistant to 
the previously mentioned antibiotics, sensitivity was often enhanced 
in C-mode variants compared to X-mode variants. This suggests that 
phenotypic differences do exist between the C-mode and the phase IV 
phenotype. This perhaps relates to the observation of Leslie and 
Gardner (1931) that phase degradation was a step-wise process. Field and 
Parker (1979) reported that during serial passage of fresh isolates of 
B. pertussis, the ability to grow on solid medium without blood occurred 
before the loss of pertussigen and HLT. Perhaps the intial stage of 
phase degradation involves loss of sensitivity to various inhibitors. 
Sensitivity to certain antibiotics may require the same transport 
proteins which are responsible for sensitivity to the inhibitors 
present in convential media such as fatty acids, colloidal sulphur 
and sulphides, organic peroxides and manganous ions. However, none of 
the eight isolated phosphonomycin resistant mutants grew on nutrient agar.
This suggests that phosphonomycin sensitivity and "nutrient-agar sensitivity" 
might be lost separately during phase degradation. The second stage of 
phase degradation might involve the loss of the same components lost during 
modulation, due to further mutations,
2.6. Respiration of substrates by variants of B* pertussis
Out of the eleven amino acids tested, washed suspensions, of B. pertussis 
respired only L-glutamate, L-aspartate, L-proline, L-serine and L-alanine 
at detectable rates. This is consistent with findings by Jebb and Tomlinson 
(1951) who tested 21 amino acids. However, these workers reported the 
respiration rate for glutamate to be about ID-fold higher than reported 
here; the respiration rates they reported for other amino acids varied
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considerably with strain. In the present studyglutamate, aspartate, 
and proline were respired at the greatest rates. .This perhaps explains 
why these are the only amino acids which have been reported to support 
growth when present as the principle carbon source (Jebb and Tomlinson, 
1955; Stainer and Scholte, 1971).
Various workers have reported that glutamate is the preferred 
carbon source and is utilized before other amino acids. In the present 
study, 8. pertussis was grown in either SS-X or SS-C which contain only 
glutamate and proline as principle carbon sources. Cells were harvested 
during the mid-exponential phase (after 24 h growth) and were shown 
to possess the potential to respire aspartate, serine and alanine.
This supports the observation of Lane (1970) that glutamate is not 
utilized preferentially unless perhaps glutamate directly antagonizes 
uptake of other amino acids. This would be entirely distinct from the 
mechanism in E. coli where glucose is preferentially utilized because 
the permeases and catabolic enzymes for other sugars are repressed.
While significant differences existed between respiration rates for 
different amino acids, there were no significant differences between the 
respiration rates for the different variants for any particular amino acid, 
As the C-mode and phase IV variants produce much lower levels of cAMP 
during growth than the X-mode variant, this suggests that cAMP is not 
involved in the regulation of the permeases or enzymes required for amino 
acid utilization. This also indicates that the mechanisms of modulation 
and phase degradation, whatever they may be, do not affect the respiration 
of amino acids. Similarly C modulation did not affect the ability 
of cells to respire acetate, pyruvate, lactate, succinate, or formate.
Phase IV and C-mode variants lack cytochrome d^gg, but larger 
quantities of other cytochromes are synthesized (Ezzell et , 1981a). 
This presumably compensates for loss of cytochrome d^^g and accounts 
for respiration rates being similar between variants. Alternatively, 
amino acid transport may be the rate limiting step in B. pertussis ,
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2.7. Cyclic AMP binding activity in B. pertussis
So far as is known, all cAMP regulatory systems in bacteria require
a functional CRP. Although a cAMP-binding protein has only been
identified in a few bacteria, eg, E. coli, S. typhimurium, Caulobacter .
crescentus. Myxococcus xanthus, Benejea harveyi, and Alcaliqenes eutrophicus,
(Pastan and Adhya, 1976; Shapiro, 1976; Orlowski, 1980; Nealson and
Hastings, 1979; Tait et al., 1981), there has never been a case reported
where a cAMP-bïnding protein has not been found where cAMP clearly
r3 1
plays a regulatory role. In this study, [ Hj cAMP binding activity 
was detected in several strains of B. pertussis and, on average, was about 
half that obtained for E. coli crp^and about four times that obtained 
for E. coli crp . It is not known whether this binding activity is 
attributable to a protein with a real physiological function. A more 
satisfactory way to detect cAMP binding proteins is to use 8-aZido- 
[^^p] cAMP, a photoaffinity analogue of cAMP in conjunction with SDS-PAGE. 
This is a more sensitive method and yields information as to how many 
cAMP binding proteins exist and their molecular weight. This analogue 
competes with cAMP for CRP in E. coli (Aiba and Krakow, 1980) and has 
been used to detect a cAMP binding protein in M. xanthus (Orlowski,
1980).
While anti-E. coli CRP gave a precipitin reaction with a cytoplasmic 
E. coli fraction, it gave no reaction with B. pertussis cytoplasmic 
fractions even at twice the protein concentration of the E. coli cytoplasmic 
fraction. Using this same antiserum, Ouchterlony double-diffusion 
studies showed cross-reactivity between purified E. coli CRP and 
cell extracts of E. coli, Proteus mirabilis, Photobacterium fisheri, 
Klebsiella aeroqenes, S. typhimurium, and Caulobacter crescentus 
(Anderson and Pastan, 1973). The cAMP receptor protein of Benekea 
harveyi is immunologically homologous with CRP from E. coli (Nealson and 
Hastings, 1979). Whether the cAMP receptor proteins of Alcaliqenes 
eutrophicus or Myxococcus xanthus are immunologically related to that
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cAMP receptor proteins exist which do not react with anti-E, coli 
CRP, The G + C ratio of B. pertussis lies at the fringe of that of 
organisms which possess a CRP immunologically homologous to E. coli 
(Table 35), Thus during evolution, an immunologically distinct CRP 
may have arisen in B. pertussis. On the other hand, AC may have _ 
evolved different functions in prokaryotes; in some it may have 
adopted a regulatory role requiring a functional CRP, whereas in others 
it may have adopted different roles not requiring CRP (eg, a role in 
virulence possibly altering cAMP-related functions in the host).
2.8» The possible role of adenylate cyclase in B. pertussis
Pastan and Perlman (1971) proposed four criteria for implicating 
cAMP in the mediation of cell phenomena, namely:- (1) cAMP levels must 
be correlated with observed cell function, (2) exogenous cAMP must 
alter the function in a predictable manner, (3) inhibitors or stimulators 
of cAMp metabolism must also alter the function, (4) the activities 
of the enzymes which synthesize or catabolize cAMP should be altered 
by the conditions which alter the cell function. With regard to the 
possible role cAMP plays in modulation in B. pertussis, only the first 
criterion has been satisfied and this is only insofaras culture supernate 
levels of cAMP correlated with production of the X bands and HSA after 
growth in various modulating media.
Several lines of evidence indicate that AC is not the target site 
for modulation and that low levels of cAMP are due to repression of AC 
synthesis, itself subject to the regulatory mechanism perturbed by the 
modulating environment
(1) Loss of intact-Tcell AC activity during MgSO^-induced modulation 
could be accounted for by complete repression of AC synthesis.
(2) All searches for direct or indirect inhibition or inactivation 
mechanisms of AC activity, which might occur during modulation were 
negative.
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Table 36; DNA relatedness of bacteria possessing a protein which 
cross reacts with anti-E. coli CRP
Bacterial species
G 4* C 
content^ 
(moles %)
Cross reaction 
anti-E.coli CRP 
or no reaction
with
(+)
(-)b
Regulatory , 
role for 
cAMP
Clostridium sticklandii 26 - NK^
Staphylococcus aureus 30-39 - NK
Proteus mirabilis 38-41 + NK
Methanosarcinia barkeri 44 - NK
Photobacterium fisheri 40-46 + NK
Benekea harveyi 45-48 Yes^
Escherichia coli 50-51 + Yes®
Salmonella typhimurium 50-53 + Yes®
Klebsiella aeroqenes 52-59 + Yes®
Caulobacter crescentus 62-67 + Yes^
Bordetella pertussis 61-70 — NK
a, data from Starr et al. (1981); b , data from Anderson and Pastan (1973)
c, not known (NK); d, Nealson and Hastings (1979); e, Botsford (1981); 
f, Shapiro (1975).
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This study also suggests that it is unlikely that cAMP plays a 
secondary role in modulation in repressing synthesis of pertussigen 
and the X polypeptides as:-
(1) Loss of intact-cell AC activity during MgSO^-induced modulation 
did not precede, but paralleled the loss of HSA and the X bands.
(2 ) After the growth and the transition of an X-mode variant to an 
I-mode variant, in medium containing calmodulin, culture supernate 
levels of cAMP were twice as high as for normal X-mode cultures, yet 
the X-bands were considerably diminished.
(3 ) Exogenous cAMP or dibutyryl cAMP in the growth medium,had no 
observable effect on intact-cell AC activity, HA activity or the presence 
of the X bands after growth of B. pertussis in X and C media.
Three observations suggest that during the course of evolution,
AC may have adopted different physiological roles in E. coli and B. pertussis 
(1 ) 50% of AC activity in B. pertussis cultures was found in the culture 
supernate and 90% was extracytoplasmic, (2) the marked responsiveness 
of B. pertussis AC to calmodulin, (3) the lack of a CRP in B. pertussis 
immunologically similar to E. coli CRP. This may be related to the 
different physiologies of the two organisms; E. coli is a facultative 
anaerobe which utilizes sugars preferentially as sources of energy,
B. pertussis is a strict aerobe which utilizes only amino acids as 
sources of energy.
Several of the components lost during modulation and phase degradation, 
such as pertussigen, HLT and F-HA, are strong or plausible candidates 
for pathogenic determinants. In view of this, perhaps AC is itself 
a virulence factor. Indeed several bacterial toxins act by penetrating 
target cells and activating the host-cell AC. Examples include cholera 
toxin, a heat-labile toxin of certain E. coli strains, and possibly 
pertussigen of B. pertussis. The former two toxins possess a subunit 
which enables attachment to specific receptors on the host cells and 
subsequent penetration of the other subunit which activates the eukaryotic 
AC. The mechanism of pertussigen is less well understood, but as pertussigen
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consists of several subunits, some are presumably responsible for attachment 
to the target cells while others are presumably responsible for activation 
of host cell AC.
B. pertussis AC is a soluble enzyme consisting only of one polypeptide
with a molecular weight of about 70,000 (Hewlett and. Wolff, 1976).
It is thus difficult to explain how AC gains access to the host cell
cytoplasm unless it acts in conjunction with another factor. Leppla
(1982) recently reported that one of three components of anthrax toxin,
edema factor (EF), is in fact an AC. Purified EF required either
boiled eukaryote cell lysate or calmodulin for detectable activity,
but specific activity in their presence was very high 
—  1 —  1
(20 pmol min” mg(protein)” ). EF requires another factor, protective 
antigen (PA), for it's toxic action (edema after intradermal injection in 
rabbits or guinea pigs). EF added with PA to Chinese hamster cells 
increased intracellular cAMP levels by 50-fold. Leppla (1982) suggests 
that PA interacts with specific receptors enabling EF to gain access 
to the cytoplasm.
The fact that B. pertussis AC also has marked responsiveness to 
calmodulin suggests that it may have evolved along similar lines and
may be another virulence factor. Perhaps B. pertussis AC acts in conjunction
!
with pertussigen. If pertussigen activates eukaryotic AC, it may 
activate B. pertussis AC. This may account for the large losses of 
activity which occurred during purification of AC in this study and by 
Hewlett and Wolff (1976). This could easily be tested by assaying AC 
activity in mixtures of purified AC and pertussigen. Adenylate cyclase 
activity is considerably higher in toxinogenic strains of V. choleras than 
non-toxinogenic strains. Furthermore, AC activity increases dramatically 
during the stationary phase of growth when toxin production is highest 
suggesting that cholera toxin activates AC of V. choleras (Chakrabarti and 
Ganguly, 1980). However, there was no evidence for pertussigen activating
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B. pertussis AC in the present study, as no activation was apparent 
when C-mode cell lysate (which contains reduced levels of pertussigen 
when compared to X-mode cell lysate) was mixed with. X-mode cell lysate 
and assayed for AC activity.
Padh and Venkitasubramanian (1980) could not detect cAMP binding 
activity in Mycobacterium smeqmatis by several assay methods. These 
workers suggest that during evolution, mycobacteria have lost the 
capacity to synthesize a functional CRP and this may explain why 
mycobacteria have lost the ability to utilize many sugars (Padh and 
Venkitasubramanian, 1980). AC may have evolved to play a role in virulence 
in some mycobacteria. Observations by Lowrie et al. (1975) suggest that 
M. microti may protect themselves in phagocytes, by releasing cAMP into 
phagosomes at concentrations which would inhibit phagosomal and lysosomal 
fusion. Muse je^ _al. (1979) reported that with nonimmune serum, phagocytosis 
by alveolar macrophages was greater for phase IV variants of 5. pertussis, 
than for jDhase I variants. Furthermore, bactericidal activity of 
phagocytized phase IV variants was considerably greater than for phase I 
variants. This may perhaps be attributable to high AC activity of 
phagocytized phase I B. pertussis. Calmodulin present in phagocytes would 
further enhance AC activity. Cyclic AMP inhibits a number of functions 
in neutrophils and macrophages such as lysosomal discharge, phagocytosis, 
chemotactic motility and antibody-dependent cellular cytotoxicity 
(ignarro, 1977).
Recently, Confer and Eaton (1982) reported that, after incubating 
neutrophils with B. pertussis extract, the intracellular level of 
cAMP in the neutrophils was higher than ever reported before. In addition, 
these neutrophils had high AC activity which these workers attributed 
to B. pertussis AC due to it's heat stability (10D®C for 5 min). However, 
in the present study, 1D0®C for 10 min destroyed all detectable 8. pertussis 
AC activity. Hewlett and Wolff (1976) reported that purified B. pertussis 
AC lost 90% of activity after 20 min at B6°C. There have been no previous 
,,r,r,n-r.4-o rrP A . nRT'f.iic.pî R Af! hBino hsat stable at 10D®C for 5 min.
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Furthermore, Confer and Eaton (1982) did not report having tested the 
heat sensitivity of B. pertussis AC themselves. Heat-stable AC activity 
in neutrophils after ingestion of B. pertussis cells is a puzzling 
observation which as yet cannot be explained by ingestion of B. pertussis 
AC or any of the other known biologically active components of B. pertussis .
Bemis and Kennedy (1981) suggested that Bordetella AC may play a 
role in ciliostasis by depleting epithelial cells of ATP. This could only 
be explained, however, if AC was able to penetrate host cells. Ciliostasis 
by B. pertussis is more likely explained by the recently reported 
tracheal cytotoxin (Goldman et , 1982).
3. Possible Mechanisms of Modulation
Time-course studies of MgSO^-induced modulation indicated that 
synthesis of AC, pertussigen and the X polypeptides was completely 
inhibited at an early stage and pre-existing X-mode components were 
merely diluted out with growth. This is consistent with recently 
published results which indicated that the X polypeptides and AC were 
diluted out in accordance with the growth rate (Hall et , 1982).
The observed rate of loss of pertussigen was less convincing due
to the insensitivity of the HSA test. Idigbe e;^  (1981) reported
that strain 18334, grown in modified Hornibrook medium containing
20 mfl flgSG^, underwent a rapid loss of HSF, LPF, HLT, MPA and the
X bands: much more so than could be accounted for by a simple growth-dilution
effect. This was concluded from an analysis of six independent experiments.
These workers suggested that selective destruction took place during
modulation. Idigbe et al. (1981) observed a much slower growth rate;
the mean generation time during exponential growth was 6 - 7 h while
that observed in the present study was about 3.2 h. Differences in results
may be due to differences in either growth rate, the strain used or
the medium used.
In the present study, growth rates were consistently slightly
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higher during growth in SS-C than in SS-X, whether determined by total 
counting or viable counting methods. A possible explanation is that 
the energy which is conserved when synthesis of X-mode components 
ceases, is used to synthesize biopolymers required for growth. However, 
in other studies (idigbe at al., 1981) growth rates were the same 
whether cells were grown in X or C medium.
Studies with chloramphenicol indicated that the loss of HSA,
AC activity and the X bands during modulation was not due to a direct 
prolonged exposure to C medium, but required growth or protein synthesis. 
There was no evidence for destructive or inactivation factors for 
pertussigen, which might have been synthesized during growth in SS-C, when 
X-mode and C-mode cell lysates were mixed together and incubated for 
24 h at 35°C. This was the case for strain Taberman grown in SS-X 
and SS-C and for strain 18334 grown in H-X and H-C. However, moderate 
destruction or inactivation of pertussigen would not be noticable 
due to the wide 95^ confidence limits obtained for the HSA tests.
It is also possible that destructive mechanisms require the integrity 
of intact cells or are extremely heat-labile. Synthesis of selectively 
destructive or inactivation factors would be a very inefficient way to 
control an organism’s physiology and is not generally observed in bacteria. 
However, it is not known if modulation has a real physiological counterpart 
in nature. The reason why the toxin of Bacillus anthracis was only 
discovered after in vivo studies, was because of an inactivating 
substance produced during growth in vitro (Harris-Smith _et al., 1957), 
Similarly, Elliott (1945) reported that the M protein of certain strains 
of group A streptoccoci was destroyed during certain growth conditions 
due to synthesis and activation of a specific protease.
The critical concentration ofMgSO^ required to repress synthesis 
of the X polypeptides was around 10 mM (using increments of 1 mfl).
In six series of concentrations,an I-mode variant which exhibited
partial loss of the X bands was. only observed once. Thus the concentration 
" "" -inHiiop the I-mode variant is extremely critical.
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lying between 10 - 11 mM. Lacey (i960) reported that 6.5 - 0.5 mM 
MgSO^ in BG, induced the I-mode variant as judged by moderate antigenic 
changes. Presumably these growth conditions cause only partial repression 
of X-mode specific components.
So far, all reported pro-C-mode organic compounds contain a carboxyl 
group. That nicotinic acid can induce modulation, but not nicotinamide, 
suggests that the carboxyl group may be important in inducing modulation.
It seems unlikely that nicotinic acid-induced modulation is related to 
nicotinic acid transport as nicotinic acid is present in such excess 
in normal SS-X that during growth, nicotinic acid uptake would always 
be saturated and at maximum velocity (W. McPheat, personal communication). 
Not all organic acids induce modulation. Na glutamate is present in 
SS-X at 57 mM. However, Lane (197D) found that growth in Cohen and 
Wheeler medium, where the casein hydrolysate was replaced by high 
levels of Na glutamate, resulted in loss of HSA and MPA. Presumably, 
other factors are involved such as molecular size and conformation, 
dissociation constants, pH etc.
Recently Schneider and Parker (1982) reported that two analogues
of nicotinic acid, 6 chloronicotinic acid and quinaldic acid, both having
a pyridine ring substituted with a carboxyl group in postions 2 or 3,
were also able to induce modulation of B. pertussis. Two analogues of
nicotinamide, isoniazid and 2-chloronicotinamide, did not induce modulation
but inhibited nicotinic acid-induced loss of X-mode antigens, Isoniazid also 
pievenbea nicotinic acid-induced loss of the X-bands whereas 2 cliloronicotinamide only 
prevented loss of X-mode antigens.Perhaps these nicotinamide analogues are able to
compete with nicotinic acid for the target site of modulation^ but
lack the carboxyl group required to induce modulation. Modification
of the carboxyl group by méthylation or acétylation abolished the
modulating activity of nicotinic acid stressing the importance of the
carboxyl group in inducing modulation. The ability of
2 chloronicotinamide to inhibit nicotinic acid-induced loss of Xnmode
antigens, but not the X bands, may.be of practical importance in
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the production an improved vaccine and requires further investigation.
As yet, there is very little information on which to base a satisfactory 
explanation of modulation. The control of X-mode and phase I specific 
components by plasmids seems unlikely aS Kloos et (1979) showed
that there was no correlation between variation and presence of extra- 
chromosomal material. The majority of components lost during modulation 
are associated with the cell surface or released into the medium.
Thus there are three stages at which modulation could act; transcription, 
translation, or post-translation modification and translocation into the 
cell envelope. The third seems unlikely as HLT, which has a cytoplasmic 
location, is lost during MgSO^-induced modulation. It has been suggested, 
however, that post-translation modification may be involved in the 
synthesis of active HLT (Pittman, 1979). In the present study, "cytoplasmic" 
levels of AC were also reduced during MgSO^-induced modulation. Of 
the former two possibilities, regulation at the level of transcription 
is by far the most common and efficient mechanism in prokaryotes.
McPheat (1981) found that nicotinamide (which does not induce 
modulation as does nicotinic acid), upon entering B. pertussis cells, 
was very rapidly metabolized to nicotinic acid. This suggests that 
nicotinic acid-induced modulation may begin at the cell surface.
A possible mechanism for modulation is given in Fig. 19. This 
model is highly speculative and is based on the assumptions that the 
first events of modulation (or at least nicotinic acid-induced modulation) 
commence at the cell surface, modulation acts at the stage of transcription, 
and that most transcription regulatory mechanisms require the involvement 
of a cytoplasmic protein.
Pro-C-mode compounds may interfere with a regulatory component 
located at the cell surface. Interference with this component may affect 
the synthesis of a diffusabls cytoplasmic factor (DCF) such as a co-repressor, 
co-inducer or regulatory nucleotide, DCF may either selectively 
activate or inactivate gene expression. X-mode specific proteins may 
be encoded on the same or different opérons, all sensitive to DCF.
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Figure 19; A possible mechanism for modulation
Pro-C-mode substances interact with a cell surface regulatory 
component (CSRC), This in turns alters the production of a diffusabls 
cytoplasmic factor(DCF). DCF acts- in conjunction with a cytoplasmic 
regulatory protein (RP) which together, either activate or inactivate 
X-mode specific gene expression. Phase IV mutations may occur at 
genes encoding CSRC or RP, or at the operon regulatory site (only if 
one operon is involved).
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DCF would presumably act in conjunction with a regulatory protein such 
as a repressor, or a protein analogous to CRP in E. coli, or a RNA 
polymerase component. Some pro-C-mode substances may act as co-repressors 
themselves similar to Fe in the regulation of diphtheria toxin 
(Murphy et al,* 1978). Phase IV mutations could exist either in the RP, ■ 
the cell surface regulatory component, or the regulatory site of the 
operon (only if the X-mode specific component’s are all linked on the 
one operon).
Glutamine synthetase has been demonstrated in B. pertussis cell
extracts by Zakharova et^  al.(1979). This enzyme plays a key regulatory
role in controlling the utilization of nitrogen sources in the enterobacteria
and several other bacterial species (Magasanik, 1977). As B. pertussis
utilizes only amino acids as carbon or energy sources, it is conceivable
that glutamine synthetase may play a key regulatory role in this organism.
However, it is difficult to apply the regulatory model of glutamine
synthetase in the enterobacteria to the physiology of B. pertussis.
As 6 . pertussis utilizes only amino acids as energy sources, the organism
is never faced with a situation where growth is limited by a lack of
nitrogen source before being limited by a lack of energy source.
In fact, cultures of B. pertussis contain high levels of NH^^. In a
preliminary experiment (results not shown), low glutamine synthetase activity
_ 1
(about 0.3 pmol )f-glutamyl hydroxamate h ) was detected in X-mode, but 
not C-mode, cell lysates of strains Taberman and 18334 after assay 
mixtures were left overnight at 35°C (the y -glutamyl hydroxamate 
transferase assay described by Shapiro and Stadtman (1970) was usedj.
The significance of this observation is not known. Glutamine synthetase 
and it's modifying enzymes (modification of glutamine synthetase 
is an important aspect of it's regulatory mechanism) have a cytoplasmic 
location in the enterobacteria (Ginsburg and Stad.tman,1973). Presumably, 
if glutamine synthetase is involved in modulation , it is involved at a 
cytoplasmic stage.
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Understanding the mechanism of modulation will probably depend on 
a greater knowledge of the genetics of 8. pertussis about which nothing 
is known at present. Perhaps the recent report on the ability to transfer
chromosomal genes via. plasmids in B. pertussis (Weiss and Falkbw, 1982)
is the starting point of a new line of research in pertussis. Most of 
the phathophysiological activities of B. pertussis are difficult to 
assay. In view of this, gene fusion studies may be useful in studying 
the regulation of virulence factors in B. pertussis. Currently, lac Z 
fusion studies are being used to study the regulation of membrane 
proteins in E. coli. A more extensive survey of pro-C-mode substances 
and anti-modulating substances (such as isonidzid and 2 chloronicotinamide 
which Schneider and Parker (1982) reported to inhibit nicotinic acid- 
induced loss of X-mode antigens) on the physiology of B. pertussis 
may also shed light on the mechanism of modulation.
Out of the sera of fifty convalescent pertussis patients, forty two 
possessed X-mode antibodies and three possessed C-mode antibodies (Lacey, 
1960). This observation suggests that modulation is not merely a laboratory 
phenomenon, but occurs in nature. While only two of the forty two sera 
with X-mode antibodies were from adults, all three sera with C-mode 
antibodies were from persons over the age of 19 who had only a mild cough. 
Thus perhaps the C-mode variant is a pathogenically dormant state 
associated with adults who act as carriers. The environment of the upper 
respiratory tract of the adult host may trigger the C-mode state.
The substances which induce the C-mode state in nature may be totally
different from those in the laboratory.
Modulation is not unique to B. pertussis; non-genetic variation 
of surface antigens occurs in several microorganisms (Lacey, 1961).
Yersinia pestis is similar to B. pertussis in that it also undergoes 
phenotypic changes when grown at different temperatures. In the gut 
of the flea vector, virulence of V. pestis is masked by growth at 25°C.
When such bacilli are phagocytized at 37°c by monocytes ( in the mammalian
179
host) they multiply intracellularly, they then emerge as virulent 
organisms possessing the antiphagocytic factors FI (a capsular protein) 
and the VW antigens (Sonnwirth and Swartz, I960).
The ability of B. pertussis to modulate in nature requires further 
investigation. Vaccines prepared from X-mode cells may not protect 
persons from infection with C-mode B. pertussis. Thus C-mode carriers 
could exist which trigger epidemics when the population of susceptible 
infants reaches the threshold level.
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Appendix 1 ; Media and Diluants 
1. 1^ (w/v) Casamino acids
g L-1
Casamino acids (Difico) 10
MgClg.GHgO 0.1
CaClg 0.016
NaCl 5
The above ingredients were dissolved in distilled water, the 
pH was adjusted to 7.1 with 1.0 N IMaOH, and the mixture was autoclaved 
(15 psi, 121°C for 15 min).
2* BG-X and BG-C
Washed, peeled and diced potatoes (312 g) were boiled in 2.5 L 
of distilled water for about 30 min until soft. The mixture was filtered 
through gauze muslin to give a potato extract infusion.
BG-X BG-C
Potato extract infusion 2 L 2 L
NaCl 5 g ——
MgSO^.THgO - 10 g
Glycerol 10 ml 10 ml
Agar (Oxoid No. 3) 20 g 20 g
The pH was adjusted to 7, and the mixtures were kept in a Koch- 
steamer for 15 min and autoclaved in 50 or 250 ml amounts.
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3, Stainer and Scholte medium
This is the "16G + IP" medium originally described by Stainer and 
Scholte (1971), but with cysteine replacing cystine.
1, L-glutamate (mpnosodium salt) 10.72
2. L-proline 0.24
3. NaCl 2.5
4. KH^PO^ 0.5
5. KCl 0.2
6. MgClg.GHgO 0.1
7. CaClg 0.02
8. Tris 6.075
9. L-cysteine 0.04
10. Fe^SO^oTH^O 0.01
11. Ascorbic acid 0.02
12. Nicotinic acid 0.004
13. Glutathione 0.1
Ingredients 1 - 8  were dissolved in distilled water, the pH was 
adjusted to 7.6 with HCl and the medium was autoclaved. Ingredients 
9 - 1 3  were sterilized by membrane filtration and were separately added 
to the medium just before use. This medium is referred to as SS-X.
SS-C was prepared in the same way, but with NaCl replaced by 5 g l""* 
MgSO^.THgO
213
4. Modified Hornibrook medium
9 L-’
1. Casamino acids (Difco Technical) ID
2. CaClg 0.002
3. KCl 0.2
4. KgHPO^ Do25
5. MgClg.GHgO 0.025
6. NaCl 5
7. Nicotinamide 0.001
8. Soluble starch 1
9. Glutathione 0.01
Components 1 - 7  were dissolved in distilled water. Starch was
dissolved in boiling water before adding to the rest of the medium.
The pH was adjusted to 7.0 with NagCO^ and the medium was autoclaved. 
Glutathione was filter sterilized and added to the medium just before use,
5o Yeast Glucose medium
9L-1
1. Yeast Extract (Difco) 10
2. KHgPO^ 5.6
3. KgHPO^ 28.9
4. Glucose 10
5. Thiamine 0.01 
Ingredients 1 - 3  were dissolved in 900 ml distilled water*
Ingredients 4 and 5 were filter sterilized in 100 ml distilled water 
and added separately to the rest of the medium.
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Appendix 2t Standard curves
Figure A1: Standard curve relating A^GOnm^^ protein concentration
and dry weight
At Af protein concentration for X- and C-mode cell suspensions respectivel 
□, H, dry weights for X- and C-mode cell suspensions respectively.
08
06
E 04
c
I
<
02
Dry weight or protein concentration (jig x 10“^)
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Figure A2; Typical standard curve obtained from a cAMP assay
ocAMP (pmoll per assay tube
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Appendix 3 : Assay Buffers and Reagents
Cyclic AMP assay buffer
Tris 6.06
Na^ EOTA 0.149
The above ingredients were dissolved in distilled water and the 
pH was adjusted to 7.5 with HCl.
Cyclic AMP standards
Cyclic AMP was dissolved in cAMP assay buffer to give 320 pmol ml ^. 
Doubling dilutions were done in assay buffer to give a series of dilutions 
from 5 pmol ml to 320 pmol ml . These were used as standards in the 
cAMP assay.
L^h I c AMP reagent for cAMP assay
[^h] cAMP was diluted in cAMP assay buffer to give 0.5 pCi ml  ^
(specific activity 25 Ci mmol ^) and stored at - 20°C.
Cyclic AMP binding protein reagent
Binding protein, prepared from rabbit muscle, was donated by 
Dr 0. P. Durham, Dept, of Clinical Onocology, Glasgow University. 
Stock suspensions were stored in 50^ (v/v) ethylene glycol at -20°C 
Cyclic AMP binding protein buffer was prepared as follows;-
Tris 1.2 g
Ma^ EDTA 297 mg
Bovine Serum Albumin 200 mg
P-mercaptoethanol 0.278 ml
The above ingredients were made up to 200 ml with distilled water and 
the pH was adjusted to 7.5 with HCl. Sufficient binding protein was
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dissolved in buffer to bind 55^ of label in the absence of unlabelled 
c.AMP under the conditions of the cAMP assay.
Charcoal reagent
Activated Charcoal 2.5 g
Bovine Serum Albumin 250 mg
These were dissolved in 100 ml cAMP assay buffer and stored at -20°C. 
During the assay, the charcoal reagent was stirred continuously for 15 min 
before adding to the assay tubes and stirring was continued throughout 
the assay.
Buffer A (for cAMP binding activity assay)
Tris ' 242 mg
K acetate 118 mg
Dithiothreitol 115.4 mg
l\la^ EDTA 7.4 mg
These were made up to 200 ml with distilled water and the pH was adjusted 
to 8.2 with glacial acetic acid.
Triton-Toluehe scintillant
Triton X-100 1 L
Toluene 2 L
2,5-Diphenyloxazole 8 g
1,4-Di-2-(4-methyl-5 phenyl- 200 mg 
oxazolyl benzene
This scintillant was not used within 10 h of preparation.
SSX and SSC buffers
These buffers were prepared in the same way as SS-X and SS-C media 
(Appendix 1) except that ingredients 1,2 and 9 - 1 3  were ommitted.
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Barbitone buffer, pH 8.3
Barbitone sodium (8.5 g) was dissolved in 450 ml distilled water, the 
pH was adjusted to 8.3 with HCl, and the volume was made up to 500 ml 
with distilled water.
0.75% Barbitone agar, pH 8.3
lonagar was made up to 0,75% (w/v) in barbitone buffer, pH 8.3, 
and placed in a Koch-steamer for 30 min.
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Appendix 4; Calculation of Respiration Rates
The percentage decline in 0^ saturation was determined both before 
and after the addition of substrate. The former was due to respiration 
of endogenous reserves.
The endogenous respiration rate (pi 0^ min ^) was calculated 
from the formula:-
A/lOO X   ^b/c
where A is the percent 0^ consumed before addition of substrate, B is 
the volume (pi) of 0^ in saturated buffer at 35°C (approximately 17 pi) 
and C is the time (min) 0^ uptake was monitored for (usually 3 or 4 min) 
The respiration rate after the addition of substrate was calculated 
in the same way . The endogenous rate was subtracted from this to 
determine the respiration rate of the substrate.
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Appendix 5t Gels and Buffers for SDS-PAGE 
Stock solutions
1. 30% Acrylamide
Acrylamide 30 g
NN'methylenebisacrylamide 0.8 g 
This was made up to 100 ml with water and filtered through Whatman 
No. 1 filter paper.
2. Running buffer, pH 8.8
Glycine 72.06 g
Sodium dodecyl sulphate (SOS) 5.0 g 
Tris 15.14 g
This was made up to 5 L with water.
3. Staining solution
Commassie blue R250 (Sigma) 1.25 g
Methanol (50% (v/u)) 454 ml
Glacial acetic acid 46 ml
4. Destaining solution
Methanol (50% (v/v)) 100 ml
Gacial acetic acid 150 ml
Water 1750 ml
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5, Solubilizing buffer
Tris 242 mg
EDTA 58 mg
p-mercaptoethanol ' 10 ml
Glycerol , 20 ml
Bromophenol blue (0.1%(u/v)) 4.ml
SOS (20%(w/v)) 20 ml
This was made up to 100 ml with water,and the pH was adjusted to 8,0.
Preparation of gels
1. Separating gel
30% Acrylamide 27.5 ml
1 M Tris-HCl, pH 8.8 28.1 ml
SOS (20%(w/u)) 375 pi
N,N,N',l\!* ,-Tetramethyl- 19 pi
ethylenediamine (TEMED)
Ammonium persulphate (l%(w/v)) 7.5 ml
Water 11.5 ml
2. Stacking gel
30% Acrylamide 3.4 ml
0.5 n Tris-HCl, pH 5.8 5.0 ml
SOS (20% (w/v)) 100 pi
TEMED 5 ml
Ammonium persulphate (1% (w/v)) 2 ml
Water 9.5 ml
Gels were prepared in 8.0 x 8.0 x 0.3 cm glass moulds. The bottom 
6 cm consisted of separating gel whilst the remaining 2 cm consisted of 
stacking gel.
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Appendix 6; Data of HSA Tests
Table A1; The HSA results used to calculate the data presented in
Tables 11 and 27 for strain Taberman
Addition to the Deaths/challenged
medium Dose per mouse (ou,ml)
20 10 5 2.5 4 2 1 0.5
NaCl 5 / 5  4 / 5  2 / 5  1 / 5 1.05
MgSG^ 2/5 1 / 5 0 / 5 0 / 5 22.70
MgClg 5 / 5  3 / 5  1 / 5 1 / 5 1.35
Na^SO^ 1/5 1 / 5 0 / 5 0 / 5 24,72
Na lactate 5 / 5 4 / 5 2 / 5 0 / 5 6.02
Na succinate 2 / 5 1 / 5 1 / 5 0 / 5 16.12
Nicotinic acid 3 / 5 1 / 5 1 / 5 0 / 5 17.40
NaCl and bovine 
catalase
5 / 5  3 / 5  1 / 5 0 / 5 1.62
MgSO^ and bovine 
catalase
2/5 1 / 5 1 / 5 0 / 5 16.12
NaCl® 5 / 5  4 / 5  2 / 5 0 / 5 1.24
MgClg 4 / 5  3 / 5  0 / 5 0 / 5 2.20
Na lactate 5 / 5 3 / 5  1 / 5 0 / 5
Na butyrate 2 / 5 1 / 5  0 / 5 0 / 5
a, thesp results are from a second independent \ISA test. Only those for
the "Na butyrate" sample were used for Table 10 and were compared using 
the "NaCl" sample as the standardo
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Table A2; The HSA results used to calculate the data presented in
Table 11 for strain 18334
Addition to the Deaths/challenged
medium Dose per mouse (ou.ml)
HSO5 O
20 10 5 2.5 4 2 1 0.5
NaCl 5 / 5 4 / 5  2 / 5 1/5 1.03
MgSD^ 1 / 3 1/5 0 / 5 0 / 5 23.81
MgCl^ 5 / 5 3 / 5  2 / 5 0 / 5 1.41
Na^SG^ 3 / 5 0 / 5 1 / 5 0 / 5 18.49
Na butyrate 2 / 5 0 / 5 1 / 5 0 / 5 22.49
Na caprylate 1/5 1 / 5 0 / 5 0 / 5 30.11
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Table A3; The HSA results used to calculate the data presented in
Table 11 for strain 18323
Addition to 
medium
the Deaths/challenged
HSO5 0
20 10
Dose per mouse (ou,ml) 
5 2.5 4 2 1 0.5
NaCl 5 / 5 3 / 5 2 / 5 0 / 5 1.41
MgClg 5 / 5 3 / 5 2 / 5 1 / 5 1.20
Mgso^ 3 / 5 2 / 5 0 / 5 0 / 5 15.17
Na^SO^ 1 / 5 0 / 5 0 / 5 0 / 5 38.90
Na butyrate 4 / 5 0 / 5 1 / 5 0 / 5 14.57
Na caprylate 5 / 5 4 / 5 1 / 5 1 / 5 1.19
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Table A4: The HSA results used to calculate the data presented in
Figure 6
Sample
Deaths/challenged
20 10
Dose per 
5 2.5
mouse (ou.ml)
1.25 4 2 1 0.5
Inoculum 5 / 5  4 / 5  2 / 5  0 / 5 1.23
Exp. 1 4 h 5 / 5 5 / 5 2 / 5 1 / 5 2.23
8 h 5 / 5 3 / 5 1 / 5 0 / 5 8.15
20 h 3 / 5 2 / 5 0 / 5 0 / 5 15.15
Exp. 2 4 h 5 / 5 4 / 5 3 / 5 1 / 5 2.29
8 h 5 / 5 2 / 5 1 / 5 1 / 5 7.76
20 h 2 / 5 1 / 5 1 / 5 0 / 5 16.79
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Table AS : The HSA results used to calculate the data presented in
Table 17
Growth conditions 
and sampling time
Deaths/challenged
Dose per mouse (ou.ml)
20 10 5 2.5 4 2 1 0.5
HSD
50
SS-X 48 h 5/5 3 / 5 1/5 0 / 5 1.72
SS-XCAP
48 h 5/5 2 / 5 1 / 5 0 / 5 1.85
SS-C 48 h 0 / 4  1 / 5  0 / 5  0 / 5 29.12
SS-CCAP
24 h 5 / 5 2 / 5 0 / 5 0 / 5 2.18
SS-CCAP
48 h 5 / 5 1 / 5 1 / 5 1 / 5 1.72
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Table A6; The HSA results used to calculate the data presented in
Table 19
Deaths/challenged
Growth conditions
20
Dose per mouse (ou.ml) 
10 5 2.5 1.25 0.625
"SD5 0
SS-X 5 / 5 4 / 5 3 / 5  2 / 5 0.83
SS-XCAP
1/5 1 / 5 0 / 5 0 / 5 43.09
SS-C 0 / 5 1 / 5 0 / 5 0 / 5 65,95
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Table A7; The HSA results used to calculate the data presented in 
Table 21
Deaths/challenged
Sample Dose per mouse (ou.ml)
"S°5D
20 10 5 2.5 1.25 0.625
X-mode cell 
lysate
5 / 5  3 / 5 2 / 5  1 / 5 1.50
C-mode cell 
lysate
0/4 0 / 4 0 / 4  0 / 3 > 20
X/c-mode cell 
lysate mixture 5 / 5 5 / 5 3 / 5  1 / 5 0 / 5 4.03
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Table A6; The HSA results used to calculate the data presented in
Table 22
Deaths/challenged
"SO5 O
tj ample
Dose per mouse (ou.ml)
20 10 5 2o 5 1.25 0.63 4 2 1 0.5
X-mode cell 
lysate (no 
incubation)
5 / 5  4 / 5 2 / 5 1 / 5 1.1
X-mode cell 
lysate
(24 h at 35°C)
5 / 5  3 / 5 2 / 5 0 / 5 1.4
x/c-mode mixture 
sample 1
5/5 5/5 4 / 5 2 / 5  0 / 5 1.6
X/c-mode mixture 
sample 2
5/5 5 / 5 3 / 5 1 / 5  0 / 5 2.0
C-mode cell 3/s 
lysate
1/5 0 / 5 0 / 5 17.0
1 ^
